Lisbon - CongressMed

Transcrição

The 17th World Congress on
Controversies in Obstetrics,
Gynecology & Infertility (COGI)
All about Women’s Health
Lisbon, Portugal, November 8-11, 2012
Congress Program
COGI
www.congressmed.com/COGILisbon
[email protected]
17 th World Congress on Controversies in Obstetrics, Gynecology & Infertility • Lisbon, Portugal, November 8-11, 2012
Timetable
Thursday, November 8, 2012
13:00-18:30
Pre-Congress joint meeting Portuguese & Spanish Societies
18:30-20:00
OPENING SESSION – Keynote Lectures
• A summary of the R.G. Edwards most recent historical and archival research findings in IVF
• Designer steroids: How do they work and how can they be used in clinical practice?
• Human uterus transplantation: Worldwide experience
20:00-21:00
Welcome reception
Friday, November 9, 2012
Infertility & ART - Hall A
08:30-10:00
POOR RESPONSE TO OVARIAN
STIMULATION
Gynecology I- Hall B
Gynecology II- Hall C
Reproductive Surgeons
meet Reproductive
Endocrinologist
PEDIATRIC ADOLESCENT
GYNECOLOGY
Fetomaternal - Hall D
Free Communications - Hall E
GESTATIONAL DIABETES
MELLITUS (GDM)
ART/IVF
PREDICTING PREECLAMPSIA
Supported in part by an
unrestricted grant from
PerkinElmer
ART/IVF
Workshop on Prenatal
diagnosis
GYNECOLOGY
HI-TECH INNOVATIVE
SOLUTIONS FOR SEVER
PATHOLOGIES
Coffee break
10:00-10:20
10:20-11:50
PREIMPLANTATION GENETIC
SCREENING (PGS) TO
PRIORITIZE EMBRYO TRANSFER
“A STORY ALL OVER AGAIN”?
FAMILY PLANNING
NEW APPROACHES IN
GYNECOLOGICAL ENDOSCOPY
Supported by an unrestricted
grant from Karl Storz
IMPROVING OOCYTES AND
EMBRYO SELECTION
unrestricted grant from Uteron
Pharma S.A.
CONTROVERSIES IN LONGTERM FAMILY PLANNING
METHODS: THE BENEFITS,
RISKS AND CLINICAL
USEFULNESS OF DMPA
SURGICAL INTERVENTIONS
BEFORE ART
BASIC LABORATORY AND
CLINICAL ASPECTS OF ART:
CLINICAL–BIOLOGICALCONFERENCE
FREE COMMUNICATIONS GYNECOLOGY
DIAGNOSIS AND TREATMENT
OF ENDOMETRIOSIS
16:30-18:00
Workshop in IVM: IN SEARCH
FOR A CONSENSUS?
Endorsed and Organized by
ISMAAR
FREE COMMUNICATIONS GYNECOLOGY
DEEP ENDOMETRIOSIS
08:30-10:00
RISKS AND DESIRED OUTCOME
IN IVF
STRESS URINARY
INCONTINENCE
Posters viewing
11:50-12:10
12:10-13:40
Lunch break
13:40-14:30
14:30-16:00
CHALLENGES IN PRENATAL
DIAGNOSIS (I)
CHALLENGES IN PRENATAL
DIAGNOSIS (II)
GYNECOLOGY
FETAL MONITORING
GYNECOLOGY
Coffee break
16:00-16:30
Saturday, November 10, 2012
The great hormone therapy
debate: 10 years to the WHI,
the need for new solutions –
Workshop
GENITAL INFECTION,
PREGNANCY OUTCOME AND
PERINATAL RISK
FAMILY PLANNING,
GYNECOLOGY &
FETOMATERNAL MEDICINE
COUNSELING
POSTMENOPAUSAL WOMEN
Coffee break
10:00-10:20
10:20-11:50
IMPROVING RESULTS IN IVF
STANDARDS OF CARE
and MALE FACTOR INFERTILITY FOR EPITHELIAL OVARIAN
CANCER
HRT: WHERE ARE WE HEADING? PATIENT SAFETY AND
MEDICAL LIABILITY IN FMM
LUTEAL PHASE SUPPORT AND
RECURRENT ABORTIONS
unrestricted grant from IBSA
Institut Biochimique SA
HPV SCREENING : THE NEXT
STEP SINCE PAPANICOLAOU
unrestricted grant from
QIAGEN
THE ROLE OF GYNECOLOGISTS
IN THE TREATMENT OF
POSTMENOPAUSAL
OSTEOPOROSIS
The Ovarian Zone Workshop
HPV VACCINES:
INTERNATIONAL EXPERIENCE
AFTER 100M DOSES
Supported by an unrestricted
grant from GSK
HORMONE THERAPY (HT) AND
CANCER RISK
Supported and Organize jointly
with the European Menopause
and Andropause Society
(EMAS)
Posters viewing
11:50-12:10
12:10-13:40
RECONSTRUCTING THE
OVARIAN STORY (I)
TOWARDS NEW CLINICAL
SOLUTION
Workshop on Emergency
Bleeding during pregnancy
and postpartum
EMERGENCY BLEEDING IN
OBSTETRICS
Coffee break
16:00-16:30
16:30-18:00
PRETERM BIRTH and PROM
Lunch break
13:40-14:30
14:30-16:00
RECONSTRUCTING THE OVARIAN SCREENING FOR OVARIAN
STORY II: MORE HI-TECH
CANCER
MEDICAL SOLUTIONS
WOMEN’S BONE HEALTH:
SECONDARY BONE LOSS
BLEEDING DURING LATE
PREGNANCY
Sunday, November 11, 2012
Infertility & ART - Hall A
08:30-10:00
WHAT AGENTS ARE SAFEST FOR LABOR INDUCTION?
ANTI-MÜLLERIAN HORMONE (AMH)
CONTROVERSIES OVER ENDLESS CESAREAN DELIVERY AND MULTIPLE PREGNANCIES
Coffee break
10:00-10:30
10:30-12:00
Fetomaternal Medicine - Hall B
GAMETE CRYOPRESERVATION
Organized jointly with
The Portuguese Federation of
Obstetrics & Gynecology (FSPOG)
Congress Program
COGI
A comprehensive Congress fully devoted to clinical Controversies, debates and consensus
on a wide spectrum of topics in Obstetrics, Gynecology and Infertility
If oocytes could speak,
they would tell you about
the new IBSA highly
purified gonadotrophins
Evidence of life
-4-
Table of Contents
Welcome letter
7
Committees
8
Endorsements
9
Sponsors & Exhibitors
10
CME Accreditation
15
General information
17
Scientific Program
19
Free communication
41
Scientific Program Index
-5-
Committed to eliminating cervical cancer
The digene HPV Test
Proven detection is the first step!
Rely on proven detection with the digene® HPV Test,
when used with the Pap:
■■ 100% sensitivity for CIN 3+
■■ 98% sensitivity for CIN 2+
■■ Published clinical data covering almost one
million women
■■ FDA approved and CE marked
Eliminate cervical cancer — www.theHPVtest.com
Trademarks: QIAGEN®, digene® (QIAGEN Group). For up-to-date licensing information and product-specific disclaimers,
see the respective QIAGEN kit handbook or user manual (available at www.qiagen.com or from your local distributor).
-6-
Sample & Assay Technologies
Welcome letter
Dear Colleagues,
It is a great pleasure to welcome you to the 17th World Congress on Controversies in Obstetrics, Gynecology & Infertility
(COGI), November 8-11, 2012, Lisbon, Portugal.
We hope that the Congress will be a rewarding and useful experience for you, as it was in the past. We also hope that the
Congress will help you to understand and to acquire knowledge in the most controversial subject in our field.
We would like to thank each of you for attending the Congress and bringing your expertise to this gathering. You are truly our
greatest asset today and tomorrow, and we could not accomplish what we do without your interest in the Congress.
We hope that we managed to maintain the high level of discussions, that has already placed this Congress as a gathering site
for experts from various subdisciplines, and a forum where
physicians with clinical interest in several fields may find solutions that would otherwise require many monothematic
congresses.
We believe that by joining this Congress you will obtain new insight and skills that will enhance your capability as clinicians,
and we are already looking forward to welcoming you again at 2013 in Vienna, Austria.
The contribution of our sponsors with generous educational grants is very much appreciated.
Our personal respect and thanks goes out to all of you.
Sincerely,
Prof. Zion Ben-Rafael, Prof. Carlos de Oliveira, Prof. Luis Graça, Prof. Bart C.J.M. Fauser
Congress Co-Chairpersons
-7-
Committees
Chairpersons
Zion Ben Rafael
C. Freire de Oliveira
Luis Graça
Bart C.J.M. Fauser
Sections Heads
Fetomaternal Medicine
Frank A. Chervenak, USA
Nuno Montenegro, Portugal
Dan Farine, Canada
Luis Graca, Portugal
ART/IVF
Ana Teresa Almeida Santos, Portugal
Zijiang Chen, China
Daniela Couto, Portugal
Rene Frydman, France
Victor Gomel, Canada
Patrizio Pasquale, USA
Carlos Simón Vallés, Spain
HPV
F. Xavier Bosch, Spain
José Alberto Moutinho, Portugal
Urogynaecology
Lina Negrão, Portugal
Oncology
Richard Moore, USA
Daniel Pereira da Silva, Portugal
Gynecology
Menopause / Family Planning /
Endometriosis / Endoscopy
Leila Adamyan, Russia
Johannes Bitzer, Switzerland
Teresa Bombas, Portugal
Fátima Faustino, Portugal
Luigi Fedele, Italy
Andrea R. Genazzani, Italy
Fernanda Geraldes, Portugal
Ludwig Kiesel, Germany
José Martinez de Oliveira, Portugal
Fernando Mota, Portugal
Alfred O. Mueck, Germany
Santiago Palacios, Spain
David Rebelo, Portugal
Fátima Romão, Portugal
Serge Rozenberg, Belgium
Daniel S. Seidman, Israel
International Organizing Committee
Leila Adamyan, Russia
Gautam N. Allahbadia, India
Aris Antsaklis, Greece
Birgit Arabin, Germany
Audrone Arlauskiene, Lithuania
Ramon Aurell, Spain
Michel Azoulay, France
Juan Balasch, Spain
Pedro N. Barri, Spain
M.A. Bashed, Bangladesh
Rashida Begum, Bangladesh
Joëlle Belaisch-Allart, France
Stefano Bettocchi, Italy
Johannes Bitzer, Switzerland
Josef Blankstein, USA
Isaac Blickstein, Israel
F. Xavier Bosch, Spain
Philippe Bouchard, France
Mark P. Brincat, Malta
Luis Cabero, Spain
Joaquin Calaf-Alsina, Spain
Zeyi Cao, China
Rui (Manuel) Carrapato, Portugal
Chen Zijiang, China
Frank A. Chervenak, USA
Judith L. Chervenak, USA
Claudio Chillik, Argentina
Herjan J.T. Coelingh Bennink, Netherlands
Jacques Cohen, USA
Juliet E. Compston, UK
Luigi Devoto, Chille
Gian Carlo Di Renzo, Italy
Klaus Diedrich, Germany
Tao Duan, China
Günter Emons, Germany
Rubens Fadini, Italy
Dan Farine, Canada
Bart C.J.M. Fauser, Netherlands
Herve Fernandez, France
Jean-Michel Foidart, Belgium
Rene Frydman, France
Marco Gambacciani, Italy
Andrea R. Genazzani, Italy
Sandro Gerli, Italy
Victor Gomel, Canada
Anne Gompel, France
Cornelius O. Granai, USA
Eduardo Gratacós, Spain
Alessandra Graziottin, Italy
Georg Griesinger, Germany
Zion Hagay, Israel
Jacques Hamou, France
Pak Chung Ho, Hong Kong
Wolfgang Holzgreve, Switzerland
Yuanhua Huang, China
Walter Jonat, Germany
Ludwig Kiesel, Germany
Asim Kurjak, Croatia
Michèle Lachowsky, France
Qinping Liao, China
Ioannis E. Messinis, Greece
Joseph Monsonego, France
Richard Moore, USA
Carmine Nappi, Italy
Camran R. Nezhat, USA
Raoul Orvieto, Israel
-8-
Santiago Palacios, Spain
Pasquale Patrizio, USA
Marie Jose Pelinck, Netherlands
Clara Pélissier, France
Felice Petraglia, Italy
Yu Qi, China
Jie Qiao, China
Serge Rozenberg, Belgium
Eyal Schiff, Israel
Daniel S. Seidman, Israel
David Serfaty, France
Duru Shah, India
Francoise Shenfield, UK
Lee P. Shulman, USA
Igno Siebert, South Africa
Nester Siseles, Argentina
Eyal Sivan, Israel
Sven O. Skouby, Denmark
Luis H Sordia Hernandez, Mexico
Michael Stark, Germany
Charles Sultan, France
Jaydeep Tank, India
Annibale Volpe, Italy
Arnaud Wattiez, France
Lihui Wie, China
Igal Wolman, Israel
Huixia Yang, China
Hakan Yarali, Turkey
Yaron Zalel, Israel
Yangyu Zhao, China
CanQuan Zhou, China
Changping Zou, China
Endorsement
European Society
of Gynecology
World Association of Perinatal
Medicine (WAPM)
The European Menopause
and Andropause Society
(EMAS)
International Society for
Mild Approaches in Assisted
Reproduction (ISMAAR)
Previous Co-Chairpersons
2012 Singapore
Christopher Chong
Bernard Chern
Lai Fon-Min
Bart C.J.M. Fauser
2011 Hainan, China
Yuanhua Huang
Canquan Zhou
Zijiang Chen
2011 Paris, France
Bart C.J.M. Fauser
Rene Frydman
2010 Berlin, Germany
K.Diedrich
Bart C.J.M. Fauser
2009 Beijing, China
K. Shen
T. Duan
Q. Yu
2008 Paris, France
R. Frydman
2007 Shangahi, China
J.H. Lang – Honorary President
D. Duan
Q. Yu
2003 Berlin, Germany
K. Diedrich
J-W. Dudenhausen
I. Mettler
H.P.G. Schneider
2007 Barcelona, Spain
S. Dexeus – Honorary President
P.N. Barri
R. Aurell
2002 Washington DC, USA
R. Lobo
M. D’Alton
A.H. DeCherney
J. Rock
P.E. Schwartz
2005 Athens, Greece
G. Creatsas
2001 Paris, France
R. Frydman
2004 Bangkok, Thailand
C.A. Kamheang
1999 Prague, Czech Republic
J. Horejsi
P. Mardesic
P. Ventruba
2004 Las Vegas, USA
R. Lobo
R. Berkowitz
M. D’Alton
A.H. DeCherney
P.E. Schwartz
-9-
Sponsors
Gold
Silver
Exhibitors
-10-
Sponsors & Exhibitors
The Organizing Committee gratefully acknowledges
the generous support of the sponsors and exhibitors
“BEBÉ VIDA
“BEBÉ VIDA – Cells and Tissue Bank, is a Portuguese company dedicated to the cryopreservation of umbilical cord blood and tissue stem cells. With its own
laboratory located in the heart of Oporto city, has already more than 20,000 cryopreserved samples, which makes it a reference laboratory in Portugal.
BEBÉ VIDA’s excellence has been recognized by its ISO 9001:2008 Quality Certification, PME Lider status and Activity Certification awarded by the
Portuguese Ministry of Health.
Know more about us at www.bebevida.com
EFFIK Portugal
Estrada Consiglieri Pedroso123
Queluz de Baixo
2730-056 Barcarena
Portugal
Tel: +351 214 340 250
Fax: +351 214 340 251
E-mail: [email protected]
Established in Portugal since 2006, EFFIK Portugal is a subsidiary of EFFIK pharmaceutical group based in Paris with affiliates also in Spain, Italy, Switzerland
and Belgium.
Founded in 1992, Effik has the ambition to be the Gynecologist's partner in the daily practice in the search for better answers to meet Women's health
needs.
In Portugal it has a diverse portfolio including natural progesterone with Progeffik®, oral contraception with Estinette®, Effiplen® and Denille®, Infertility with
Dufine®, Felcontrol Duo® and Spermox®, obstetrics with Matervita® and Zeneleg®, infectiology with Geliofil®, and others.
Despite recent, Effik Portugal already has leading products in their market segments and a very promising portfolio to launch in the future.
FUJIFILM Europe GmbH – Sucursal em Portugal
Edifício Tower Plaza, Rotunda Eng.º Edgar Cardoso, 23-10º
4400-676 Vila Nova de Gaia – Portugal
www.fujifilm.eu/pt
Tel. +351 226 194 266 | Fax. +351 226 194 215
[email protected]
Fujifilm is a pioneer in diagnostic imaging and information systems for healthcare facilities. Our clinically proven products and technologies are constantly
evolving to help medical professionals perform more effectively and efficiently.
In the field of breast cancer diagnosis, FUJIFILM introduced the "FCR PROFECT CS," a high-definition cassette-based digital mammography system in
2003. The "PROFECT CS" has already sold over 6.000 units globally and has gained solid trust and high praise from numerous healthcare institutions
from around the world. By adding AMULET, the Full Field Digital Mammography (FFDM) system, to its lineup FUJIFILM will continue to provide the best
solutions to meet the wide-ranging needs of mammographic imaging.
Fujirebio Diagnostics AB
Elof Lindälvsgata 13, 414 58 Gothenburg, Sweden
Tel: +46 31 857030
Email: [email protected]
www.fdab.com
Fujirebio Diagnostics is a premier diagnostics company and the industry leader in the development of oncology biomarkers. Fujirebio Diagnostic’s
primary focus is the development, manufacture, and commercialization of in vitro diagnostic oncology products. Our core products include CA 125II a
biomarker considered the gold standard for ovarian cancer. The Fujirebio Diagnostics HE4 biomarker is CE-marked in Europe as an aid in estimating the
risk of EOC in premenopausal or postmenopausal women presenting with pelvic mass.
Gedeon Richter (1901)
Gyömrői út 19–21., Budapest H-1103, Hungary
Tel: +36 1 431 4000, +36 20 885 2000
Fax: +36 1 260 6650, +36 1 260 4891
Email: [email protected]
Website: www.richter.hu
The tradition of manufacturing gynaecological products dates back to the founding of Gedeon Richter (1901) and the production of the first
organotherapeutic preparations.
On the basis of valuable experience gained from manufacturing hormones, the Company is in possession of a world-class knowledge base in steroid
chemistry.
Utilizing this base the gynaecological product range of Richter has significantly expanded over the past decades and grown to include modern
contraceptives, emergency contraceptive pills, several hormonal replacement products including two hormonal patches, anti-infective agents for
gynaecological infections, and other gynaecological products, covering the needs of all age groups.
-11-
GlaxoSmithKline Vaccines
GlaxoSmithKline Vaccines, a division of GlaxoSmithKline group, is the world’s leading vaccine company and a leader in innovation. The company is
active in vaccine research, development and production with over 30 vaccines approved and 20 more in development - both in the prophylactic and
therapeutic fields. Headquartered in Belgium, GSK Vaccines has 14 manufacturing sites strategically positioned around the globe. In 2011, GSK Vaccines
distributed 1.1 billion doses to 173 countries in both the developed and the developing world.
Through its accomplished and dedicated workforce, GSK Vaccines applies its expertise to the discovery of innovative vaccines that contribute to the
health and well-being of people of all generations around the world.
GlaxoSmithKline – one of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of
human life by enabling people to do more, feel better and live longer. For further information, please visit www.gsk.com
Hologic, Inc
Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic and medical imaging systems and surgical products dedicated to
serving the healthcare needs of women. Hologic leads the industry in digital mammography systems and offers the most advanced technology for breast
imaging and intervention.
Hologic is committed to enhancing women’s lives through earlier detection, improved diagnosis and less invasive treatments. Core business units are
focused on mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for mennorrhagia,
osteoporosis assessment, preterm birth screening, and mini C-arm and extremity MRI imaging for orthopedic applications.
IBSA Institut Biochimique SA
Tel: +41 58 360 10 00
Fax: +41 58 360 16 47
Email Address: [email protected]
www.ibsa-international.com
IBSA is an international pharmaceutical company with headquarters in Lugano, Switzerland, delivering different therapeutic solutions for follicular
stimulation and luteal support. IBSA has developed an entirely new purification process for obtaining a full range of highly purified, human
gonadotrophins: hFSH (Fostimon), hMG and hCG.
This unique patented process was conceived to ensure both high purity and the respect of the structure-correlate activities of the gonadotrophins
(natural glycosylation).
The fact that IBSA manufactures its products entirely in-house ensures the same global quality system in company-owned plants, right from the raw
materials at the beginning to the final lyophilized products.
Other franchises of the company include osteoarthritis, pain-management, dermatology and thyroid diseases.
INTERSONO
INTERSONO Egg Donation Center is a part of INTERSONO Medical Centre – a leading ART clinic working since 2001 in IVF sphere.
Our benefits: more than 100 donors (screened according EU Tissues and Cells Directive) per month available; morphological survival rate for vitrification is
up to 90%; average fertilization rate is more than 70%; сlinical pregnancy rate with donor eggs is more than 60%.
Our advantages: 11 years’ experience in exporting of donor materials to European IVF clinics accurate selection and screening of donors according to EU
requirements; over 3500 sq.m fully equipped modern private medical center at the heart of Europe; highly professional English speaking doctors and
medical stuff; high quality of donor material.
IMS Health, Lda./ Take the Wind, Lda.
IMS Health, Lda.
Portugal Managing Director: Jorge Lemos
Tel. +351 214 875 900
[email protected]
www.imshealth.com
Lagoas Park, Edificio 7, 1º
2740-299 Porto Salvo, Portugal
Take the Wind, Lda.
Chief Executive Officer: Pedro Pinto
Tel. +351 239 700 322
[email protected]
www.takethewind.com
Headquarters: Instituto Pedro Nunes, Rua Pedro Nunes,
3030-199 Coimbra, Portugal
IMS Health is a leading provider of information, services and technology for the healthcare industry, covering markets in 100+ countries around the
world.
Take the Wind is a reputed company specialized on digital health communication and education. With our products, we promote personalized
knowledge and services to enlighten a balanced lifestyle.
Certified by ISO EN 9001:2008 and ISO NP EN 4457:2007
Karl Storz
KARL STORZ is a renowned manufacturer that is well established in all fields of endoscopy and can be considered as market leader in rigid endoscopy.
The still family held company was founded in 1945 in Tuttlingen, Germany, and has grown to one with a worldwide presence and 5800 employees.
KARL STORZ offers a range of both rigid and flexible endoscopes for a broad variety of applications. Today’s product range also includes fully integrated
concepts for the OR and servicing.
Merck Sharp & Dohme, MSD
MSD is a global healthcare leader working to help the world be well.
Today's MSD is a global healthcare leader working to help the world be well. MSD is a tradename of Merck & Co., Inc., with headquarters in Whitehouse
Station, N.J., U.S.A. Through our prescription medicines, vaccines, biologic therapies, and consumer care and animal health products, we work with
customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to
healthcare through far-reaching policies, programs and partnerships.
For more information, visit www.msd.com or www.msd.pt and connect with us on Twitter, Facebook and YouTube.
-12-
PerkinElmer, Inc.
Diagnostics
Ms. Tarja Ahola
Mustionkatu 6, 20750 Turku, Finland
Tel: +358-2-2678 111
Fax: +358-2-2678 332
[email protected]
www.perkinelmer.com
PerkinElmer is a global company focused on improving the health and safety of people and their environment.
Targeting health right at the start of life, the company supplies a range of instruments and serum-based or dried blood spot-based assays for 1st and 2nd
trimester aneuploidy screening.
For faster and more comprehensive prenatal diagnosis Prenatal BoBs™ is a bead-based multiplex assay designed to detect aneuploidies of chromosomes
13, 18, 21, X and Y, as well as copy number changes in 9 common microdeletion syndrome regions.
PerkinElmer has also recently launched the world’s first PlGF assay intended for 1st trimester prediction of pre-eclampsia.
Pfizer
At Pfizer, we apply science and our global resources to improve health and well‐being at every stage of life. We strive to set the standard for quality, safety
and value in the discovery, development and manufacturing of medicines for people and animals.
Our diversified global health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional
products and many of the world’s best‐known consumer products. Every day, Pfizer colleagues work across developed and emerging markets to advance
wellness, prevention, treatments and cures that challenge the most feared diseases of our time.
Consistent with our responsibility as the world’s leading Biopharmaceutical Company, we also collaborate with health care providers, governments and
local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make
a difference for all who rely on us.
QIAGEN
QIAGEN is the leading global provider of sample and assay technologies. Sample technologies are used to isolate and process DNA, RNA and proteins
from biological samples. Assay technologies are used to make these isolated biomolecules visible. QIAGEN has developed and markets more than 500
sample and assay products as well as automated solutions for such consumables. QIAGEN’s assay technologies include one of the broadest panels of
molecular diagnostic tests available worldwide. This panel includes the first FDA-approved and CE-IVD approved test for human papillomavirus (HPV), the
primary cause of cervical cancer. Further information can be found at www.qiagen.com
Siemens
The Siemens Healthcare Sector is one of the world’s largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory
diagnostics, medical information technology and hearing aids. Siemens offers its customers products and solutions for the entire range of patient care
from a single source – from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most
common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 51,000 employees worldwide
and operates around the world. In fiscal year 2011 (to September 30), the Sector posted revenue of 12.5 billion euros and profit of around 1.3 billion euros.
For further information please visit: www.siemens.com/healthcare
SPECULUM
SPECULUM S.A is a Portuguese Medical Equipment, Software and Disposables distributor. Since 1993 we’ve been keeping the philosophy of bringing
innovation to the market, becoming the number one distributor in both Gynecology and Obstetrics markets.
Due to SPECULUM clients demand, the company now supplies products to a broad diversity of medical fields on the Portuguese territory, but also
Hospitals around the world, especially due to the success of OMNIVIEW (www.omniview.eu).
SPECULUM expects a continuous growth to the upcoming years. Our goal is to successfully manage what we’ve already achieved and to keep servicing
Health Care with innovative knowledge and products.
TECNIMEDE
TECNIMEDE start operating in Portugal in 1976 and today it is one of the biggest Portuguese pharmaceutical.
TECNIMEDE has started its international implementation with the acquisition of TECNIMEDE MOROCCO, TECNIMEDE ESPAÑA and LICENCE-OUT for more
than 40 countries.
In Portugal, TECNIMEDE offers a comprehensive product portfolio with a focus in the following main areas of Obstetrics & Gynecology, Urology,
Gastroenterology, Rheumatology, Cardiology and Central Nervous System.
The activity of TECNIMEDE GROUP has his core business, on the development, promotion and sales of pharmaceutical products, with a strong positioning
in the non-generics market and with a clear orientation for the quality and technological innovation.
Uteron Pharma S.A
Uteron Pharma, headquartered in Liège (Belgium), is a development-based company dedicated to female healthcare. The company has a broad and
diversified product portfolio of innovative products in different stages of development with some products having clear blockbuster potential. Its first
product, a hormonal intra-uterine device called Levosert®, is under registration in selected countries in Europe. The product development portfolio also
includes a new generation of oral contraceptives based on natural hormones, a new generation of test that will significantly increase in-vitro fertilization
success rate and treatments for cervical dysplasia. The Company operates a GMP approved, 3000 square meters facility in Liège. This facility serves as a
production facility for Levosert® and as a production and quality control facility supporting the clinical trials and R&D activity.
-13-
Better Vision
GYN 58/02/2012/A-E
Conization with the VITOM® 25
Exoscope System
KARL STORZ GmbH & Co. KG, Mittelstraße 8, 78532 Tuttlingen/Germany, Phone: +49 (0)7461 708-0, Fax: +49 (0)7461 708-105, E-Mail: [email protected]
KARL STORZ Endoscopy America, Inc, 2151 E. Grand Avenue, El Segundo, CA 90245-5017, USA, Phone: +1 424 218-8100, Fax: +1 800 321-1304, E-Mail: [email protected]
KARL STORZ Endoscopia Latino-America, 815 N. W. 57 Av., Suite No. 480, Miami, FL 33126-2042, USA, Phone: +1 305 262-8980, Fax: +1 305 262-89 86, E-Mail: [email protected]
KARL STORZ Endoscopy Canada Ltd., 7171 Millcreek Drive, Mississauga, ON L5N 3R3, Phone: +1 905 816-4500, Fax: +1 905 858-4599, E-Mail: [email protected]
www.karlstorz.com
-14-
CME Accreditation
Serono Symposia International Foundation (www.seronosymposia.org) is accredited by the European Accreditation
Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The
EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net
Each medical specialist should claim only those credits that he/she actually spent in the educational activity. EACCME
credits are recognized by the American Medical Association towards the Physician's Recognition Award (PRA). To convert
EACCME credit to AMA PRA category 1 credit, please contact the AMA.
The CME accreditation is valid for the main congress program only.
To receive your CME credits, please complete the questionnaire online at:
www.seronosymposia.org/17th-COGI
After completing the questionnaire, you will receive your certificate directly
from Serono Symposia
The link will be open for 3 weeks starting on Saturday, November 10, 2012; 18:00
Italian Participates
In order to receive the CME credits Italian participants have to complete a PEF form. To receive the forms please contact
the registration desk.
ISO 9001 Certification:
Serono Symposia International Foundation has received the ISO 9001 Certification of Quality Management Systems. This
Quality certification requires all participants to fill in a scientific questionnaire and to evaluate the overall quality of the
event. Questionnaires will be distributed onsite during the congress.
-15-
WHY WAIT
UNTIL THE 2
© 2012 PerkinElmer, Inc. 2012. All trademarks or registered trademarks are the property of PerkinElmer, Inc. and/or its subsidiaries. 400269_01
ND
TRIMESTER?
FIRST TRIMESTER SCREENING FOR PRE-ECLAMPSIA
Pre-eclampsia screening in the first trimester has been validated, most recently
in a large prospective study involving 58,884 pregnancies1.
The maternal serum marker, PlGF* used with other markers detects >90%
of the pregnancies at risk by week 13. This means that aspirin prophylaxis - a
confirmed means to reduce and delay preterm pre-eclampsia - can be started
at the optimal time.
1.
Akolekar R, Syngelaki A, Poon, L, Wright D, Nicolaides KH. (2012) Competing Risks Model
in Early Screening for Preclampsia by Biophysical and Biochemical markers, Fetal Diagn Ther
doi:10.1159/000341264. Published online: August 16th, 2012
* PlGF products are not available in the USA and may not be available
in Canada, Latin-America and some Asian countries
www.perkinelmer.com/pre-eclampsia
-16-
Please visit the PerkinElmer booth
- Booth 2 - to learn more about
this important new study and its
implications.
General Information
Congress Venue
Lisboa Congress Center (LCC)
Praça das Indústrias
1300-307 Lisbon
Portugal
Tel: +351 (21) 360 1400
Fax: +351 (21) 360 1499
www.lisboacc.pt
Language
English is the official language of the Congress
Registration Desk
The registration desk at the Lisboa Congress Center will operate during the following hours:
Thursday, November 8
12:00-20:00
Friday, November 9
07:30-18:00
Saturday, November 10
08:00-18:00
Sunday, November 11
08:00-12:30
Congress Kit and Nametag
The congress kit you have received contains your nametag. Please wear your nametag to all sessions and events.
Certificate of Attendance
Your Certificate of Attendance was attached to your nametag. For any change please contact the registration desk.
Refreshments
Welcome Reception on Thursday, November 8 at 20:00 will be held at the exhibition area.
Coffee will be served in the exhibition area during the coffee breaks.
Lunch will be available for participants of the Congress on Friday, November 9 and Saturday, November 10.
Entrance will be with nametags only.
Exhibition Opening Hours
Thursday, November 8
Friday, November 9
Sunday, November 11
18:30-21:00
08:30-18:00
08:30-18:00
08:30-12:00
Speakers’ Preview Room
Invited Speakers are invited to visit the Speakers’ Preview Room to upload their presentations at the following times:
Thursday November 8
13:00 to 19:00
Friday, November 9
07:30 to 18:00
07:30 to 18:00
Sunday, November 11
07:30 to 10:30
E-Posters
Posters can be viewed at any time during the Congress on the screens at the e-posters area.
The dedicated e-posters viewing times are on Friday, November 9 and Saturday November 10 from 11:50-12:10.
Poster Presenters should plan to be at the e-posters area during these times and during coffee breaks.
If you have paid registration fee and did not receive an uploading password, please approach our team at the registration desk for assistance.
Safety and Security
Please do not leave any bags or suitcases unattended at any time, whether inside or outside session halls.
Liability
The Congress Secretariat and Organizers cannot accept liability for personal accidents or loss or damage to private property of participants either
during or directly arising from The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Participants should make their own
arrangements with respect to health and travel insurance.
-17-
WOME
PORQUE TODAS
AS MULHERES
SÃO ÚNICAS
Laboratórios Pfizer, Lda.
Lagoas Park, Edifício 10. 2740-271 Porto Salvo – Portugal
Contribuinte Nº 500 162 166
-18-
1OTHE1209003
CONCRETIZAMOS
DIFERENTES SOLUÇÕES
N
HEALTH
Scientific Program
COGI
-19-
THURSDAY, NOVEMBER 8, 2012
PRE-CONGRESS JOINT MEETING HELD IN PORTUGUESE AND SPANISH
By:
The Portuguese Federation of Obstetrics & Gynecology (FSPOG)
President: Prof. Carlos de Oliveira
The Spanish Society of Gynecology and Obstetrics (SEGO)
President: Prof. Josep Mª Lailla Vicens
15:30-16:30
PERINATOLOGY
Organized and endorsed by the Portuguese Federation of Obstetrics & Gynecology (FSPOG), Portugal
Debate: Glucorticoids for fetal lung maturity should be given to pregnant women after 34 weeks gestation?
No: S. Santo, Portugal
Yes: A.I. Machado, Portugal
16:30-16:45
Break
16:45-18:15
CONTROVERSIES IN GYNECOLOGICAL ONCOLOGY SURGERY
Organized and endorsed by the Spanish Society of Obstetrics & Gynecology (SEGO)
Delayed child bearing created the need to deviate from the standard treatment of radical hysterectomy, and to offer more conservative
management for cervical cancer. As in the case of breast cancer, reduction of radical surgery will not compromise the results, and will
provide an authentic alternative for women who wish to conserve their fertility
Capsule
Moderators
16:45-17:30
Capsule
17:30-18:15
J. Ponce, Spain
J. Xercavins, Spain
D. Pereira da Silva, Portugal
Debate: cervical cancer: Conservative or radical treatment?
Yes: Radical trachelectomy can offer similar results to those of radical hysterectomy with partial conservation of fertility
J.C. Muruzabal, Spain
No: Radical surgery can offer better survival and should remain the procedure of choice
E.G. Bosquet, Spain
Discussion
What are the advantages, if any, for robotic surgery in ovarian cancer?
Debate: Robotic-Laparoscopic surgery for ovarian cancer
Pros: M. Assumpció Pérez Benavente, Spain
Cons: Á. Sanchez del Rio, Spain
Discussion
-20-
18:30-20:00
Chairpersons
Presenter
OPENING SESSION
Z. Ben Rafael, Israel
C. de Oliveira, Portugal
R. Frydman, France
Nobel Prize Laureate-Robert G. Edwards: First annual lecture
J. Cohen, USA
18:30-19:00
A summary of R.G. Edwards’ most recent historical and archival research findings in IVF from the late 1950s to the birth of
Louise Brown in 1978 and its aftermath
M.H. Johnson, UK
Professor of Reproductive Sciences, University of Cambridge
19:00-19:30
Designer steroids: How do they work and how can they be used in clinical practice?
P. Bouchard, France
Professor of Medicine and the Head of Endocrinology, Hôpital St. Antoine, Paris
19:30-20:00
Human uterus transplantation: Worldwide experience
M. Brännström, Sweden
Professor and Chairman, Sahlgrenska Academy, University of Gothenburg
20:00-21:00
WELCOME RECEPTION COCKTAIL
-21-
FRIDAY, NOVEMBER 9, 2012
INFERTILITY & ART
HALL A
08:30-10:00
Capsule
POOR RESPONSE TO OVARIAN STIMULATION
Age-related poor response to stimulation remains a frustrating and easily diagnosed condition. The problem does not lie in the absence of
diagnostic criteria or prediction methods, but rather, in the absence of real effective methods for modification of ovarian response. What
are the options that can be offered to these patients?
Chairpersons
R. Frydman, France
G. Nargund, UK
A. Ellenbogen, Israel
08:30-08:50
Can the addition of androgens affect the results of treatment with diminished ovarian reserve (DOR)?
N. Gleicher, USA
08:50-09:10
Does growth hormone have any value in the stimulation of poor ovarian responders?
R. Frydman, France
09:10-09:30
What can be learned from meta-analysis of randomized trials for the treatment of poor ovarian response?
N. Macklon, UK
09:30-09:50
Modified natural-cycle in IVF should be the first approach in young poor responders
G. Nargund, UK
09:50-10:00
Discussion
Can we agree on an algorithm for treatment?
10:00-10:20
Coffee break
10:20-11:50
Capsule
PREIMPLANTATION GENETIC SCREENING (PGS) TO PRIORITIZE EMBRYO TRANSFER: “A STORY ALL OVER AGAIN”?
PGS has now evolved into "new PGS" involving an array of techniques (CGH and SNP) and trophectoderm biopsy. Is "new PGS” associated
with better IVF outcomes than "old PGS"? Or does the damage to embryos during the biopsy explain why a "New” or “Old” PGS has not
provided the anticipated benefits? The question is whether we should continue to refine the technique or declare that PGS for the detection
of aneuploidyis is a risky procedure that should be avoided
Chairperson
B.C.J.M. Fauser, Netherlands
10:20-11:05
Debate: PGS to improve IVF outcome?
Proposition: New PGS can serve as a routine tool for improvement of IVF results
S. Fishel, UK
Opposition: Embryonic biopsy is associated with decreased implantation which should be offset by the results to make it a viable option
N. Gleicher, USA
Discussion
11:05-11:50
Debate: Is the case for accurate diagnosis of embryo ploidy using current technologies now proven?
Yes: S. Fishel, UK
No, but…: J. Cohen, USA
Discussion
11:50-12:10
Posters viewing
12:10-13:40
IMPROVING OOCYTES AND EMBRYO SELECTION
Supported in part by an unrestricted grant from Uteron Pharma S.A.
Some apparently simple questions remain controversial. New technologies, such as the time-lapse system tevaluate embryonic
quality and new sensitive assay to assess oocytes quality, may prove to be important in improving pregnancy rate . With a better
selection of embryos offered, should we limit to a single embryo? Should we strive for state regulation, or leave it to the physician’s
and the patient’s discretion?
Capsule
Chairpersons
S. Fishel, UK
S.M. Nelson, UK
12:10-12:40
Follicular Fluid G-CSF: A marker for the assessment of the oocyte quality
N. Lédée, France
12:40-13:10
Selection of the best embryo
S. Fishel, UK
-22-
13:10-13:40
The UK's HFEA “one embryo transfer” and “multiple birth strategy” have unnecessarily compromised patients’ rights
S. Daya, Canada
13:40-14:30
Lunch break
14:30-16:00
BASIC LABORATORY AND CLINICAL ASPECTS OF ART: CLINICAL–BIOLOGICAL–CONFERENCE
Chairpersons
S. Fishel, UK
Expert opinions and audience interaction on what clinicians and biologists should know about each other’s work
Panelists
N. Macklon, UK
N. Gleicher, USA
J. Cohen, USA
S. Lindenberg, Denmark
Questions to the panel:
Laboratory aspects
1. Single vs. multiple embryo culture?
2. Media, single, sequential, new trends
3. How to avoid mistakes in an IVF laboratory?
4. Selecting the best embryos: Genomics, proteomics, markers and time lapse; where have all the promises gone?
Clinical aspects
1. Is less expensive IVF less effective?
2. Should we use extensive tests of ovarian reserve or just have a "trial of stimulation"?
3. OC's, before GH & androgen during COH: Any role?
4. COS, Estradiol, aspirin in the luteal phase?
16:00-16:30
Coffee break
16:30-18:00
Workshop in IVM: IN SEARCH OF A CONSENSUS?
Endorsed and Organized by by the International Society for Mild Approaches in Assisted Reproduction (ISMAAR)
IVM was developed with the goal of going through IVF without the need for stimulation and the risk of hyperstimulation syndrome. IVM
useful in PCOS patients who are very sensitive to stimulation, provided that in RCT it proves to be more advantageous than may be
different forms of milder stimulation. IVM also provides the obvious advantages of immediate aspiration, maturation and fertilization or
freezing of eggs without stimulation before chemo- or radiotherapy. However, although it is an effective procedure, with results
comparable to IVF, its long-term risks are still unknown. The question is: What advantages do IVM provide to all other patients?
Capsule
Chairpersons
R. Frydman, France
P. Patrizio, USA
G. Nargund, UK
16:30-16:45
Definition and Terminology
16:45-17:30
Debate: What advantages does IVM offer to non-PCO patients?
Proposition: IVM offers an advantage to IVF patients
Opposition: IVM does not offer any advantages over current IVF practice and the associated risks are unknown
N. Macklon, UK
Discussion
Discussants
S. Fishel, UK
P. Patrizio, USA
N. Macklon, UK
17:30-17:40
Tricks of the trade; expert panel on:
1. Prerequisites to increasing the success rate bar in IVM
2. Lower dose for stimulation, GnRH-a to trigger ovulation, SET, IVM: Do we need another strategy to prevent OHSS?
3. Luteal phase support: Is IVM different from IVF?
17:40-18:00
Clinical outcomes and follow-up of children born
R-C. Chian, China
-23-
GYNECOLOGY I: Pediatric, Family planning
HALL B
08:30–10:00
Capsule
PEDIATRIC ADOLESCENT GYNECOLOGY
It is common to trace the origin of some of the endocrinopathies and adult gynecological symptoms to the adolescent years
Chairpersons
C. Sultan, France
S. Skouby, Denmark
08:30-09:00
Diagnosis of adolescent hyperandrogenism
C. Sultan, France
09:00-09:30
Adolescent dysmenorrhea
J. Bitzer, Switzerland
09:30-10:00
Management of early puberty
C. Sultan, France
10:00–10:20
Coffee Break
10:20-11:50
Capsule
FAMILY PLANNING
The WHO have published the Medical Eligibility Criteria (MEC) for Contraceptive Use, which provides global guidance on the safety and use
in special conditions for those who are developing family planning guidance at the country level
Chairpersons
T.A. Bombas, Portugal
10:20-10:40
WHO - MEC for contraceptive use: Main topics for practical use
A.O. Mueck, Germany
10:40-11:05
Androgen enrichment of oral contraceptives: Can it live up to the promise?
H.J.T. Coelingh Bennink, Netherlands
11:05-11:25
The right contraceptive for the right woman: A holistic challenge
11:25-11:50
Post abortion contraception: A window of opportunity?
Objectives
To acquire knowledge regarding the following:
• To understand what MEC is
• The place of androgen addition to the OC
• Tailoring contraception, not just prescribing
11:50–12:10
Posters viewing
12:10-13:40
Capsule
CONTROVERSIES IN LONG-TERM FAMILY PLANNING METHODS: THE BENEFITS, RISKS AND CLINICAL USEFULNESS OF DMPA
The well-established bone density (BMD) effects of DMPA – and the potential for an increased risk of bone fractures with long-term use –
have led to significant controversy. Since 2005, the FDA has suggestedlimiting use to 2 years in order to avoid this potential risk.
However, the recent Quebec consensus, recognizing the very high contraceptive efficacy of DMPA, concluded that the patient’s risk for
unintended pregnancy should also be considered in determining length of use. DMPA has been used for more than three decades
as a long-term reversible method of contraception. It is often prescribed to women at particularly high risk for unintended pregnancy
or who have medical contraindications to a combined oral contraceptive pill - creating the need to critically assess the overall benefits and
risks of DMPA. The discussion will include recent clinical data regarding the reversibility of the BMD effect, and new data on the risk for
fractures before and after DMPA use began. The potential advantages and disadvantages of a new SC-DMPA will also be addressed
Chairpersons/Discussants
Z. Harel, USA
S. Skouby, Denmark
K. Wolter, USA
-24-
12:10-13:10
Debate: Does the new subcutaneous DMPA offer a useful alternative for women seeking a highly effective contraceptive?
Yes: SC-DMPA is effective, tolerable, safe and important, particularly in populations of women with medical conditions and
irregular lifestyles
Z. Harel, USA / S. Skouby, Denmark
No: There is a plethora of safer choices!
S. Skouby, Denmark / Z. Harel, USA
Discussion
13:10-13:40
Tricks of the trade; Expert opinions on the following issues:
1. Should supplements of calcium and vitamin D be offered routinely to all patients using DMPA?
2. Do women using DMPA need to undergo bone density scans?
3. In what circumstances can DMPA be offered to teenagers?
4. Should DMPA be used in women with known metabolic bone disease?
Objectives
• Bone loss effect of DMPA and its relationship to fracture risk
• The clinical role for DMPA among competing methods for long term contraception, based on a comprehensive discussion of benefits
and risks
13:40-14:30
Lunch break
14:30–16:00
Free Communications see page 43
16:00–16:30
Coffee break
16:30-18:00
Free Communications see page 43
GYNECOLOGY II
HALL C
REPRODUCTIVE SURGEONS MEET REPRODUCTIVE ENDOCRINOLOGIST
08:30-10:00
Capsules
HI-TECH INNOVATIVE SOLUTIONS FOR SEVER PATHOLOGIES
Failure of implantation is mostly due to embryonic defects, however, when the problem is entrenched in the uterus or endometrium it is
often helpless. Is there any new hope for the present or the future?
Chairpersons
M. Brännström, Sweden
S. Daya, Canada
08:30-09:00
Endometrial regeneration
J. Santamaría Costa / C. Simon, Spain
09:00-09:30
MicroRNA in embryo endometrial integration. A new perspective
09:30-10:00
Uterine transplantation in non-human primates: What are the implications for humans?
L. Johannesson, Sweden
10:00-10:20
Coffee break
10:20-11:50
NEW APPROACHES IN GYNECOLOGICAL ENDOSCOPY
Supported by an unrestricted grant from Karl Storz GMBH & Co. KG
New technical developments promise to diversify capabilities while minimizing risks and side effects
Capsule
Chairpersons
V. Gomel, Canada
F. Ghezzi, Italy
10:20-10:50
Surgical specimen retrieval: New approaches
S. Uccella, Italy
10:50-11:20
Bipolar and monopolar resection in intrauterine surgery
J. Hucke, Germany
11:20-11:50
Possibilities of minilaparoscopy in gynecology
F. Ghezzi, Italy
11:50-12:10
Posters viewing
-25-
12:10-13:40
Capsule
SURGICAL INTERVENTIONS BEFORE ART
The search for the etiology of repeated implantation failure often leads to more "surgical solutions" for various problems which seem to
be associated with infertility, but without true evidence that they are the cause thereof. In most cases, it is hard to identify the supporting
level 1 evidence in the literature, be it more diagnostic hysteroscopy offered after failures, septum separation, salpingectomies,
endometrioma operations, myomectomies, etc. When should we operate and when not? Can we base our decision entirely on evidence?
Chairpersons
K. Diedrich, Germany
V. Gomel, Canada
12:10-12:40
What do and don’t we know about the need for myomectomy before IVF?
12:40-13:10
Endometrioma: Why is it so poorly managed and when should we operate before IVF?
R. Frydman, France
13:10-13:40
Uterine septum: Should we operate on all patients or only following pregnancy failures?
V. Gomel, Canada
13:40-14:30
Lunch break
14:30-16:00
Capsule
DIAGNOSIS AND TREATMENT OF ENDOMETRIOSIS
No simple methods are available for the diagnosis of endometriosis. Poor correlation between symptoms, visible implants and treatment
creates a constant need for more research and refinement of our methods of diagnosis and therapy. What promise does the new treatment
bring to the patients?
Chairpersons
R. Aurell, Spain
S. Daya, Canada
14:30-15:00
What are the limitations of current diagnostic methods?
L. Kiesel, Germany
15:00-15:30
Should we operate on endometriosis before infertility treatments?
S. Daya, Canada
15:30-16:00
New medical treatment of endometriosis
M. Brincat, Malta
Objectives
Upon completion of this session, the audience will have learned:
• Shortcomings of current diagnostic methods
• Why we need newer diagnostic tools
• Special attention required to treat endometrioma
• When not to operate before endometriosis
• New medical treatments
16:00-16:30
Coffee break
16:30-18:00
Capsule
DEEP ENDOMETRIOSIS
Deep endometriosis deserves special attention and thorough understanding. However, no agreement exists on the optimal diagnosis
and management of special types of endometriosis
Chairpersons
L. Kiesel, Germany
V. Gomel, Canada
16:30-17:30
Debate: Diagnosing deep endometriosis: Should we be satisfied with current methods?
Proposition: Imaging is the best method for diagnosis of deep endometriosis
M. Brincat, Malta
Opposition: Biomarkers are the future for diagnosis of endometriosis
L. Kiesel, Germany
Discussion
17:30-18:00
New surgical technique for deep endometriosis
S. Uccella, Italy
Objectives
• Definition and pathophysiology of deep endometriosis
• The advantages and shortcomings of 'noninvasive' diagnostic methods
-26-
FETOMATERNAL
HALL D
08:30-10:00
Capsule
GESTATIONAL DIABETES MELLITUS (GDM)
The association of milder forms of GDM with perinatal morbidity and mortality remains unclear, primarily because the condition is often
confounded with other risk factors such as maternal obesity, age, and parity, which increase risks of adverse pregnancy outcomes.
Implementation of the HAPO results increased the number of patients labeled to have GDM from 4% to 16%. While many would
welcome the doubling of their patient load, the question is: Will increased expenditure improve the outcome?
Chairpersons
D. Farine, Canada
N. Clode, Portugal
08:30-09:15
Debate: Proposition: HAPO increases the number of patients labeled as GDM, but this does not improve the pregnancy outcome
G.H.A. Visser, Netherlands
Opposition: Implementation of the HAPO study recommendations will increase the safety of pregnancy follow-up
R.S. Lindsay, UK
Discussion
Discussants
R.S. Lindsay, UK
09:15-09:35
1. Should women with obesity and DM try to lose weight while pregnant?
2. Long term effects of GDM on neonates
3. Fetal origin of maternal diseases
4. Can we prevent delivery complications of the macrosomic fetus?
09:35-10:00
Fetal liver length to predict macrosomia
J. Murlewska, Poland
Objectives
To acquire knowledge on the following:
• The disadvantages of HAPO study implementation
• Long term effects and complications of GDM
• Risks of obesity in GDM
10:00-10:20
Coffee break
10:20-11:50
PREDICTING PREECLAMPSIA
Supported in part by an unrestricted grant from PerkinElmer
Hypertensive disorders are associated with underlying placental and maternal changes, and are associated with endothelial dysfunction
and vasospasm, leading to placental insufficiency and serious consequences to the mother and infant. A major development was
achieved in recent years in identifying various markers and tools for predicting the disorders. However, since the exact pathophysiological
mechanism leading to this condition is still poorly understood, it is difficult to devise a prevention plan. Hence, the question is: What is the
medical benefit for prediction? Should we keep investing in prediction in the absence of an ultimate preventive treatment?
Capsule
Chairpersons
J. Correia, Portugal
10:20-10:50
Pre-eclampsia: A spectrum disorder
J. Cruz, Portugal
10:50-11:20
1st trimester screening for early-onset pre-eclampsia
L. Poon, UK
11:20-11:50
Aspirin treatment staring before 16 weeks
E. Bujold, Canada
11:50-12:10
Posters viewing
-27-
WORKSHOP ON PRENATAL DIAGNOSIS
12:10-13:40
Capsule
CHALLENGES IN PRENATAL DIAGNOSIS (I)
Fetal anomalies are diagnosed ever earlier, and with better precision. What are the limits?
Chairpersons
D. Farine, Canada
A. Antsaklis, Greece
A. Matias, Portugal
12:10-12:40
Implications of increased NT
M. Bronshtein, Israel
12:40-13:10
Screening for aneuploidies: New FMF algorithm
L. Poon, UK
13:10-13:40
Prenatal care: The small but important difference between folate and folic acid
K. Pietrzik, Germany
13:40-14:30
Lunch break
14:30-16:00
Capsule
CHALLENGES IN PRENATAL DIAGNOSIS (II)
Fetal anomalies are diagnosed ever earlier, and with better precision. What are the limits?
Chairpersons
B. Arabin, Germany
I. Blickstein, Israel
14:30-15:00
9 out of 10 Down’s Syndrome cases can be identified by early scan-experience based on 72,000 cases
15:00-15:30
Thesignificance of the ductus venosus
A. Matias, Portugal
15:30-16:00
Early diagnosis of cardiac anomalies
Objective
To acquire knowledge on morphological US signs for Down’s Syndrome, and cardiac diseases
16:00-16:30
Coffee break
16:30-18:00
Capsule
FETAL MONITORING
The decade's long debate has never been solved: Which is the ideal fetal monitoring?
Chairpersons
A. Grunebaum, USA
M. Kacerovsky, Czech Republic
D. Ayres-de-Campos, Portugal
16:30-17:00
FHR vs. auscultation as the primary mode
D. Farine, Canada
17:00-17:30
Advances in CTG
17:30-18:00
Should we replace our conventional FHR monitors by STAN?
Objective
To acquire knowledge on advantages and disadvantageous of fetal monitoring modes
-28-
SATURDAY, NOVEMBER 10, 2012
INFERTILITY & ART
HALL A
08:30-10:00
Capsule
RISKS AND DESIRED OUTCOME IN IVF
Even though the risks involved in ART are not very high, we should remain vigilant. What are the risks of using damaged sperm? What is
the desired outcome of ART treatment and what kind of risks and long-term health implications are there for children born after ART?
Chairpersons
N. Macklon, UK
Z. Chen, China
08:30-08:50
Sperm DNA damage and sperm infection: Can they affect the miscarriage rate?
N. Garrido Puchalt, Spain
08:50-09:15
The effect of IVF culture medium on epigenetic profile alteration of the gametes and zygotes
T. Makino, Japan
09:15-09:35
Effect of stimulation on children’s health in ART
09:35-10:00
The future of IVF: A prognosis based on Moore’s Law
J. Cohen, USA
10:00-10:20
Coffee break
10:20-11:50
Capsule
IMPROVING RESULTS IN IVF and MALE FACTOR INFERTILITY
For some time, it appeared that ICSI had put to rest most of the male infertility evaluation processes and treatments. Nonetheless, the jury
is still out on this issue. Can evaluation and treatment of male infertility before IVF ensure a better destiny for future generations? Does
IMSI (intracytoplasmic morphologically selected sperm injection) improve IVF results and outcomes beyond ICSI, thus making the extra
investment cost-effective in cases of poor sperm quality?
Chairpersons
R. Frydman, France
K. Dietrich, Germany
10:20-10:45
IMSI vs. ICSI: Advantages and pitfalls
J. Cohen, USA
10:45-11:30
Debate: Do we need to diagnose and treat male factor, or simply use the sperm for ICSI?
Treat the sperm
J. Cohen, USA
Treat the husband to prevent effects on future generations
R. Levy, France
Discussion
11:30-11:50
Rescue ICSI within six hours after insemination to improve the outcome of IVF
Z. Chen, China
11:50-12:10
Posters viewing
12:10-13:40
LUTEAL PHASE SUPPORT AND RECURRENT ABORTIONS
Supported in part by an unrestricted grant from IBSA Institut Biochimique SA
Luteal phase support remains a very creative but controversial practice. While there is little doubt of the need to support the luteal phase
with progestogens in IVF treatments, the questions remain with what, when to start, and when to end? The role of progestogens in
recurrent abortions is even more complex and is based on expert opinion rather than on level one proof
Capsule
Chairpersons
Z. Ben-Rafael, Israel
J. Garcia Velasco, Spain
12:10-12:40
Luteal support with progesterone for infertility: Do we need anything else?
S. Daya, Canada
12:40-13:10
Thrombophilia and autoimmune disease in implantation failure
J. Garcia Velasco, Spain
13:10-13:40
Recurrent miscarriage: The role of progesterone from the perinatologist's point of view
G.C. Di Renzo, Italy
13:40-14:30
Lunch break
-29-
THE OVARIAN ZONE WORKSHOP
14:30-16:00
Capsule
RECONSTRUCTING THE OVARIAN STORY (I): TOWARDS NEW CLINICAL SOLUTIONS
There is a need for more breakthroughs to overcome certain forms of infertility that current ART technologies cannot resolve.
The story of the ovary is being told all over again; sensational findings are on the horizon which might widen the treatment options
and revolutionize daily practice.
Join us as the "renaissance" of the ovarian physiology is being unfolded by eminent researchers with cutting edge science
Chairpersons
R. Frydman, France
14:30-15:00
How to make dormant ovarian follicles grow
A. Hsueh, USA
15:00-15:30
Engineering new follicles from ovarian stem cells
J. Tilly, USA
15:30-16:00
Reprogramming as a new approach to obtain patient-specific stem cells
R. Vassena, Spain
16:00-16:30
Coffee break
16:30-18:00
RECONSTRUCTING THE OVARIAN STORY (II): MORE HI-TECH MEDICAL SOLUTIONS
Chairpersons
R. Frydman, France
J. Tilly, USA
16:30-17:00
Autologous mitochondria to rejuvenate aging oocytes: Potential new treatment?
S. Chappel, USA
17:00-17:30
Human embryonic stem cells: are they ready for our patients?
R. Vassena, Spain
17:30-18:00
Where are we in understanding how stem cells can serve as a source of gametes?
J. Santamaría Costa / C. Simon, Spain
-30-
GYNECOLOGY I: Pediatric, Family planning
HALL B
08:30-10:00
Capsule
STRESS URINARY INCONTINENCE
Urinary incontinence is a common and potentially debilitating problem. Hundreds of surgical procedures have been described and they
continue to evolve to improve efficacy, safety, cost-effectiveness, and to minimize invasiveness and recurrences. The key to an optimal
therapeutic outcome is an accurate diagnosis and tailoring the appropriate intervention that is acceptable to the patient. Are any of the
newest procedures emerging as the best?
Chairpersons
T. Mascarenhas, Portugal
A. Lourenco, Portugal
08:30-09:30
Debate: Should we do any operation other than TVT? Are colposuspensions obsolete?
Proposition: TVT has revolutionized the field and provides better results than any colposuspension, with fewer complications
Opposition: Colposuspension operations are worth performing in selected cases
M. Neuman, Israel
Discussion
Discussants
M. Neuman, Israel
T. Mascarenhas, Portugal
09:30-10:00
Tricks of the trade; Expert opinions on overactive bladder (OAB):
1. How to diagnose an overactive bladder
2. Overactive bladder: What treatment options?
3. Drug action in OAB
4. What to do with mixed incontinence?
Objectives
• Conservative and non-mesh anti-incontinence operations: Options and outcome
• TVT milestones and principles
• Evidence based: Cure vs. complications of TVT
• Pathophysiology and DD of overactive bladder
• Drug action and pharmacokinetics in OAB; neuromodulation
10:00-10:20
Coffee break
10:20-11:50
Capsule
STANDARDS OF CARE FOR EPITHELIAL OVARIAN CANCER
Adjuvant chemotherapy is a mainstay of ovarian cancer treatment. Recent data suggest that intraperitoneal or neoadjuvant (primary)
chemotherapy might be superior to standard IV chemotherapy following cytoreductive surgery
Chairpersons
C. Freire de Oliveira, Portugal
P. Benedetti Panici, Italy
10:20-11:20
Debate: What should be the first choice for epithelial ovarian cancer?
Intraperitoneal chemotherapy
TBA
Intravenous chemotherapy
P. Benedetti Panici , Italy
Discussion
11:20-11:50
Is ovarian cancer a tubal disease?
V. Gomel, Canada
Objectives
• Is intraperitoneal chemotherapy for ovarian cancer better than IV application? If so, in which patients?
• Is neoadjuvant (primary) chemotherapy followed by interval cytoreductive surgery better than surgery followed by chemotherapy?
If so, in which patient group?
-31-
12:10-13:40
HPV SCREENING: THE NEXT STEP SINCE PAPANICOLAOU
Supported in part by an unrestricted grant from QIAGEN
Chairperson & Discussion Moderator
X. Bosch, Spain
Discussants
M. Poljak, Slovenia
J. Paavonen, Finland
J.A. Fonseca Moutinho, Portugal
1. The potential gain in using HPV as the first line test instead of cytology
2. The need for a triage test of HPV+ women: The role of cytology
3. Screening of vaccinated cohorts
4. The logistics of the change
5. Type specific testing vs. cocktail testing
6. mRNA technology: What is to be gained
13:40-14:30
Lunch break
14:30–16:00
HPV VACCINES: INTERNATIONAL EXPERIENCE AFTER 100M DOSES
Supported by an unrestricted grant from GlaxoSmithKline Biologicals
Chairperson & Discussion Moderator
X. Bosch, Spain
Discussants
J. Paavonen, Finland
J.A. Fonseca Moutinho, Portugal
M. Poljak, Slovenia
1. Vaccine introduction worldwide. School based programs
2. What is the appropriate age range for HPV vaccination?
3. Are HPV vaccines efficacious in population based programs?
4. Are HPV vaccines safe?
5. Do we have to consider vaccinating boys?
6. Are HPV vaccines therapeutic?
7. Are there contraindications for vaccination?
8. Any suggestions that they might be a viral type-replacement?
16:00-16:30
Coffee break
16:30-18:00
Capsule
SCREENING FOR OVARIAN CANCER
Can survival for epithelial ovarian cancer be improved through early detection and triage?
Chairpersons
C. Freire de Oliveira, Portugal
F. Mota, Portugal
16:30-17:00
Ovarian cancer screening in the general population: The use of biomarkers and imaging
A. Rosenthal, UK
17:00-17:30
Sentinel lymph node dissection in gynecological malignancies: “To do or not to do"
P. Benedetti Panici, Italy
17:30-18:00
Ovarian cancer screening in BRCA and familial ovarian cancer patients
A. Rosenthal, UK
Objectives
• Screening strategies for ovarian cancer
• Screening strategies for women at high risk for ovarian cancer
-32-
GYNECOLOGY II
HALL C
THE GREAT HORMONE THERAPY DEBATE: “10 YEARS TO THE WHI; THE NEED FOR NEW SOLUTIONS”
Workshop
Introduction:
Following the unprecedented panic of the WHI publication and the massive drop in HRT use, some claimed that the WHI “did more
harm than good” calling for independent review WHI’s publications. WHI researchers admitted that “overgeneralizing the results
from the women who were about 12 years past of menopause to all postmenopausal women led to needless suffering and lost
opportunities”. Accumulation of new information leads to new confusion amongst physicians, patients and industry, but also some
conclusions are emerging.
Which way to go from here? Should we drop this effective meansof HT altogether? Or should we go back to prescribing HT to
climacteric-symptomatic patients? Should we search for alternatives, or just combine SERM’s and HT to enjoy the best of both worlds?
The great debate will bring together world leaders in the field to sort out the answers to the most pressing issues of the day
08:30–10:00
Capsule
COUNSELING POSTMENOPAUSAL WOMEN
With the massive drop in HT usage, the questions are how to counsel and treat menopausal symptoms and can we combine the best of
SERMs with HT?
Chairpersons
A. Martins, Portugal
M. Brincat, Malta
08:30-09:00
Keeping quality of life and staying healthy
M. Neves-e-Castro, Portugal
09:00-09:30
Treating the climacteric symptoms, risks and alternatives
M. Brincat, Malta
09:30-10:00
PMDD, bipolar depression and estrogen therapy: A tragic confusion
J. Studd, UK
10:00–10:20
Coffee break
10:20-11:50
Capsule
HRT: WHERE ARE WE HEADING?
A key criticism of WHI is the age of the population selected, which is well above the critical age window where HRT is still (if at all) expected
to prevent cardiovascular disease (CVD). The questions of whether all (“class effect”) or only certain types of progesterone are to be
blamed and whether estrogens are really carcinogenic constitute another controversial aspect of this discussion
Chairpersons
S. Palacios, Spain
J. Studd, UK
10:20-10:40
The WHO defines estrogens as “carcinogenic”: Is this true?
A.O. Mueck, Germany
10:40-11:25
Debate: Is there evidence for a critical HRT window to prevent disease?
Proposition: HRT should be started early to have an effect
R. Langer, USA
Opposition: 10 years following the WHI report: No evidence exists for the “critical window” theory
S. Skouby, Denmark
Discussion
11:25-11:50
Where do we come from? Where are we heading?
R. Langer, USA
Objectives
• About the critical window and what proof there is of its existence
• Whether it is still customary to prescribe HRT and to whom
• If HRT is a must in premature menopause
• Are estrogens carcinogenic?
11:50-12:10
Posters viewing
-33-
12:10-13:40
Capsule
THE ROLE OF GYNECOLOGISTS IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS
Patients with low bone mineral density and fracture risk who are seen by a gynecologist are usually relatively young. The question is:
Do gynecologists have a role in seeking and preventing early postmenopausal osteoporosis? Do we have effective treatments for this
window of opportunity?
Chairpersons
A.O. Mueck, Germany
X. Ruan, China
12:10-13:10
Debate: Do gynecologists have a role in the management of postmenopausal osteoporosis?
Yes: J. Studd, UK
No: S. Skouby, Denmark
Discussion
13:10-13:40
Should we treat women with low bone mineral density?
S. Palacios, Spain
Objectives
To acquire knowledge of the following:
• Who should take care of cases of osteopenia?
• Risk factors and prevalence of osteopenia and osteoporosis in women over 60 years
• FRAX index in this age group
• DEXA indication
• Options of treatment for postmenopausal women
13:40-14:30
Lunch break
14:30-16:00
HORMONE THERAPY (HT) AND CANCER RISK
Supported and Organized jointly with the European Menopause and Andropause Society (EMAS)
The fear of cancer still dominates the decisions of physicians and patients regarding initiation and continuation of HT
Capsule
Chairpersons
14:30-15:15
J. Studd, UK
M. Brincat, Malta
Debate: Proposition: Breast cancer risk is related to the recommended HT dose and regimen
A.O. Mueck, Germany
Opposition: It is impossible to predict women in whom HT will not increase the risk for breast cancer, and in any event
it is unrelated to the dose and regimen
S. Skouby, Denmark
Discussion
15:15-15:40
Pharmacological interventions in the prevention of breast cancer
M. Brincat, Malta
15:40-16:00
Breast cancer risk and hormone replacement therapy: Is the choice of the progestogens important?
X. Ruan, China
Objectives
Upon completion of this session, the audience will acquire knowledge:
• Risk and prevention of HT associated breast cancer
• What risks are associated with progesterone?
16:00-16:30
Coffee break
16:30-18:00
WOMEN’S BONE HEALTH: SECONDARY BONE LOSS
Organized by the Portuguesa de Doenças Ósseas Metabólicas (SPODOM)
Chairpersons
D. Pereira da Silva, Portugal
P. Coelho, Portugal
S. Skouby, Denmark
16:30-16:50
Hypovitaminosis D
E. Simoes, Portugal
16:50-17:15
Iatrogenic bone loss beyond corticosteroids
A.P. Barbosa, Portugal
17:15-17:35
Body weight and bone mass
M.R. Mascarenhas, Portugal
17:35-18:00
Anorexia nervosa and osteoporosis
I. do Carmo, Portugal
-34-
FETOMATERNAL
HALL D
08:30-10:00
Capsule
GENITAL INFECTION, PREGNANCY OUTCOME AND PERINATAL RISK
Infection during pregnancy is associated with maternal and fetal risks. However, antibiotics must be used judiciously since it can be
accompanied with a risk to the fetus. What do we know and what we do not know?
Chairpersons
G.C. Di Renzo, Italy
08:30-08:50
Bacterial vaginosis and STI as a cause of fetal growth restriction
N. Vedmedovska, Latvia
08:50-09:15
Is an abnormal gut microbioma a contributing factor for gestational diabetes and late preeclampsia?
E. Ferrazzi, Italy
09:15-09:35
Why bacterial vaginosis is not the question and metronidazole is not the answer in preventing infection related preterm birth
G. Donders, Belgium
09:35-10:00
Can we use antibiotics for prophylaxis without long term outcomes on the neonates?
D. Farine, Canada
Objective
To acquire knowledge on diagnosing and treating gestational infections, and impacts on the mother and neonate
10:00-10:20
Coffee break
10:20-11:50
Capsule
PATIENT SAFETY AND MEDICAL LIABILITY IN FMM
Pregnancy and delivery are probably two of the riskiest of all medical situations. How to reduce the risk should certain modes of
delivery be banned for the sake of safety? Are there ways to reduce liabilities?
Chairpersons
A. Grunebaum, USA
10:20-10:40
Can labor and delivery be made safer and medical liability reduced in a hostile environment?
A. Grunebaum, USA
10:40-11:05
Operative maneuvers including delivery of twins/triplets
B. Arabin, Germany
11:05-11:25
Are the current criteria valid for defining a causal relationship for cerebral palsy?
11:25-11:50
Who sues the obstetrician, when and why?
D. Farine, Canada
Objective
To acquire knowledge on the legal risks associated with deliveries and how to reduce them
11:50-12:10
Posters viewing
-35-
12:10-13:40
Capsule
PRETERM BIRTH and PROM
Preterm labor (PTL) is a leading cause of neonatal morbidity including RDS, bronchopulmonary dysplasia, neurologic deficit and mortality.
Cervical length measurements and detection of Fibronectin in cervicovaginal secretions are considered highly sensitive in the detection
and early diagnosis of PTL. Can all this lead to effective preventive methods? How should we treat PROM?
Chairpersons
B. Arabin, Germany
F. Serrano, Portugal
12:10-12:40
Markers to diagnose infection in PROM
12:40-13:10
What is the management of early PROM
D. Farine, Canada
13:10-13:40
Premature labor should not be stopped for more than two days
Objectives
• Prevention of passive cervical dilatation
• Treatment of PROM
• Diagnosis of infection
• For how long should we use tocolytics
13:40-14:30
Lunch break
WORKSHOP ON EMERGENCY BLEEDING DURING PREGNANCY AND POSTPARTUM
14:30-16:00
Capsule
EMERGENCY BLEEDING IN OBSTETRICS
Acute bleeding during pregnancy may have devastating consequences on the mother and fetus, and is a challenge even to an experienced
physician. Early diagnosis and prompt treatment can allow for a more conservative approach
Chairpersons
L. Graca, Portugal
14:30-15:30
Debate: Uterine rupture: Hysterectomy, yes or no?
Proposition: Hysterectomy should be the first solution, delaying hysterectomy might be time consuming and risky
M. Robson, Ireland
Opposition: Prevention of hysterectomy is possible if early decision is taken
E. Sheiner, Israel
Discussion
Discussants
M. Robson, Ireland
E. Sheiner, Israel
D. Farine, Canada
D. Blickstein, Israel
15:30-16:00
1. Prevention of uterine atony
2. Uterine atony: Uterine compression with u-Suture after CS – simple and useful to preserve fertility?
3. Management of placenta accreta during CS: Manual separation? Are we abusing embolization?
4. Atony in the developing world: Secondary to poor post-partum management?
5. Consumption coagulopathy: More than just blood replacement?
Objectives
• Frequency of uterine rupture: Can it be predicted?
• Which proportion of ruptures occurs in unscarred uteruses?
• Preventive measures for dealing with placenta previa or accreta
• How to treat DIC and uterine atony
16:00-16:30
Coffee break
-36-
16:30-18:00
Capsule
BLEEDING DURING LATE PREGNANCY
Bleeding during late pregnancy, delivery and postpartum is associated with serious morbidity and risk of fatality. Prediction, early
diagnosis and proper management of such bleedings remain a challenge and a corner stone in safer obstetrics
Chairpersons
B. Serra Zantop, Spain
16:30-16:50
Vasa previa: Is the consequence avoidable?
E. Sheiner, Israel
16:50-17:15
Can PPH be predicted and avoided?
D. Farine, Canada
17:15-17:35
Novel hematological approaches to PPH
17:35-18:00
Management of placenta accrete: The role of embolization
E. Sheiner, Israel
Objectives
• Vasa previa: To screen or not to screen, how to manage
• PPH- prediction, bleeding estimate, management
• Placenta accreta: Diagnosis and modern management
-37-
SUNDAY, NOVEMBER 11, 2012
INFERTILITY & ART
HALL A
08:30-10:00
Capsule
GAMETE CRYOPRESERVATION
There are ever growing requests for an effective, reliable freezing method for oocytes and embryos. The many possible techniques
require selection of the best approach
Chairpersons
S.M. Nelson, UK
A. Arav, Israel
08:30-09:30
Debate: Donor oocytes from egg banks
Yes: Frozen oocytes donation is as good as fresh
P. Patrizio, USA
No: Fresh oocytes should be preferred for egg donation when possible
A. Arav, Israel
Discussion
09:30-10:00
Safety of ovarian cortex transplantation: Is there a risk of reimplanting malignant cells
M.M. Dolmans, Belgium
10:00-10:30
Coffee break
10:30-12:00
Capsule
ANTI-MÜLLERIAN HORMONE (AMH)
The indications for the use of AMH to predict ovarian response keep expanding to questions such as, can AMH predict pregnancy rate?
Does the AMH level correlate with ovarian response?
Chairpersons
M.M. Dolmans, Belgium
10:30-10:55
AMH and individualized dosing for ovarian stimulation for IVF
S.M. Nelson, UK
10:55-11:15
AMH as a novel marker for ovarian dysfunction in PCOS
J.S.E. Laven, Netherlands
11:15-12:00
Debate: Can AMH predict pregnancy rates better than other markers?
Yes: S.M. Nelson, UK
No: B. Aydogan, Turkey
Discussion
-38-
FETOMATERNAL
HALL B
08:30-10:00
Capsule
WHAT AGENTS ARE SAFEST FOR LABOR INDUCTION?
Induction of labor has become even more important, both with and without medical indications. Both oxytocin and misoprostol have
been associated with potentially adverse outcomes; both have been used for decades in many various protocols and dosages. More
recently, research has shown that using a uniform protocol throughout an institution may be safer. Which protocol is best and
should an institution use only one uniform protocol? Are the advantages and the effectiveness of misoprostol worth the potential risks,
such as tachysystole or uterine rupture?
Chairpersons
L. Graca, Portugal
08:30-08:55
Non-hemostatic effects of heparin in Obstetrics and Gynecology
08:55-09:40
Should misoprostol be banned from labor and delivery units?
Misoprostol is safe, effective and inexpensive for labor induction
09:40-10:00
Should we induce twins?
T. Simoes, Portugal
Objective
To learn which agent and protocol are safe for effective labor induction and how to induce twins
10:00-10:30
Coffee break
10:30-12:00
Capsule
CONTROVERSIES OVER ENDLESS CESAREAN DELIVERY AND MULTIPLE PREGNANCIES
Cesarean delivery, the most common surgical procedure performed, continues to generate controversies that challenge all obstetricians.
The almost universal use of CS to deliver multiple pregnancies adds to the problem
Chairperson
D. Farine, Canada
10:30-10:50
Understanding overall caesarean section rates will help limit the rising rates
M. Robson, Ireland
10:50-11:15
Timing of twin births
11:15-11:35
What is the ideal cesarean delivery rate?
B. Serra Zantop, Spain
11:35-12:00
Outcome of multiple pregnancies - 2012: Spontaneous vs. iatrogenic
M. Carrapato, Portugal
Objectives
• Why CS deliveries are on the rise, how to limit them and what is the ideal rate
• How and when to deliver twins and what is the expected outcome
-39-
L i s b o n
Portugal
November
8-11, 2012
-40-
FREE COMMUNICATION
COGI
-41-
h o l o g i c
p r e n a t a l
h e a l t h
Tommy’s to receive
£1 for every Fetal
FIbronectin Test sold
Fetal Fibronectin is proven to assess
the risk oF preterm delivery
in women who are 22-35 weeks pregnant 1
The Rapid fFN 10Q system also reports the ffN concentration
(ng/ml) of the sample. Currently, there are no performance data
associated with the ffN concentration value displayed with the
result at this time.
AMNION
CHORION
FETAL FIBRONECTIN (fFN)
DECIDUA
Fetal fibronectin is the
adhesive glycoprotein
“glue” at the maternal-fetal
interface. Its premature
presence in the vagina is a
direct biochemical predictor
of risk for preterm birth.
Implementing Rapid fFN, The Fetal Fibronectin Test
for the risk assessment of women with signs and
symptoms of preterm labour has demonstrated...
•
•
•
•
•
•
99.2% of women with a negative ffN
result did NOT deliver within 14 days2
90% reduction of in-utero transfers3
85% reduction in use of corticosteroids4
84% reduction in hospital costs5
81% reduction in average hospital stays5
64% reduction in use of tocolytic therapy3
…thus enabling provision of care to those patients
most at risk of preterm birth and resulting in more
appropriate use of hospital resources
www.ffntest.com
Experience the new Rapid ffN 10Q system for the detection of fetal
fibronectin, the best in class solution for assessing the risk of preterm birth.
© 2012 Hologic Inc
REfERENCEs: 1. Goldenberg RL, Iams JD, Mercer BM et al. The Preterm Prediction study: The value of new vs standard risk factors in
predicting early and all spontaneous preterm births. Am J Public Health. 1998;88:233-238. 2. Peaceman A, Andrews W, Thorp W et al, fetal
fibronectin as a predictor of preterm birth in patients with symptoms: a multicenter trial, AJOB Gyn 1997 177:1:13-18. 3. Giles W. Bistis A,
Knox M, et al. The effect of fetal fibronectin Testing on admissions to a tertiary maternal fetal Medicine unit and cost savings. AAJOG, 2000,
182:439-42. 4. Honest H, Bachmann LM, Gupta JK et al. Accuracy of cervicovaginal fetal fibronectin test in predicting risk of spontaneous
preterm birth: systematic review. BMJ, 2002; 325:301-304. 5. Abenhaim, H Morin,L Benjamin,A. Does availability of fetal fibronectin testing
-42- labour affect the utililization of hospital resources, JOGC July 2005 pp 889-94.
in the management of threatened preterm
GBR-11-019-EN-C
contact hologic on:
email: [email protected] tel: 00 44 (0)1293 522080 Fax: 00 44 (0)1293 528010
Oral Presentations
HALL B
14:30-16:00
GYNECOLOGY
Chairpersons
G. Ventolini, United States
14:30-14:38
Axillary reverse mapping: The future for preventing lymphedema during axillary lymph node dissection?
R. Sousa, A. Teixeira, F. Martins, Portugal
14:38-14:46
Prevalence and predictors of abnormal papanicolaou smears in HIV positive women
M. Vide Tavares, F. Nunes, S. Saleiro, F. Mota, I. Torgal, Portugal
14:46-14:54
Controversies in vaginal microflora ecosystem, immunity, bacterial vaginosis and vulvodynia
G. Ventolini, United States
14:54-15:02
Study on the relationship between the curative efficiency and dosage of focused ultrasound therapy for cervical
intraepithelial neoplasia i?
C. Lin, C. Li, China
15:02-15:10
Proteomic biomarkers of type 2 diabetes mellitus (T2DM) risk in women with polycystic ovary syndrome (PCOS)
N. Galazis, T. Afxentiou, M. Xenophontos, E. Diamanti-Kandarakis, W. Atiomo, United Kingdom
15:10-15:18
HRT versus oral contraceptives for preventing osteoporosis in premature menopause
T. Chung, C. Haines, Hong Kong
15:18-15:26
Pulsatile administration of testosterone during menopause using Pentravan® in the vulval region
H. Maia Jr., C. Haddad, C.E. Franca, R. Maia, J. Casoy, Brazil
15:26-15:34
Endometrial polyp on ultrasound: Its diagnosis and importance in pre-menopausal women? A 5-year retrospective study
N. Barros, C. Pardal, L. Braga, E. Fernandes, A. Rocha, J. Pena, Portugal
15:34-15:42
Can cytobrush replace endocervical curettage in detection of cervical dysplasia and malignancy?
A. Franco, D. Bruno, M. Miranda, E. Landim, V. Santos, A. Oliveira, A. Pedro, J. Silva Pereira, Portugal
15:42-15:50
Correlation of the amount of reseptor IGF-1expresion and endometrial gland rattus novergicus strain Wistar as PCOS models
B. Santoso, E. Susanto, Samsulhadi, Widjiati, Indonesia
16:30-18:00
GYNECOLOGY
Chairpersons
R. Aurell, Spain
J. Sousa, Portugal
16:30-16:38
Atypical glandular cells and cervical cancer- experience in colposcopy unit
J. Sousa, T. Diniz-da-Costa, A. Colaço, C. Calhaz-Jorge, Portugal
16:38-16:46
Prevalence in albania of gestational trophoblastic disease in ectopic pregnancy
I. Tasha, H. Klosi, K. Dasho, F. Cenko, N. Manoku, Albania
16:46-16:54
Value of medical history in prediction of endometrial carcinoma
R. Torres, C. Pedroso, C. Marques, J.L. Reis, S. Valadares, C. Marques, Portugal
16:54-17:02
Influence of pre-surgical breast MRI on mastectomy decisions
A. Vicente, F. Estevinho, E. Sousa, M. Nogueira, J. Fiel, J. Teixeira, Portugal
17:02-17:10
Factors influencing additional nodal disease following a positive sentinel lymph node biopsy in breast cancer patients
B. Vides, M. Rocha, A. Ferreira, L. Castro, F. Pardal, Portugal
17:10-17:18
Expanded range point-of-care assays for FSH and LH
L. Hwang, K. Motamed, C. Hsiao, V. Trieu, United States
17:18-17:26
Inflammation and immunosuppression in patients with ovarian cancer regarding clinical stage and debulking status
M. Nowak, E. Glowacka, P. Lewkowicz, M. Banasik, M. Szpakowski, K. Szyllo, A. Malinowski,
H. Tchorzewski, J.R. Wilczynski, Poland
-43-
17:26-17:34
Laparoscopic extraperitoneal para-aortic lymphadenectomy in locally advanced cervical cancer
L. Raposo, P. Aldinhas Santos, E. Cruz, F. Mártires, D.P. Silva, Portugal
17:34-17:42
A multigenic model based in low penetrance genes to evaluate breast cancer risk in a Portuguese population
A.C. Ramalhinho, J.A. Fonseca-Moutinho, L. Breitenfeld, Portugal
17:42-17:50
Proteomic biomarkers for ovarian cancer risk in women with polycystic ovary syndrome (PCOS): A systematic review and
biomarker database integration
N. Galazis, S. Drymiotou, S-N. Thoukididou, W. Atiomo, United Kingdom
17:50-17:58
DNMT1 activity and global DNA methylation pattern in endometrial cancer
K. Romanek-Piva, K. Galczynski, K. Postawski, Poland
Oral Presentations
HALL E
08:30-10:00
ART/IVF
Chairpersons
S. Daya, Canada
A.S. Blazar, United States
08:30-08:38
Is ovarian reserve testing of use to the clinician?
A.S. Blazar, United States
08:38-08:46
The biological will – A new paradigm in art?
I. Rosenblum, Israel
08:46-08:54
Improved sperm quality and intrauterine insemination outcomes using a novel sperm selection device
A. Brandao, K. Dreier, Kerstin, S. Vrancic, J. Zech, Austria
08:54-09:02
What to expect from poor responders?
A. Cardoso, C. Leal, A. Pinto, J. Mesquita-Guimarães, Portugal
09:02-09:10
Influence of FSH receptor polymorphism on ovarian stimulation response
L. Casalinho, S. Fernandes, A.P. Sousa, A.T. Almeida-Sousa, Portugal
09:10-09:18
Human embryo cryopreservation: One-step slow freezing does it all?
Y.S. Chong, M.L.H. Chan, S. Nadarajah, H.H. Tan, Singapore
09:18-09:26
The effect of the use of the GnrH antagonist protocol on clinical outcomes and OHSS incidence, and burden in women with
polycystic ovaries
B. Deval, U. Shukla, M. Kreatsas, M. Mittal, H. Hamoda, M. Savvas, N. Narvekar, United Kingdom
09:26-09:34
The influence of embryo transfer depth in uterine cavity on pregnancy rate in IVF/ICSI program
P.N. Kumar, A. Chandana, A. Ramachandran, R. Bhakta, S. Adiga, India
09:34-09:42
Only non-selective embryos are available for transfer. Is it possible to develop a good pregnancy rate in such conditions?
C. Leal, A. Pinto, J. Mesquita-Guimarâes, Portugal
09:42-09:50
High pregnancy rates with administration of biophotonic energy in an intratubal insemination program
G. Menaldo, S. Serrano, S. Benvenuto, B. Lopez, Italy
09:50-:09-58
Is fertility at risk? What do young people know about infertility?
J. Mesquita-Guimarães, A. Pinto, Portugal
10:20-11:50
ART/IVF
Chairpersons
G. Nargund, UK
10:20-10:28
Changes in mitochondrial distribution during different stages of human oocytes maturation
A. Ellenbogen, G. Paz, S. Hantisteanu, M. Michaeli, O. Fainaru, Israel
10:28-10:36
Two decades of in vitro fertilization treatments at Centro Hospitalar de Vila Nova de Gaia/Espinho, Epe: Analysis, trends
and reflections
I. Pires, M. Cabral, M. Osório, S. Pinelo, H. Serra, A. Barbosa, H. Figueiredo, E. Felgueira, A. Tavares, Portugal
-44-
10:36-10:44
Success rate of in vitro fertilization (IVF) in patients with moderate/severe endometrosis versus tubal factor
S. Ribeiro, C. Rodrigues, A. Aguiar, S. Sousa, J. Nunes, A.P. Soares, M. Carvalho, F. Leal, I. Cordeiro, C. Calhaz-Jorge, Portugal
10:44-10:52
Ovarian hyperstimulation syndrome: Experience of a reproductive medicine center from 2005-2011
C. Oliveira, M. Lima, M. Sousa, J. Silva, J. Teixeira da Silva, M. Cunha, P. Viana, A. Barros, Portugal
10:52-11:00
Measuring human error in the IVF laboratory using an electronic witnessing system
A.R. Thornhill, X.O. Brunetti, S. Bird, United Kingdom
11:00-11:08
Psychological aspects of assisted reproductive treatments in infertile couples
S. Reis, M.R. Xavier, J.P. Neves, R. Coelho, N. Montenegro, Portugal
11:08-11:16
Mechanical embryo implantation (seed) with egg donors
M. Kamrava, United States
11:16-11:24
Can cycle day 7 FSH concentration during controlled ovarian stimulation be used to guide FSH dosing for in vitro fertilization?
Y. Bentov, E. Burstein, C. Firestone, R. Firestone, N. Esfandiari, R.F. Casper, Canada
11:24-11:32
Appraisals of assisted reproductive technology enterprise: Economic perspective
H. Eskandarani, Saudi Arabia
11:32-11:40
Factors of obstetrical and neonatal risks after art
N. Aleksandrova, Russian Federation
11:40-11:48
Metformin for the treatment of diabetes in pregnancy: Better outcomes for both mother and baby
S. Vali, A. Leyland, S. Duthie, M. Elrishi, United Kingdom
12:10-13:40
GYNECOLOGY
Chairpersons
M. Brincat, Malta
J. Calleja-Agius, Malta
12:10-12:18
Endometriosis in infertility
J. Calleja-Agius, M. Brincat, Malta
12:18-12:26
Can the addition of a paracervical block to systemic or local analgesics improve the pain perceived by the patient during
hysterosalpingography? A prospective, randomized and double-blind trial
S. Hacivelioglu, M. Gencer, A. Cakir Gungor, S. Kosar, E. Koc, E. Cosar, Turkey
12:26-12:34
Concentration of angiogenic factors in serum and peritoneal fluid of women with endometriosis and idiopathic infertility
M. Gogacz, K. Galczynski, K. Romanek, K. Perzylo, A. Adamiak-Godlewska, Poland
12:34-12:42
Novel endoglin gene polymorphism associated with endometriosis-an observational study in a cohort of Indonesian women
F. Manuaba, Indonesia
12:42-12:50
An in vitro evaluation of promising cationic surfactants with contraception properties
M. Baptista, R. Tavares, S. Publicover, J. Ramalho-Santos, Portugal
12:50-12:58
Fertility outcome after open reversal of sterilisation
N. Ray-Gaheer, R. Kumar, A. Pandravada, United Kingdom
12:58-13:06
Long-term exposure to environmentally relevant DDE concentrations exerts deleterious effects on human sperm
R. Tavares, M. Baptista, C. Paiva, S. Amaral, S. Publicover, J. Ramalho-Santos, Portugal/ United Kingdom
13:06-13:14
Estrogen-DNA adducts mediated pathway as a cause of infertility associated with schistosomiasis infection
M.C. Botelho, N. Vale, M.J. Gouveia, J. Santos, L. Santos, J.M. Correia da Costa, Portugal/Angola
13:14-13:22
Is detorsion the viable alternative?
Y. Gurtovoya, M.M. Abdullah Agha, E. Opara, United Kingdom
13:22-13:30
A case of molar ectopic pregnancy
A. Dokle, Albania
13:30-13:38
Risk factors for gestational trophoblastic disease: A hospital-based analysis of 17 years
D. Ferreira, H. Afonso, C. Duarte, P. Figueiredo, H. Azevedo, I. Reis, Portugal
-45-
14:30-16:00
GYNECOLOGY
Chairpersons
S. Hacivelioglu, Turkey
14:30-14:38
Is there an advantage of three dimensional computed tomography scanning over plain abdominal radiograph in the
detection of retained needles in the abdomen?
S. Hacivelioglu, O. Karatag, A. Cakir Gungor, M. Gencer, S. Kosar, B. Kizildag, Y. Yildiz, S. Bas, Turkey
14:38-14:46
Cervical fibroid- a herculean task to manage
J. Hameed, K. Pandurangan, R. S. India
14:46-14:54
Evaluation of gene expression in endometrial receptivity in women operated on for embolization of uterine myomas: A
clinical study
S. Hilário, N. Bozzini, M. Messina, R. Borsari, K. Carvalho, E. Baracat, Brazil
14:54-15:02
MRgFUS for uterine myomas: Safety, effectiveness and pathogenesis
J. Kurashvili, A. Stepanov; V. Bytchenko; E. Chmyr, E. Kulabuchova, I. Lugina, O. Batarshina, Russian Federation
15:02-15:10
Vaginal ovarian cystectomy revisited- a pilot case control study to assess outcomes and patient satisfaction
W. Lodhi, S. Walker, A. Fakokunde, W. Yoong, B. Subba, United Kingdom
15:10-15:18
Pelvic schwannoma in the right parametrium: The first case
N. Machairiotis, P. Zarogoulidis, A. Stylianaki, E. Karatrasoglou, G. Sotiropoulou, A. Florescou,
E. Chatzi, A. Karamani, N. Courcoutsakis, C. Machairiotis, Greece
15:18-15:26
Audit: Lletz treatment under LA and GA
G. Majeed, United Kingdom
15:26-15:34
Can current national surveillance systems aid the evaluation of the true European epidemiology of STIs with focus on
chlamydial infections?
P-A. Mårdh, Sweden
15:34-15:42
Comparison between endometrial ultrasound features and hysteroscopy/biopsy findings
C. Rasteiro, A.S. Fernandes, I. Pestana, M. Martinho, F. José, Portugal
15:42-15:50
Residual lesion after CIN2/3 treatment – The experience of our cervical pathology unit
M. Simoes, C. Pedroso, S. Barreto, T. Paula, J. Borrego, Portugal
15:50-15:58
The value of the “ovarian crescent sign” in the differential diagnosis of adnexal masses
T. Castro, A. Fernandes, L. Machado, S. Duarte, T. Carraca, J. Ferreira, J. Beires, Portuga
16:30-18:00
GYNECOLOGY
Chairpersons
A.O. Mueck, Germany
X. Ruan, China
16:30-16:38
Possible mechanism for the observed increased breast cancer risk using norethisterone in hormone therapy
X. Ruan, H. Neubauer, H. Seeger, T. Fehm, A.O. Mueck, China/Germany
16:38-16:46
Comparative study between two distension media during office hysteroscopy in postmenopausal women: a random clinical trial
V. Fausto, I. Monteiro, Brazil
16:46-16:54
Office operative hysteroscopy: feasibility and pain tolerance
E. Gonçalves, J. Carvalho, C. Marinho, A. Melo, C. Oliveira, I. Meireles, C. Nunes, Portugal
16:54-17:02
Internal iliac arteries temporary occlusion during laparoscopic myomectomy
K. Puchkov, N. Podzolkova, J. Andreeva, V. Korennaya, Russian Federation
17:02-17:10
Outpatient hysteroscopy performance – Retrospective study
M. Ledo, M. Silva, P. Silva, F. Bacelar, T. Freitas, L. Remesso, C. Freitas, Portugal
17:10-17:18
Hysteroscopy in patients with endometrial cancer
D. Melo Castro, J. Lisboa, P. Correia, Z. Gomes, H. Martins, O. Moutinho, Portugal
17:18-17:26
Minimally invasive laser procedure for early stages of stress urinary incontinence (SUI)
I. Fistonic, S. Findri Guštek, N. Fistonic, I. Sorta Bilajac Turina, M. Fistonic, Croatia (Hrvatska)
-46-
17:26-17:34
Five-year outcomes after abdominal sacrocolpopexy
J. Lisboa, A. Castro, D. Castro, P. Correia, O. Moutinho, Portugal
17:34-17:42
The Manchester operation for uterine prolapse: a retrospective study of 17 patients
A. Macaes, S. Fernandes, M.G. Castro, C. Aparício, A. Catarino, L. Negrão, Liana, Portugal
17:42-17:50
A novel method for evaluating stress urinary incontinence using vaginal ultrasound gray-level histogram
S. Olgan, O. Piri Mantar, E. Okyay, S. Altunyurt, B. Gulekli, Turkey
17:50-17:58
Transvaginal mesh procedures for pelvic organ prolapse - A clinical outcome study
M. Silva, M. Ledo, T. Freitas, P. Silva, F. Bacelar, K. Brazão, C. Sousa, R. Freitas, Portugal
Oral Presentations
HALL E
08:30-10:00
FAMILY PLANNING, GYNECOLOGY & FETOMATERNAL MEDICINE
Chairpersons
E. Sheiner, Israel
F. Ferreira, Portugal
08:30-08:38
Insulin resistance and metabolic syndrome in women with polycystic ovarian syndrome
F. Ferreira, A. Soares, L. Patricio, J. Nunes, S. Sousa, A. Aguiar, C. Rodrigues, C. Calhaz-Jorge, Portugal
08:38-08:46
Conservative surgical treatment for bowel endometriosis
M. Veujoz, E. Faller, C. Zacharopoulou, J. Albornoz, M. Puga, A. Wattiez, France
08:46-08:54
Comparison of peri-operative outcomes associated with robotic assisted hysterectomy and myomectomy
K. Huang, United States
08:54-09:02
Misoprostol prior to inserting an intrauterine device in nulliparas: a randomized clinical trial
A. Scavuzzi, M.R. Amorim, A.S. Souza, A.R. Costa, Brazil
09:02-09:10
Rapid repeat pregnancy in adolescence: Can we do something about it?
F. Abreu Dos Santos, M. Silva, M. Ledo, S. Câmara, P. Pinto, H. Pereira, Portugal
09:10-09:18
Urinary infection in pregnancy – A two years monitoring
D. Almeida, T. Leite, T. Macedo, R. Guerreiro, J. Dias, I. Lobo, Portugal
09:18-09:26
Caesarean section versus vaginal delivery in women with severe preeclampsia: A cohort study
M.M.R. Amorim, L. Katz, A. Souza, Alex Sandro, A. Scavuzzi, A. Faúndes, Brazil
09:26-09:34
Evolution of computer-analysed fetal heart rate parameters throughout gestation
C. Amorim-Costa, J. Cruz, C. Costa-Santos, D. Ayres-de-Campos, J. Bernardes, Portugal
09:34-09:42
Conversion of peripheral blood NK cells
A.S. Cerdeira, A. Rajakumar, C.M. Royle, A. Lo, Z. Hussain, R.I. Thadhani, V.P. Sukhatme,
S.A. Karumanchi, H.D. Kopcow, United States
09:42-09:50
Knowledge and attitude of Hong Kong pregnant women on group B streptococcus screening
T.Y. Chow, L.W.D. Chan, W.K.W. To, Hong Kong
09:50-09:58
Obstetric admission in intensive care unit for 5 years
P. Correia, M. Andrade, J. Lisboa, E. Francisco, O. Moutinho, Portugal
10:20-11:50
Chairpersons
A. Weissman, Israel
10:20-10:28
Clinical presentation of HELLP syndrome: 5-year retrospective analysis
I. De Barros Pereira, D. Martins, P. Rocha, A. Henriques, H. Ferreira, Portugal
10:28-10:36
Single ultrasound evaluation for follicle and endometrium during ovulation induction compare with progesterone
midluteal phase
J. Dewantiningrum, Indonesia
-47-
10:36-10:44
Outcome of triplet pregnancies – Has something changed in the past 3 decades?
A. Weissman, S. Blazer, I. Olanovski, A. Drugan, Israel
10:44-10:52
Fetal reduction in triplet gestations – Twins still fare better
A. Drugan, I. Olnowsky, Y. Burke, S. Blazer, A. Weissman, Israel
10:52-11:00
Shoulder dystocia – A risk management point of view
C. Burrell, H. O’Connor, United Kingdom
11:00-11:08
Surrogacy pregnancy: A risk management point of view
H. O'Connor, C. Burrell, United Kingdom
11:08-11:16
Diagnosis of fetal heart beat positive abdominal pregnancy by ultrasonography, CT and MRI
T. Hoshino, Y. Matsumoto, T. Miyamoto, N. Hayashi, R. Oyama, A. Hirao, N. Ohtake, S. Kitamura, M. Suga, K. Miyamoto, A. Takaoka,
T. Aoki, Y. Imamura, M. Kita, Japan
11:16-11:24
Safety of myomectomy during LSCS
U.M. Joglekar, V.B. Bangal, India
11:24-11:32
The new mediator of human labor-onset
T. Kotani, T. Nakano, Y. Watanabe, Y. Mano, H. Tsuda, H. Li, F. Kikkawa, Japan
11:32-11:40
Dunnigan syndrome: An unusual diagnosis in pregnancy
J. Lima-Silva, S. Bessa-Monteiro, C. Gamboa, A. Magalhães, R. Mesquita, N. Montenegro,
J. Cavaco-Gomes, Portugal
11:40-11:48
Iron intake, haemoglobin and risk of gestational diabetes: A prospective cohort study
R.M. Luoto, T.I. Kinnunen, A. Helin, J. Raitanen, S. Ahonen, S.M. Virtanen, Finland
12:10-13:40
Chairpersons
G. Papaioannou, United Kingdom
12:10-12:18
Cortical maturation in fetuses referred for “isolated” mild ventriculomegaly: A longitudinal ultrasound assessment
R.F. Miguelote, B. Vides, R. Santos, J. Palha, A. Matias, N. Sousa, Portugal
12:18-12:26
Alpha 1-antitrypsin deficiency: A curious finding in pregnancy
A. Miranda, C. Silva, A. Cadilhe, M. Saleiro, L. Castro, Portugal
12:26-12:34
Systemic lupus erythematosus and antiphospholipid antibody syndrome in pregnancy: The experience of a
multidisciplinary consultation in a tertiary-care hospital
J.P. Neves, J. Lima Silva, C. Dias, M. Guimarães, Portugal
12:34-12:42
Assessment of labor preinduction by mifepristone in preterm prelabor rupture of the membranes at 34-36+6days
weeks’ gestation
V. Novikova, G.A. Penzhoyan, O.K. Fedorovich, Russian Federation
12:42-12:50
Placental chorangioma: A clinical case and pregnancy outcome
P.N. Oliveira, R. Caldas, C. Pina, F. Mak, C. Araújo,A. Pinto, C. Barbedo, S. Ferreira, A. Lanhoso, Portugal
12:50-12:58
Ultrasound markers of preeclampsia and fetal growth restriction at 6-10 weeks
G. Papaioannou, A. Syngelaki, N. Maiz, J. Ross, K. Nicolaides, United Kingdom/Spain
12:58-13:06
Preeclampsia: prophylactic during pregnancy
N.M. Pasman, E.R. Chernych, N.A. Chonina, A.N. Drobinskaja, Russian Federation
13:06-13:14
Antibiotic prophylaxis in premature rupture of membranes at term
F.F.V. Passos, K. Cardoso, A. Coelho, A. Graça, N. Clode, L. Mendes da Graça, Portugal
13:14-13:22
The challenges of conducting clinical research in intrapartum care
H. Phipps, B. de Vries, J. Hyett, Australia
13:22-13:30
Surgical technique of laparoscopic transabdominal cerclage
A. Rodrigues, M. Afonso, T. Diniz da Costa, M. Centeno, F. Osório, C. Alho, C. Calhaz Jorge, Portugal
13:30-13:38
Management and outcome of extremely premature infants
I. Sá, M. Fonte, C. Carvalho, P. Soares, A. Almeida, A. Januário, S. Gouveia, J. Saraiva, Portugal
-48-
14:30-16:00
Chairpersons
A. Grunebaum, USA
C. Gameiro, Portugal
14:30-14:38
Overt diabetes and first-trimester assessment: from pregnancy planning to optimal metabolic control and presence of
congenital abnormalities
C. Gameiro, M. Torgal, C. Vilhena, A. Santos, E. Casal, F. Romão, Portugal
14:38-14:46
Abdominal pain in pregnancy - A challenging diagnosis
A. Santos, J. Cavaco-Gomes, S. Duarte, C. Gamboa, R.M. Mesquita, N. Montenegro, Portugal
14:46-14:54
Screening of bacterial vaginosis in preterm labour
D. Sarkar, V. Acharya, India
14:54-15:02
Uterine rupture in second trimester due to placenta percreta
S. Sheik, V. Gowri, F. Al Ali, M. Mathew, L. Al Kharusi, Oman
15:02-15:10
Fetal well-being monitoring through non-invasive fetal electrocardiography
R. Simoes, C. Gonçalves, J. Sousa, C. Nogueira-Silva, Portugal
15:10-15:18
Fetal growth assessment amongst primary care physicians
R. Sousa-Santos, A. Castro, M. Alves, R. Miguelote, R. Cruz-Correia, A. Costa-Pereira, Portugal
15:18-15:26
Maternal and neonatal morbidity after vaginal delivery using Thierry's spatulas – Experience of Hospital de Braga
E. Vale Fernandes, F. Rodrigues, N. Teixeira, C. Pardal, L. Carvalho, D. Jardim Pena, Portugal
15:26-15:34
Female sexual functioning and body exposure in term pregnancy
C. Verissimo, Portugal
15:34-14:42
Amniotic lamellar body counts can be useful to predict of hypoplasia in congenital diaphragmatic hernia
Y. Watanabe, H. Tsuda, H. Li, Y. Mano, T. Kotani, F. Kikkawa, Japan
14:42-14:50
Risk of isolated ventricular septal defect in euploid fetuses with increased or borderline nuchal translucency in the first trimester
C. Barbisan, P. Zielinsky, A. Naujorks, E. Becker Jr., R. Frajndlich, L.H. Nicoloso, A.L. Piccoli Jr.,
P. Pizzato, L. Bender, S. Busato, M. Lopes, C. Klein, M. de Fátima Leite, Brazil
14:50-14:58
Epidemiological consequences of the new iadps criteria for screening for GDM
A-S. Page, Belgium
16:30-18:00
Chairpersons
N. Galazis, United Kingdom
16:30-16:38
Gestational diabetes and maternal cardiovascular risk factors
M.I. Reis, I.M. Brito, M. Mouraz, S. Proença, L. Martins, A. Gonçalves, F. Nunes, Portugal
16:38-16:46
Induction of labour and its outcome
A. Bimbashi, A. Dokle, E. Ndoni, Albania
16:46-16:54
Preterm delivery before and after 28 weeks: Are there differences?
A. Gonçalves, L. Correia, P. Silva, Patricia A. Massa, S. Aguilar, V. Ribeiro, F. Palma, Portugal
16:54-17:02
Proteomic biomarkers of preterm birth risk in women with polycystic ovary syndrome (PCOS): A
systematic review and biomarker database integration
N. Galazis, N. Docheva, K. Nicolaides, W. Atiomo, William, United Kingdom
17:02-17:10
Prediction of success in external cephalic version
C. Vaz De Macedo, N. Clode, R.M. Carvalho, L. Mendes da Graça, Portugal
17:10-17:18
Large scale evidence of the role of maternal levels of homocysteine, folic acid and vitamin B12 in pre-eclampsia
E. Staines Urias, N.C. Serrano, M.C. Paez, P. Doyle, F. Dudbridge, A.D. Hingorani, J.P. Casas, United Kingdom, Colombia
17:18-17:26
Hemolytic-uremic syndrome during pregnancy – About a case report
S. Proença, M. Mouraz, M.I. Reis, I. Brito, C. Gama Pinto, S. Pedroso, H. Santos Pereira,
R. Rodrigues, F. Nunes, Portugal
17:26-17:34
Pudendal nerve block and obstetric simulation
L. Guedes-Martins, A. Reynolds, L. Guedes, Portugal
-49-
CA125 + HE4
The
new formula
for
diagnostic clarity
of ovarian cancer
© 2012 Fujirebio Diagnostics. FDAB-007, r0
From the company that brought you CA125, Fujirebio Diagnostics
introduces HE4, the first new biomarker in 25 years
for ovarian cancer management. 1
www.he4test.com
1
Diamandis E, et al. Cancer Biomarkers: Can we turn recent failures into success? J Natl Cancer Inst. 2010;102:1-6.
-50-
Posters
ART/IVF
P1
ELECTIVE SINGLE EMBRYO TRANSFER (ESET), THE MALAYSIAN PERSPECTIVE
Abdul Wahab, Azantee Yazmie, Zainuddin, Ahmad Murad; Ramli, Roszaman; Mohd Yatim, Hayati; Mohd Bustaman, Siti Khadijah; Md Arifin, Norsina;
Kuantan, Pahang, Malaysia
P2
PSYCHOLOGICAL IMPACT OF FERTILITY TREATMENT AMONG MALAYSIAN MEN
Abdul Wahab, Azantee Yazmie, Kuantan, Pahang; Zainuddin, Ahmad Murad; Musa, Ramli; Abdul Rahim, Faszrul Aidil; Mohd Yatim, Hayati; Mohd Bustaman,
Siti Khadijah; Md Arifin, Norsin; Kuantan, Pahang, Malaysia
P3
ADVERSE OUTCOME OF THE METHYLENTETRAHYDROFOLATE REDUCTASE A1298C POLYMORPHISMS ON OVARIAN ACTIVITY
Andreeva, Petya, Dimitrov, Ivan; Shterev, Atanas, Bulgaria
P4
EARLY PREGNANCY LOSS FOLLOWING FIV/ICSI TREATMENT
Brás, Filipa; Santos, Ricardo; Ramalho, Rita; Dantas, Sofia; Reis, Isabel, Portugal
P5
THE SIGNIFICANCE OF SERUM PROGESTERONE LEVEL IN THE LUTEAL PHASE IN ASSISTED REPRODUCTION CYCLES
Brincat, Mark, Vassallo, Marie Claire; Tsar, Olha M.; Vella, Katia; Cin-Custo, Malta
P6
AN ANALYSIS OF 15 YEARS PRESERVING MALE FERTILITY IN ONCOLOGICAL PATIENTS
Cabral, Madalena, Portugal
P7
FROM AZOOSPERMIA TO A SPONTANEOUS PREGNANCY: CASE REPORT
Cardoso, Ana, Louro, Nuno; Barreiro, Márcia; Pinto, Alice; Leal, Carla; Mesquita-Guimarães, Joana, Portugal
P8
SEVERE OVARIAN HYPERSTIMULATION SYNDROME: A CASE REPORT
Castro, Ana, Lisboa, Joana; Castro, Diana; Correia, Patrícia; Moutinho, Osvaldo, Portugal
P9
PRELIMARY RETROPECTIVE ASSESSMENT OF THE APPLICATION OF PGS FOR PATIENTS WITH LOW EMBRYO NUMBERS
Cater, Ellen, Jenner, Lucy; Fishel, Simon, United Kingdom
P10
COMPARISON OF CLINICAL OUTCOME BETWEEN UNILATERAL AND BILATERAL LAPAROSCOPIC VARICOCELECTOMY IN INFERTILE PATIENT WITH
LEFT VARICOCELE AND RIGHT SUBCLINICAL VARICOCELE
Chen, Shiou-Sheng, Taiwan
P11
ASSISTED REPRODUCTIVE TECHNIQUES: DEPRESSION AS A CONSEQUENCE AND NURSING CARE RELATED
Delerue, Estefânia, Campos, Maria Cristina, Portugal
P12
EFFECT OF POOR RESPONSE IN WOMEN LESS THAN 30 YEARS ON EMBRYOS QUALITY IN CONTROLLED OVARIAN STIMULATION FOR IN VITRO
FERTILIZATION
Eldar, Ido, Israel
P13
OVARIAN FOLLICLUAR BLOOD FLOW CORRELATES WITH THE PRESENCE OF MATURE DENDRITIC CELLS WITHIN THE FOLLICLE
Ellenbogen, Adrian; Geva, Mika; Hantisteanu, Shai; Michaeli, Medeia; Rotfarb, Nechami; Hallak, Mordechai; Fainaru, Ofer, Israel
P14
DROP-OUT IN INFERTILITY TREATMENT
Fernandes, Mónica, Mesquita-Guimarães, Joana; Lopes, Tânia; Freitas, Paula, Portugal
P15
SHORT ANTAGONIST PROTOCOL VERSUS LONG AGONIST PROTOCOL
Gjata, Elinda, Berisha, Fatlinda, Albania; Papatheodorou, Akilea; Prapas, Nikos; Prapas, Yannisi, Greece
-51-
P16
SOME ALBANIAN DATAS ABOUT SOME CHARACTERISTICS OF THE WOMEN TRYING TO TACKLE INFERTILITY IN OUR CLINIC
Gjata, Elinda, Albania, Apatheodorou, Akilea; Prapas, Yannis N.; Prapas, Nikos, Greece
P17
SUCCESSFUL PREGNANCY OUTCOME WITH THE USE OF IN VITRO FERTILIZATION AFTER ESSURE® HYDROSALPINX OCCLUSION
Guedes-Martins, Luís, Mesquita-Guimarães, Joana; Barreiro, Márcia, Portugal
P18
SOME CHARACTERISTICS OF SPERM AND EGG DONORS IN THE CZECH REPUBLIC
Konecna, Hana, Mardesic, Tonko; Rumpikova, Tatana; Dostal, Jiri; Rumpik, David, Czech Republic
P19
CROSS BORDER REPRODUCTIVE CARE IN THE CZECH REPUBLIC – ARE THERE DIFFERENCES BETWEEN FOREIGN AND CZECH PATIENTS?
Konecna, Hana, Rumpikova, Tatana; Mardesic, Tonko; Rumpik, David; Dostal, Jiri, Czech Republic
P20
AMH LEVELS AND DOSES OF GONADOTROIPNS IN IVF STIMULATION
Rumpik, David, Rumpikova, Tatana; Loucky, Jaroslav; Kucera, Radek; Belaskova, Silvie; Topolcan, Ondrej, Czech Republic
P21
GONADOTROPIN THERAPIES IN ART: SAFETY, EFFICACY AND COSTS EVALUATION
Lisi, Franco, Italy
P22
TUNEL AND COMET ASSAY: USEFULNESS OF THESE TECHNIQUES IN THE STUDY OF THE DNA FRAGMENTATION IN SPERMATOZOA
Lopes, Fernando, Gomes, Zélia; Moutinho, Osvaldo; Peixoto, Francisco, Gaivão, Isabel; Pinto Leite, Rosário, Portugal
P23
APPLICATION OF A COATED NITINOL STENT FOR THE TREATMENT OF RECURRENT CERVICAL STENOSIS AND INFERTILITY
Mangler, Mandy, Grund, Klaus-Ernst; Lanowska, Malgorzata; Köhler, Christhardt; Schneider, Achim; Speiser, Dorothee, Germany
P24
INCIDENCE OF ANTI-N-METHYL-D-ASPARTATE RECEPTOR ANTIBODIES IN PATIENTS WITH BENIGN OVARIAN DISEASES
Mangler, Mandy, Vasiljeva, Jekaterina; Speiser, Dorothee; Schneider, Achim; Meisel, Andreas; Trebesch de Perez, Isabel, Germany
P25
EGG AND SPERM DONATION BANK: THE ROLE OF NURSING STAFF
Marques, Alexandra, Gouveia, Palmira; Leal, Carla; Pinto, Alice; Pereira, Isabel, Portugal
P26
THE OUTPATIENT HYSTEROSCOPY PRIOR TO IVF CYCLE DO NOT INTERFERE WITH PREGNANCY RATE
Masliy, Yuliya, Sudoma, Iryna; Plakhotna, Oksana, Ukraine
P27
IMPACT OF MECHANICAL ENDOMETRIAL WASHING: AN IN-VITRO MODEL
Maxia, Nicoletta, Gandolfi, Andrea, Italy
P28
PREGNANCY AFTER ASSISTED REPRODUCTIVE TREATMENT IN HERLYN-WERNER-WUNDERLICH SYNDROME
Melo Castro, Diana, Pinto, Alice; Barreiro, Márcia; Mesquita Guimarães, Joana, Portugal
P29
COMPARISON OF ICSI OUTCOME USING MICRODOSE OF G-CSF AND IL-10
Menaldo, Giovanni, Benvenuto, Sara; Lopez, Betsy, Italy
P30
RECOMBINANT LH RESCUES THE LUTEAL PHASE AFTER GNRH AGONIST TRIGGERING OF OVULATION: A COMPARATIVE STUDY
Munoz, Elkin, Taboas, Esther; Aguilar, Jesus; Martinez, Berta; Fernandez, Iria; Portela, Susana ; Remohí, Jose, Spain
P31
ESTIMATION OF THE CONTRIBUTION OF ASSISTED AND NON-ASSISTED REPRODUCTIVE TECHNOLOGY FERTILITY TREATMENTS TO MULTIPLE
BIRTHS DURING THE LAST THIRTY YEARS IN JAPAN: 1979-2011
Ooki, Syuichi, Japan
P32
INTRAMYOMETRIAL ECTOPIC PREGNANCY IN A PATIENT UNDERGOING IN VITRO FERTILIZATION AND HARBOURING AN ADENOMYOTIC UTERUS
Phoon, Cheng-Fun, Lee, Sook-Ling SL; Tan, Wei-Ching WC; Yu, Su-Ling SL, Singapore
-52-
P33
NEW FAMILIES WITH THE CONTRIBUTION OF THE FIRST PORTUGUESE PUBLIC BANK OF GAMETES
Pinto, Alice, Leal, Carla; Marques, Alexandra; Sousa Pereira, Isabel; Mesquita-Guimarães, Joana, Portugal
P34
FERTILITY OUTCOME AFTER MICROSURGICAL REVERSAL OF TUBAL STERILIZATION
Ramos, Vera, Gomes, Andrea; Marques, João P; Santos, Rui L.; Falção, Franscisco; Torgal, Isabel, Portugal
P35
TIME TRENDS IN FERTILITY-COMPARISON OF TWO COHORTS OF POSTMENPAUSAL WOMEN IN NORWAY
Rostad, Berit, Schei, Berit; Sundby, Johanne; Schmidt, Lone, Denmark
P36
UNEXPLAINED RECURRENT PREGNANCY LOSS: NO THERAPY SHOULD BE OFFERED
Sapra, Eshanjit, Kayaalp, Emre; Inglis, Steven, United States
P37
POOR RESPONSE IN CONTROLLED OVARIAN STIMULATION FOR IVF/ICSI CYCLES: THREE YEAR RETROSPECTIVE ANALYSIS
Silva, Joana R., Lourenço, Cátia; Osório, Marta; Cabral, Madalena; Pires, Ilda; Pinelo, Suel; Serra, Helena; Barbosa, António; Figueiredo, Helena; Felgueira,
Eduarda; Tavares, Angelina, Portugal
P38
THE DIFF-QUIK STAIN: A CLINICALLY VALUABLE TOOL TO EVALUATE HUMAN SPERM CHROMATIN STATUS
Tavares, Renata, Silva, Andreia; Almeida-Santos, Teresa; Sousa, Ana Paula; Ramalho-Santos, João, Portugal
P39
THE ROLE OF AMH IN THE EGG DONATION PROGRAM
Rumpikova, Tatana, Rumpik, David; Loucky, Jaroslav; Topolcan, Ondrej; Kucera, Radek; Belaskova, Silvie, Czech Republic
P40
KALLMANN SYNDROME IN A MAN: A GYNECOLOGIST’S DIAGNOSIS
Verissimo, Carlos, Portugal
P41
EFFECT OF MALE PARTNER AGE ON EARLY PREGNANCY LOSS RATES AMONG WOMEN YOUNGER THAN 38 YEARS UNDERGOING IVF/ICSI
TREATMENT
Verwoerd, Gideon, United Kingdom
P42
THE COMPI FERTILITY PROBLEM STRESS SCALES AND THE COMPI COPING STRATEGY SCALES: A PSYCHOMETRIC VALIDATION STUDY IN TURKISH
INFERTILE COUPLES
Sahin Yilmaz, Tulay, Yesiltepe Oskay, Umran , Turkey
P43
METHODS TO COPE WITH INFERTILITY STRESS OF INFERTILE COUPLES
Sahin Yilmaz, Tulay, Yesiltepe Oskay, Umran, Turkey
GYNECOLOGY
P44
HEMATOCOLPOS AND LOWER ABDOMINAL PAIN SECONDARY TO IMPERFORATE HYMEN
Abreu, Cátia, Ricardo, Cardoso; Cabrita, Pedro; Coutinho, Teresa; Jardim da Pena, Domingos, Portugal
P45
ADENOMYOSIS: AN ATYPICAL PRESENTATION
Afonso, Maria, Castro, Catarina; Osório, Filipa; Clode, Nuno, Portugal
P46
DIAGNOSIS AND TREATMENT OF CERVICAL INTRAEPITHELIAL NEOPLASIA; AT THE SAME TIME OR AS A SEPARATED PROCEDURE
Bajraktari, Denisa, Hoxhaj, Odeta, Albania; Gjoni, Maksim, Algeria
P47
DETORSION OF THE TWISTED OVARY AT 14 WEEKS GESTATION – CASE REPORT
Bello, Ana, Nércio, Ana; Barros, Liliana; Leitao, Carla; Sousa, Filomena, Portugal
-53-
P48
CERVICAL CANCER IN SIERRA LEONE- RESPONDING TO THIS PUBLIC HEALTH CHALLENGE
Bhoobun, Shalinee, McIntosh, Carol; Horner, Cynthia; Tegan, Edres; Cantwell, Mary Beth; Edmiston, Kirsten H., United Kingdom/United States/Sierra Leone
P49
PLAMA VITAMIN D LEVEL AMONG WOMEN WITH AND WITHOUT POLYCYSTIC OVARIAN SYNDROME
Broughton, Kenneth S, Redinger, Derek; Abdi, Jemilla, United States
P50
HYPEREMESIS GRAVIDARUM: AGGREVATING FACTORS AND MANAGEMENT
Bulugma, Mustafa Mustafa, Elmariamy, Omaima, Libyan Arab Jamahiriya
P51
HYPOPLASTIC UTERUS
Carvalho, Joana, Cubal, Adelaide; Torres, Sílvia; Costa, Fernanda; Mota, Lurdes; Torgal, Ana; Carmo, Olímpia, Portugal
P52
HYSTEROSCOPY IN THE DIAGNOSIS OF PATIENTS WITH POSTMENOPAUSAL UTERINE BLEEDING
Castro, Catarina, Godinho, Beatriz; Rodrigues, Andreia; Costa, Teresa Osório, Filipa; Alho, Conceição; Calhaz-Jorge, Carlos , Portugal
P53
OVARIAN TERATOMAS: A 6 YEAR CASUISTRY
Couto, Silvia M., Portugal
P54
A STRANGE LUNG METASTASIS DURING BREAST CANCER STAGING
Cunha, Vera, Valadares, Sara; Sereno, Pedro, Portugal
P55
THE ROLE OF HYSTEROSCOPY IN ASYMPTOMATIC WOMEN
Dias, Goncalo, Mendinhos, Gustavo; Igreja, Fernando; Pereira, José; Nazaré, Antónia, Portugal
P56
UTERINE FIBROID EMBOLIZATION - ALWAYS THE SOLUTION?
Faria, Barbara, Cubal, Adelaide; Carvalho, Joana; Marinho, Carla; Oliveira, Cristina; Carmo, Olimpia, Portugal
P57
TETRAPLOID PARTIAL HYDATIDIFORM MOLE: A CASE REPORT
Ferreira, Anabel, Oliveira, Nuno; Santos, Ana Cláudia; Moreira, Clara; Oliveira, Mario, Portugal
P58
EFFICACY OF 5-FLUOROURACIL, INTERFERON, AND ALBOTHYL IN THE TREATMENT OF HRHPV-RELATED OR UNRELATED CERVICAL
INTRAEPITHELIAL NEOPLASIA
Findri Gustek, Stefica, Orešcanin, V.; Fistonic, Ivan; Mlinaric-Missoni, Emilija, Croatia (Hrvatska))
P59
CORRELATION OF THE INFECTIONS OF THE GENITAL TRACT OF WOMEN AND THEIR LIFESTYLE WITH THE FREQUENCY OF MICRONUCLEI
Findri Gustek, Stefica, Orešcanin, V; Kopjar, N.; Petrovic-Raškovski, B.; Hunjak, B., Croatia (Hrvatska)
P60
PERITONEAL TUBERCULOSIS: A CASE REPORT
Franco, Adriana, Bruno, Diogo; Santos, Vanessa; Miranda, Mariana; Verissimo, Carlos; Pedro, Amélia; Igreja, Fernando; Silva Pereira, José, Portugal
P61
ACUTE ABDOMEN CAUSED BY SPLENIC PTOSIS AFTER HISTERECTOMY: A RARE DIAGNOSIS
Gameiro, Cátia, Vilhena, Cristina; Couto, Silvia; Mulet, Javier; Saraiva, João; Romão, Fátima, Portugal
P62
A NEW OPTION FOR TREATMENT OF LOCALIZED PROVOKED VULVODYNIA
Giraldo, Paulo, Yoshida, Laura; Ferreira Souza, Samantha; Breda, Nadia; Gonçalves, Ana Katherine; Amaral, Rose Luce, Brazil
P63
CERVICAL CANCER: HPV INFECTION AND HIPERESTROGENISM SINERGY
Doru, Campean, Giurea, I.A., Teodorescu, C., Romania
P64
GENITAL TUBERCULOSIS – A CASE REPORT
Fialho Gomes, Rui, Ramilo, Irina; Vanessa Santos, Ana; Franco, Adriana; Mendinhos, Gustavo; Igreja, Fernando; Azevedo, Luísa; Silva Pereira, José; Nazaré,
Antónia, Portugal
-54-
P65
CERVICAL DYSPLASIA AND MULLERIAN DUCT MALFORMATION (A CASE REPORT)
Gonçalves, Elisabete, Cubal, Adelaide; Marinho, Carla; Costa, Fernanda; Torgal, Ana; Carrapatoso, Cristina, Portugal
P66
COST-EFFECTIVENESS ANALYSIS OF VACUUM-ASSISTED CLOSURE TECHNICAL TO REDUCE THE HOSPITAL STAYS IN GYNECOLOGIC SURGERY SITE
INFECTION
González-Díaz, Oscar Armando, Torcida Gonzalez, Miguel Eloy; Briones-Lara, Evangelina; Caballero-Trejo, Amilcar; Mercado-Velazquez, Erika del Rocio., Mexico
P67
LAPAROSCOPIC AND VAGINAL OVARIAN CYSTECTOMY
Haxhihyseni, Arben, Vercuni, Daniela; Prifti, Migena, Albania
P68
HYSTERESCOPY VERSUS BLIND BIOPSY IN DIAGNOSING INTRACAVITARY LESIONS IN POSTMENOPAUSAL WOMAN WITH ABNORMAL UTERINE
BLEEDING: A SHORT SURVEY
Hoxhaj, Odeta, Bajraktari, Denisa; Dede, Eneida; Qirko, Robert, Albania
P69
DIAGNOSING CAUSES OF ABNORMAL UTERINE BLEEDING; TRANSVAGINAL SONOGRAPHY VERSUS SONOHYSTEROGRAPHY
Hoxhaj, Odeta, Alushani, Merita; Bare, Teuta; Paluka, Ermir, Albania
P70
EXPANDED RANGE POINT-OF-CARE ASSAY FOR HCG
Motamed, Kouros, Hwang, Larn; Hsiao, Chao; Trieu, Vuong, United States
P71
INVESTIGATION OF IN VITRO EFFECTS OF ESTROGENS AND SELECTIVE ESTROGEN RECEPTOR MODULATORS (SERMs) ON
TRICHOMONAS VAGINALIS
Inceboz, Tonay, Yalcin, Gulter; Bayrakal, Vahide; Inceboz, Umit; Derici, Yeser, Turkey
P72
A CASE REPORT: UTERINE LEIOMYOSARCOMA
Tavares Izzo, Ingrid, Alvarez, Ana Paula; Soares, Paulo Roberto; Telles, Maria Luiza; Fontes, Tereza ; Carvalhosa, Roberto, Brazil
P73
AMENORRHEA SECONDARY TO HERPETIC MENINGOENCEPHALITIS: CASE REPORT
Jesus, André, Custódio, Ana; Varela, Maria Gil; Torgal, Isabel, Portugal
P74
GENDER BIAS AT ACCEPTANCE OF STERILIZATION
Joglekar, Uday M., Bangal, Vidydhar B., India
P75
KRUKENBERG TUMOR - A CASE REPORT
Landim, Elsa , Catia, Paixão; Franco, Adriana; Miranda, Mariana; Bruno, Diogo; Silva Pereira, Jose, Portugal
P76
THE STUDY ON THE EXPRESSION OF SELECTED ANGIOGENESIS-RELATED GENES IN OVARIAN CANCER
Laudanski, Piotr, Charkiewic, Radoslaw; Kisielewski, Rafal; Klasa-Mazurkiewicz, Dagmara; Milczek, Tomasz; Rysak-Luberowicz, Dominik; Baranowski,
Wlodzimierz; Niklinski, Jacek, Poland
P77
COMPLEX OF TOLL-LIKE RECEPTORS 1, 2, 4 AND 10 INVOLVED TO PATHOGENESIS OF EARLY MISCARRIAGES
Lebedeva, Olga P., Pakhomov, Sergey; Ivashova, Olesya; Starceva, Natalia; Churnosov, Mikhail, Russian Federation
P78
UTEROVAGINAL APLASIA: MAYER-ROKITANSKY-KUSTER-HAUSER SYNDROME OR A NEW VARIANT OF MULTIPLE PTERYGIUM SYNDROME?
Lopes, Helena, Fernandes, Eugénia, Portugal
P79
EARLY ONSET CENTRAL PRECOCIOUS PUBERTY: SUCCESSFUL OUTCOME WITH LEUPROLIDE THERAPY
Machado, Lovina S.M., Mathew, Mariam, Oman
P80
HYSTEROSCOPIC AND LAPAROSCOPIC MANAGEMENT OF A C-SECTION SCAR HEMATOMA
Malafaia, Sofia, Sampaio, Joana; Sarmento, Inês; Soares, Fátima; Rebelo, Cláudio; Silva, Pedro Tiago, Portugal
-55-
P81
CROHN’S INVOLVEMENT OF THE VULVA: A CASE REPORT
Marinho, Carla, Cubal, Adelaide; Costa, Fernanda; Barros, Luísa; Morgado, Ana; Carmo, Olímpia, Portugal
P82
OVARIAN MUCINOUS CYSTADENOMA WITH A MURAL LEIOMYOMA MASQURADING AS A MALIGNANCY
Mathew, Mariam, Machado, Lovina; Gonsalves, Hazel; Saparamadu, Pam, Oman
P83
CHANGES OF WATER VOLUME IN THE UPPER AND LOWER LIMBS DURING THE MENSTRUAL CYCLE IN JAPANESE
Matsuda, Kaori, Japan
P84
HORMONAL CONTRACEPTION AND BENIGN VASCULAR TUMORS
Mendonça, Rubina, Machado, Ana Isabel; Gomes, Rui, Portugal
P85
ROLE OF ANTIMULLERIAN HORMONE IN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME
Micallef Fava, Alison, Vella, Katia; Tsar, Olha; Calleja Aguis, Jean; Brincat, Mark P., Malta
P86
MANAGEMENT OF PELVIC INFLAMMATORY DISEASE
Miranda, Mariana, Franco, A.; Landim, E.; Diogo, B.; Paixão, C.; Pedro, A.; Silva Pereira, J.; Nazaré, A., Portugal
P87
APPENDICEAL MUCOCELE MIMICKING AN ADNEXAL MASS: ULTRASOUND FINDINGS IN TWO CASES
Nadasan, Vijeyaletchimi, Wong, Wai-Leng; Lee, Sook-Ling; Tang, Choong-Leong; Ho, Tew-Hong, Singapore
P88
LYMPHANGIOLEIOMYOMATOSIS IN A PREMENOPAUSAL WOMAN – CASE REPORT
Nércio, Ana C., Condeço, Raquel; Sousa, Filomena, Portugal
P89
THE USE OF LNG-IUS AFTER CONSERVATIVE MYOMECTOMY AS A METHOD OF ANTIRECURRENT TREATMENT OF UTERINE FIBROIDS
Novikova, Vladislava A., Anatoly, Zatzepin V.; Penzhoyan, Grigory A.; Fedorovich, Oleg K., Russian Federation
P90
MOTIVATIONS TO EXCHANGE CONDOM, BAHAVIORAL, INJECTABLE OR ORAL CONTRACEPTIVES TO LEVONORGESTREL-RELEASING
INTRAUTERINE SYSTEM
Ferreira, Jéssica, Nunes, Fabiana; Bahamondes, Luis, Brazil
P91
WHEN AN UNDESIRED PREGNANCY HAPPENS: HOW DOES IT CHANGE CONTRACEPTION?
Oliveira, Natacha, Correia, Lúcia; Rosado, Vanessa; Machado, Ana Isabel; Alves, Maria José, Portugal
P92
SURGICAL COMPLICATIONS IN GYNECOLOGY – TWO YEARS EXPERIENCE IN OUR DEPARTMENT
Paixao, Catia, Ramilo, Irin; Mendinhos, Gustavo; Igreja, Fernando; Pereira, Jose, Portugal
P93
KRUKENBERG METASTASES– A CASE REPORT
Paixao, Cátia, Costa, Jorge; Landim, Elsa; Miranda, Mariana; Igreja, Fernando Paixão; Martins, Carlos; Pereira, Jose Paixão, Portugal
P94
ORAL CONTRACEPTION IN TREATMENT OF MYOMA AND ENDOMETRIOSIS
Pasman, Natalia M., Bespalov, Irina V; Smirnova, Ylia A., Russian Federation
P95
ADNEXAL MASS: OVARY TUMOR OR PELVIC TUMOR? – CASE REPORT
Pedroso, Célia, Robalo, Raquel; Antunes, Inês; Mendes, Neuza; Sereno, Pedro; Barros, Carlos; Marques, Carlos, Portugal
P96
OVARIAN TORSION DURING PREGNANCY: ABOUT A CASE REPORT
Proenca, Sara, Reis, Maria Ines; Brito, Iris; Mouraz, Mariana; Santos Pereira, Helena; Rodrigues, Rosalinda; Nunes, Filomena, Portugal
P97
CHARACTERIZATION OF LESIONS CLASSIFIED AS B3 IN BREAST NEEDLE CORE BIOPSY
Rasteiro, Cátia, Caldeira, Beatriz; Braga, José; Costa, Susy; Correia, Alda; Fougo, José; Amendoeira, Isabel, Portugal
-56-
P98
HYSTEROSCOPIC STERILIZATION (ESSURE®): EVALUATION OF 114 CASES
Reis, Ana, Vieira, Bruna; Carvalho, Susana; Teixeira, Marcilia; Barreiro, Marcia; Leal, Manuela, Portugal
P99
VAGINAL EVISCERATION FOLLOWING FIRST POSTOPERATIVE COITUS: REPORT OF TWO CASES
Ribeiro, Rita, Vicente, Ana; Teixeira, José, Portugal
P100
GIANT VULVAR SOFT TISSUE TUMOURS: TWO CASES REPORT
Rodrigues, Ana Isabel, Fan, Yida; Silva, Teresa; Lourenço, Cláudia; Vizcaíno, Ramon; Fernandes, Eugénia; Morgado, Alexandre, Portugal
P101
SIGNIFICANCE OF ABNORMAL ENDOMETRIAL THICKNESS IN POSTMENOPAUSAL WOMEN WITH AND WITHOUT BLEEDING
Rodrigues, Andreia, Castro, Catarina; Godinho, Beatriz; Osório, Filipa; Alho, Conceição; Calhaz Jorge, Carlos, Portugal
P102
LEVONORGESTREL INTRAUTERINE DEVICE IN MENORRHAGIA TREATMENT – EFFICACY AND ADVERSE EFFECTS
Rosado, Vanessa, Oliveira, Natacha; Reis, J, Portugal
P103
PELVIC LYMPHANGIOLEIOMYOMATOSIS, A TUBEROUS SCLEROSIS COMPLEX ASSOCIATED FORM : A CASE REPORT
Sampaio, Joana , Gonçalves, Inês; Malafaia, Sofia; Rebelo, Claudio; Silva, Pedro; Amaro, Teresina ,Portugal
P104
CYTOCOLPOHYSTOLOGICAL CORRELATION IN PATIENTS WITH INTRACERVICAL LESION
Santos, Joana, Pinto, Rita; Morais, Marta; Andrade, Cláudia; Solheiro, Helena, Portugal
P105
THE ROLE OF MAGNETIC RESONANCE IMAGING IN THE DIAGNOSIS OF MULLERIAN DUCT ANOMALIES OF THE UTERUS
Santos, Mónica, Nunes, Filipa; Noruegas, Maria José; Geraldes, Fernanda; Barbosa, Luciana , Portugal
P106
LONG-ACTING REVERSIBLE CONTRACEPTION WITH CONTRACEPTIVE IMPLANT IN WOMEN WITH DISABILITIES
Santos, Monica, Nunes, Filipa; Geraldes, Fernanda, Portugal
P107
CLINICAL,MICROBIAL AND CYTOPATHOLOGICAL STUDY OF INTRAUTERINE CONTRACEPTIVE DEVICE USERS
Sarkar, Debashish, Acharya, V., India
P108
HYDROSALPINX IN PEDIATRIC AGE – CASE REPORT
Silva, Fátima, Quintas, Andrea; Felgueira, Eduarda; Ramalho, Graça, Portugal
P109
A CASE OF ATYPICAL GLANDULAR CELLS FAVOR NEOPLASTIC – IN PURSUIT OF A DIAGNOSIS
Silva, Patrícia, Fernandes, Fátima; Ledo, Marta; Remesso, Lília; Tania, Freitas, Portugal
P110
LEVONORGESTREL INTRAUTERINE SYSTEM AS A TREATMENT OPTION FOR SEVERE MENORRHAGIA IN ADOLESCENT WITH TYPE III VON
WILLEBRAND DISEASE – CASE REPORT
Silva, Carla, Nunes, Elsa; Geraldes, Fernanda; Salvado, Rámon, Portugal
P111
ADENOMATOID TUMOR OF THE UTERUS IN A PATIENT WITH TRANSCERVICAL MASS
Song, Yong Jung, Na, Yong Jin, Republic of Korea
P112
RADIOGUIDED OCCULT LESION LOCALIZATION AND SENTINEL NODE OCCULT LESION LOCALIZATION – OUR EXPERIENCE
Sousa, Rita, Teixeira, Álvaro; Martins, Fernando, Portugal
P113
BODY WEIGHT AND COMPOSITION OF DEPOT MEDROXYPROGESTERONE ACETATE USERS
DalÁva, Natália, Bahamondes, Luis Monteiro, Ilza, Brazil
P114
MIGRATION OF A LEVONORGESTREL-RELEASING INTRAUTERINE SYSTEM INTO THE SIGMOID COLON: ENDOSCOPIC APPROACH
Teixeira, Neusa, Prata, João; Vale, Emidio; Rodrigues, Fedra; Silva, Cristina; Carvalho, Agostinho; Lopes, Luis, Portugal
-57-
P115
CASE REPORT: BREAST TUBERCULOSIS
Teles, Maria Luiza, Tavares, Ingrid; Fontes, Tereza; Carvalhosa, Roberto; de Paula, Thales; Alvim, Katia, Brazil
P116
A CASE REPORT: AXILLARY METASTATIC MELANOMA
Tavares, Ingrid, Teles, Maria Luiza; Fontes, Tereza; Carvalhosa, Roberto; de Paula, Thales; Soares, Paulo, Brazil
P117
A CASE REPORT: MAMMARY CARCINOSARCOMA
Teles, Maria Luiza, Tavares, Ingrid; Fontes, Tereza; Carvalhosa, Roberto; de Paula, Thales; Gutman, Tereza, Brazil
P118
EFFECT OF HUMAN CORIONIC GONADOTROPIN (RHCG), URINARY (UHCG) AND RECOMBINANT (RHCG), ON HIGH MOBILITY GROUP BOX-1
(HMGB-1) EXPRESSION IN HUMAN ENDOMETRIUM AND FETAL MEMBRANES
Ticconi, Carlo, Pietropolli, Adalgisa; Mari, Emanuela; Bruno, Valentina; Piccione, Emilio;Zicari, Alessandra, Italy
P119
CONTROVERSY IN THE TREATMENT OF CIN II
Tinoco, Leopoldo, Nicolalde, Angelo,Carrillo, Sonia; Tinoco, Ramiro; León, Erika; Avilés, Pablo, Ecuador
P120
ASC-US (ATYPICAL SQUAMOUS CELL UNDETERMINATED SIGNIFICANCE)
Tinoco, Leopoldo, Nicolalde, Angelo;Sonia, Carrillo; Tinoco, Diana; Diaz, Mary Paz; Avilés, Pablo, Ecuador
P121
IS ENHANCED RECOVERY PROGRAMME REALLY COST EFFECTIVE FOR VAGINAL HYSTERECTOMY?. A COMPARISON OF PRE AND POST
IMPLEMENTATION EXPENDITURES
Lodhi, Wasim, Bell, Alex; Relph, Sophie; Tsar, Olha, Malta; Sivashanmugarajan, Viswa; Munro, K.; Yoong, Wai, United Kingdom
P122
THE MAMMOGRAPHIC ACCURACY IN PATIENT WITH NEWLY DIAGNOSED SOLID PALPABLE BREAST LESIONS: OUR EXPERIENCE
Vaidakis, Dennis, Makris, George- Marios; Vaidakis, Dennis; Kouloura, Andriana; Siristatidis, Charalambos; Chrelias, Charalambos, Greece
P123
INTRAVENOUS LEIOMYOMATOSIS: A BENIGN UTERINE VARIANT WITH POTENTIAL EXTRAUTERINE DISEASE – LITERATURE REVIEW
FROM A CASE REPORT
Vale Fernandes, Emídio, Rodrigues, Fedra; Barros, Nuno; Braga, Luís; Carvalho, Luís; Serrano, Paula; Jardim Pena, Domingos, Portugal
P124
VIRTUAL REALITY SIMULATION FOR LAPAROSCOPIC TUBAL STERILIZATION TRAINING
Bharathan, Rasiah, Vali, Saaliha; Setchall, Tom; Miskry, Tariq; Darzi, Ara; Aggarwal, Rajesh, United Kingdom
P125
A 5 YEARS EXPERIENCE WITH LEVONORGESTREL RELEASING INTRAUTERINE SYSTEM IN MENORRHAGIA THERAPY IN LATVIA
Vasaraudze, Ineta, Rezeberga, Dace; Lejnieks, Aivars, Latvia
P126
EMERGENCY CONTRACEPTION – WHAT WOMEN KNOW?
Vasconcelos, Catarina, Simões, Ana; Machado, Ana Isabel; Delgado, Elsa, Portugal
P127
INTERSTITIAL ECTOPIC PREGNANCY – CONTROVERSIES IN MANAGEMENT AND TREATMENT
Vilar Soares, Sandra, Casanova, João; Paiva, Catarina; Rodrigues, Rosa Maria; Cunha, Ana Cristina, Portugal
P128
PREMENSTRUAL SYNDROME ON UNIVERSITY STUDENTS
Bakir, Nazife, Yangin, Hatice Balci, Turkey
P129
REASONS WHY PARTNERS PREFER TRADITIONAL CONTRACEPTIVE METHODS
Buldurucu, Sinem, Turkey
P130
A DOUBLE-BLIND, MULTIPLE-DOSE ESCALATION RCT OF A CHINESE HERBAL MEDICINE FOR THE TREATMENT OF SEVERE MENOPAUSAL
SYMPTOMS IN CHINESE WOMEN
Chung, Tony, Hong Kong
-58-
P131
ACCURACY OF ULTRASONOGRAPHIC AND HISTEROSCOPIC EVALUATION IN POSTMENOPAUSAL METRORRHAGIA
Ferraz, Zita, Ramos, Vera; Moita, Bárbara; Carvalho, Giselda; Falcão, Francisco; Torgal, Isabel, Portugal
P132
ENDOMETRIAL PATHOLOGY IN POSTMENOPAUSAL WOMEN WITH METRORRHAGIA
Ferraz, Zita , Moita, Bárbara; Ramos, Vera; Carvalho, Giselda; Falcão, Francisco; Torgal, Isabel, Portugal
P133
SLEEP QUALITY AND AEROBIC TRAINING AMONG MENOPAUSAL WOMEN – A RANDOMIZED CONTROLLED TRIAL
Luoto, Riitta M., Mansikkamäki, Kirsi; Raitanen, Jani; Nygård, Clas-Håkan; Heinonen, Reetta; Mikkola, Tomi; Tomas, Eija, Finland
P134
EFFECT OF CONTINUOUS VS. SEQUENTIAL ESTRADIOL/PROGESTOGEN ON THE PROLIFERATION OF HUMAN BREAST CANCER CELLS
OVEREXPRESSING PGRMC1
Ruan, Xiangyan, China, Helen, Schneck; Neubauer, Hans; Seeger, Harald; Fehm, Tanja; Mueck, Alfred O, Germany
P135
HYSTEROSCOPY IN ASYMPTOMATIC POSTMENOPAUSAL WOMEN WITH ULTRASOUND ENDOMETRIAL THICKENING
Ramos, Vera, Barbara, Moita; Zita, Ferraz; Marques, João P.; Falção, Franscisco; Torgal, Isabel, Portugal
P136
CORRELATION BETWEEN STEROID ENDOMETRIAL RECEPTORS, KI-67 AND BCL-2 WITH INSULIN RESISTANCE AFTER MENOPAUSE
Wolff, Luis Paulo, Vassallo, José; Pinto, Cristina Laguna; Bahamondes, Luis G.; Monteiro, Ilza Maria Imu, Brazil
P137
ENDOMETRIAL ASSESSMENT IN POSTMENOPAUSAL WOMEN AND THE CORRELATION WITH IMC
Wolff, Luis Paulo, Atti, Carolina de Souza; Vassallo, José; Andrade, Liliana Lada; Monteiro, Ilza Imu, Brazil
P138
SYNCHRONOUS OVARIAN ENDOMETRIOID ADENOCARCINOMA AND TRANSITIONEL CELL BLADDER CARCINOMA IN PREGNANCY:
A CASE REPORT
Inceboz, Umit , Guler, Cem; Ureyen, Eda; Kucukyangoz, Ahmet; Keyik, Bahar; Uzgoren, Engin, Turkey
P139
CLEAR CELL CARCINOMA OF THE ABDOMINAL WAlll: CASE REPORT
Jesus, André, Frutuoso, Cristina; Torgal, Isabel, Portugal
P140
POSTMENOPAUSAL ENDOMETRIOSIS DIAGNOSED BY LAPAROSCOPY WITHOUT PREVIOUS HORMONAL REPLACEMENT
Ki, Kyung-Do, Lee, Jong-Min, Republic of Korea
P141
LAPAROSCOPIC TREATMENT OF RARE FORMS OF ENDOMETRIOSIS
Puchkov, Konstantin, Podzolkova, Natalya; Andreeva, Julia; Korennaya, Vera; Dobychina, Anna, Russian Federation
P142
QUALITY OF LIFE IN WOMEN WITH ENDOMETRIOSIS
Nunes, Fabiana, Ferreira, Jéssica; Bahamondes, Luis, Brazil
P143
EXPRESSION OF CD44 IN ENDOMETRIAL CELLS AND CORRELATION WITH ADHERENCE TO PERITONEAL MESOTHELIAL CELLS FROM
WOMEN WITH AND WITHOUT ENDOMETRIOSIS
Na, Yong Jin, Song, Yong Jung, Republic of Korea
P144
POTENTIAL MARKERS FOR DETECTION OF ADENOMYOSIS
Sorokina, Anna, Radzinsky, Victor E.; Ziganshin, Rustam X.; Arapidi, George A., Russian Federation
P145
EFFECT OF INDOLE-3-CARBINOL AND EPIGALLOCATECHIN GALLATE OF TREATMENT OF WOMEN WITH SYMPTOMATIC ADENOMYOSIS
Sorokina, Anna, Russian Federation
P146
ENDOMETRIAL POLYPS: CORRELATION BETWEEN ULTRASONOGRAPHIC, HYSTEROSCOPIC AND PATHOLOGIC FINDINGS
Godinho, Ana Beatriz, Castro, Catarina; Rodrigues, Andreia; Costa, Teresa; Osório, Filipa; Alho, Conceição; Calhaz-Jorge, Carlos, Portugal
P147
A NEW APPROACH IN LAPAROSCOPIC CORNUECTOMY: A CASE SERIES OF 4 PATIENTS USING THE ENDO GIA STAPLER
Lodhi, Wasim, Anderson, Katherine; Yoong, Wai, United Kingdom
-59-
P148
RESULTS OF LAPAROSCOPIC TUBAL RECONSTRUCTIVE SURGERY: EXPERIENCE OF MOHAMED VI HOSPITAL IN MARRAKESH, MOROCCO
Mansouri, Mohamed Zakaria, Aboulfalah, Abderrahim; Ait Benkaddour, Yassir; Asmouki, Hamid; Soummani, Abderraouf, Morocco
P149
‘THE DALTON TECHNIQUE’, A MODIFIED HASSON APPROACH TO LAPAROSCOPIC ENTRY IN GYNAECOLOGICAL SURGERY –
HOW LONG DOES IT TAKE?
Wilde, Carolyn, Milne, Katie J., Australia
P150
HYSTEROSCOPIC TREATMENT FOR ADENOMYOSIS
Shpati, Dritan, Qirko, Robert; Qirko (Cipo), Margareta; Nonaj, Blenard; Shkurti, Endrin, Albania
P151
TUBAL PATENCY EVALUATION IN INFERTILE FEMALES BY POST DIAGNOSTIC HYSTEROSCOPIC ULTRASOUND EXAM IN COMPARISON WITH
CHROMOPERTUBATION LAPAROSCOPY
Qirko, Robert, Shpati, Dritan; Kosova, Halim; Cakoni, Albert; Metushi, Shpresa; Vata, Ervis, Albania
P152
COST-EFFECTIVENESS ANALYSIS COMPARING THE ESSURE TUBAL STERILIZATION PROCEDURE AND LAPAROSCOPIC TUBAL STERILIZATION
Regalo, Ana, Caseiro, Lara; Fernandes, Fernando, Portugal
P153
RESECTOSCOPY FOR UTERINE FIBROID TREATMENT
Rijo, Cláudia, Costa, Ana; Pereira, Ana Paula, Portugal
P154
INTRAPERITONEAL SUB-DIAPHRAGMATIC INSTILLATION OF BUPIVACAINE PLUS MORPHINE FOR REDUCING POSTOPERATIVE SHOULDER PAIN
AFTER GYNECOLOGIC ENDOSCOPY
Sutchritpongsa, Pavit, Thailand
P155
CLINICAL SIGNIFICANCE AND HISTOLOGICAL CORRESPONDENCE OF ATYPICAL GLANDULAR CELLS
Batista, Joana, Ferreira, Carolina; Oliveira, Elda; Santos Paulo, António; Solheiro, Helena, Portugal
P156
DOES SIZE CONE MATTERS?
Ferreira, Leonor, Ribeiro, Vera; Cruz, Carmo; Gago, Carlos; Viana, Jose; Pacheco, Amalia; Capela, Eunice, Portugal
P157
HPV TESTING IN THE EVALUATION OF ATYPICAL SQUAMOUS CELLS OF UNDETERMINED SIGNIFICANCE (ASC-US)
Gomes, Guida, Antunes, Inês; Ambrosio, Paula; Paula, Tereza; Borrego, Jorge , Portugal
P158
EVALUATION OF HPV TESTING AS A FOLLOWUP METHOD IN WOMEN TREATED WITH CONIZATION
Henic, Emir, Borgfeldt, Christer; Alenius, Julia; Darlin, Lotten, Sweden
P159
GIGGLE INCONTINENCE: HOW TO TREAT?
Abreu, Cátia, Ricardo, Cardoso; Cabrita, Pedro; Mira Coelho, Manuela; Jardim da Pena, Domingos, Portugal
P160
CONSEQUENCES OF LEVATOR ANI AVULSION ON PELVIC FLOOR DYSFUNCTION
Condeco, Raquel, Bello, Ana; Nercio, Ana Cristina; Bernardo, Maria José; Mira, Ricardo, Portugal
P161
TRANSPERINEAL ULTRASOUND AND URINARY INCONTINENCE
Condeco, Raquel, Bello, Ana; Nercio, Ana Cristina; Bernardo, Maria José; Mira, Ricardo, Portugal
P162
ADOLESCENT ACUTE URINARY RETENTION
Das, Sayantana, Das, Debasis; Long, Lisa; Clarke, Sonji, United Kingdom
P163
URETHRAL ALTERATIONS OF SEVERE DIABETES AND PREGNANCY IN RATS
Marini, Gabriela, Piculo, Fernanda; Damasceno, Debora Cristina; Michelin Matheus, Selma Maria; Felisbino, Sérgio Luis; Pascon Barbosa, Angélica Mércia;
Daneshgari, Firouz; Hijaz, Adonis; Vieira Cunha Rudge, Marilza, Brazil/United States
-60-
P164
RETROPUBIC SLING (TENSION-FREE VAGINAL TAPE – TVT) AS AN OPTION FOR SURGICAL TREATMENT OF STRESS URINARY INCONTINENCE
(SUI) – REVIEW OF LAST SEVEN YEARS OF EXPERIENCE (2005-2011)
C Nunes, Filipa, Carvalho, Giselda; Falcão, Francisco; Torgal, Isabel, Portugal
P165
STRESS URINARY INCONTINENCE AFTER GENITAL PROLAPSE SURGERY
Nunes, Elsa Silva, Carla; Castro, Geraldina; Aparício, Conceição; Catarino, André; Negrão, Liana, Portugal
P166
STRUCTURAL ANALYSIS OF THE EXTRACELLULAR MATRIX AND URETHRAL STRIATED MUSCLE IN DIABETIC PREGNANT RATS
Piculo, Fernanda, Marini, Gabriela; Damasceno, Débora Cristina; Pascon Barbosa, Angélica Mércia; Michelin Matheus, Selma Maria; Felisbino, Sérgio Luis,
Brazil; Daneshgari, Firouz; Hijaz, Adonis; Vieira Cunha Rudge, Marilza, Brazil/United States
P167
IS IT PERINEAL ULTRASOUND IMPORTANT FOR STRESS URINARY INCONTINENCE (SUI) DIAGNOSIS?
Rijo, Cláudia, Viana, Rui; Grilo, Isabel; Colaço, João, Portugal
P168
UNDERSTANDING WOMEN’S EXPERIENCES OF ELECTRONIC INTERVIEWING DURING THE CLINICAL EPISODE IN UROGYNAECOLOGY:
A QUALITATIVE STUDY
Dulai, Anupreet, Radley, Stephen; Sidhu, Herjit, United Kingdom
P169
PREDICTORS OF FAILURE WITH TOT PROCEDURE IN THE TREATMENT OF SUI - A RETROSPECTIVE STUDY
Simões, Mafalda, Alves, João ; Reis, Maria Inês; Viana, Rui; Grilo, Isabel; Serra, Filipe; Colaço, João, Portugal
P170
UTERINE SARCOMAS: ARE THEY RARE? FIVE YEARS EXPERIENCE OF A TERTIARY CENTER
Afonso, Maria, Mendes, Sofia; Rodrigues, Ana; Calhaz Jorge, Carlos, Portugal
P171
CASE REPORT: A RARE CASE OF ADENOCARCINOMA OF VAGINA
Braga, Luís, Fernandes, E; Abreu, Cátia; Cabrita, Pedro; Serrano, Paula; Pena, Jardim, Portugal
P172
AN INCREDIBLE GIANT ADNEXAL CYST: A CASE REPORT
Brás, Filipa, Sardinha, Rosa; Afonso, Herminia; Costa, Sofia; Vieira de Castro, Pedro, Portugal)
P173
PARTIAL HYDATIDIFORM MOLE WITH ASSOCIATED HYPERTHYROIDISM – A CASE-BASED UPDATE IN MANAGEMENT AND FOLLOWUP OF GESTATIONAL TROPHOBLASTIC DISEASE
Brito, Íris, Reis, Inês M.; Mouraz, Mariana; Proença, Sara; Conde, Pedro; Pedroso, Sónia; Grilo, Isabel; Nunes, Filomena, Portugal
P174
OVARIAN METASTATIC TUMOR OF CHOLANGIOCARCINOMA: A RARE TYPE OF KRUKENBERG’S
Caetano, Cecilia, Guerra, Carlos; Mota, Fernando; Torgal, Isabel, Portugal
P175
ENDOMETRIAL CANCER IN YOUNG WOMEN UNDER 45 – TEN YEARS OF OUTCOMES
Coelho, Diana, Costa, Sofia; Afonso, Herminia; Graça, Lucinda; Castro, Pedro V., Portugal
P176
A RETROSPECTIVE STUDY OF 43 BORDERLINE TUMORS OF THE OVARY A REVIEW OF CLINICOPATHOLOGIC FEATURES AND
TREATMENT MODALITIES
Dokle, Anika, Albania
P177
CANCER OF THE FALLOPIAN TUBE: REPORT OF TWO CASES
Eladel, Chahrazad, Jadid, Imane; Aboulfalah, Abderrahim; Asmouki, Hamid; Soummani, Aabderraouf, Morocco
P178
ENDOMETRIAL CARCINOMA PRESENTING AS PARARECTAL METASTASIS
Estevinho, Sofia, Sousa, Evanira; Vicente, Ana; Madeira, Lara; Estrela, António; Nogueira, Madalena; Fiel, José; Teixeira, José, Portugal
P179
A CASE OF SQUAMOUS CELL CARCINOMA OF THE UTERINE CERVIX IN A 49-YEAR-OLD VIRGIN
Figueiredo, Odete , Carvalho, Joana; Torgal, Ana; Costa, Fernanda; Branco, Paula; Gouveia, Alfredo; Salgado, Lurdes, Portugal
-61-
P180
UNSUCCESSFUL PREGNANCIES ATTEMPTS AFTER GESTATIONAL TROPHOBLASTIC DISEASE (GTD): CASE REPORT
Figueiredo, Pedro, Afonso, Hermínia; Duarte, Carla; Ferreira, Dânia; Mesquita, Manuela; Reis, Isabel, Portugal
P181
PREGNANCY AFTER GESTACIONAL TROPHOBLASTIC DISEASE: EXPERIENCE OF 17- YEARS
Figueiredo, Pedro, Afonso, Hermínia; Duarte, Carla; Ferreira, Dânia; Mesquita, Manuela; Reis, Isabel, Portugal
P182
FERTILITY AND THE WISH TO HAVE CHILDREN AS SPECIFIC ISSUES OF YOUNG ONCOLOGICAL PATIENTS
Geue, Kristina, Richter, Diana; Schmidt, Ricarda; Sender, Annekathrin; Siedentopf, Freiderike; Stoebel-Richter, Yve; Braehler, Elmar, Germany
P183
INFORMATION ACQUISITION AND NEEDS AMONG YOUNG WOMEN WITH CANCER REGARDING FERTILITY PRESERVATION TREATMENT OPTIONS
Hershberger, Patricia E., Finnegan, Lorna; Altfeld, Susan; Lake, Sara; Hirshfeld-Cytron, Jennifer; Scoccia, Bert , United States
P184
HE4 AND OTHER TUMOR MARKERS IN OVARIAN CANCER DIAGNOSTICS
Kucera, Radek, Topolcan, Ondrej; Svobodova, Sarka; Presl, Jiri; Fuchsova, Radka; Vrzalova, Jindra; Rokyta, Zdenek; Betincova, Lucie; Novotny, Zdenek, Czech
Republic
P185
CLINICAL SIGNIFICANCE OF FOXP3-POSITIVE REGULATORY T CELLS IN CERVICAL CANCER
Lee, Jong-Min, Ki, Kyung-Do; Tong, Seo-Yeon; Lee, Kwang-Beom, Republic of Korea
P186
ADULT GRANULOSA CELL TUMOR – A CASE REPORT
Miranda, Mariana, Paixão, C.; Landim, E.; Bruno, D.; Igreja, F.; Campo, M.; Pereira, J., Portugal
P187
CLINICAL EVALUATION AND ROLE OF SURGERY IN OVARIAN CARCINOMA
Mohamed, Mawloud A., Bulugma, Mustafa; Gawas, Mustafa , Libyan Arab Jamahiriya
P188
ENDOMETRIAL CANCER IN PATIENTS WITH PREOPERATIVE DIAGNOSIS OF COMPLEX ATYPICAL HYPERPLASIA
Moita, Bárbara, Frutuoso, Cristina; Amaral, Natalia; Torgal, Isabel, Portugal
P189
Tamoxifen and endometrial lesions: hysteroscopic and histological findings
Moita, Bárbara, Ferraz, Zita; Ramos, Vera; Falcão, Francisco; Amaral, Natalia; Torgal, Isabel, Portugal
P190
EVALUATING ROBOTIC SURGERY VERSUS LAPAROTOMY IN THE OBESE GYNAE ONCOLOGICAL PATIENT: REVIEW
Myriokefalitaki, Eva, Smith, Michael; Ahmed, Ahmed, United Kingdom
P191
THE USE OF HE4 AND ROMA IN THE PREOPERATIVE DIAGNOSIS OF OVARIAN TUMORS
Janas, Lukasz, Nowak, Marek; Glowacka, Ewa; Stetkiewicz, Tomasz; Wilczynski, Jacek R., Poland
P192
TUMOR BUDDING AS A PROGNOSTIC MARKER IN CERVICAL CARCINOMA
Olgan, Safak, Saatli, Bahadir; Okyay, Emre; Gorken, Ilknur B.; Saygili, Ugur; Koyuncuoglu, Meral, Turkey
P193
MYELOID SARCOMA OF THE OVARY IN A PATIENT WITH ACUTE MYELOID LEUKEMIA
Pardal, Catarina, Vale Fernandes, Emídio; Barros, Nuno; Serrano, Paula, Portugal
P194
MANAGING SIMPLE OVARIAN CYSTS IN YOUNG WOMEN - A CASE REPORT OF A MUCINOUS CARCINOMA OF THE OVARY IN A 22 YEAR-OLD
Prata, Joao Pedro, Coutinho-Borges, José; Santos, Angela; Magalhaes, Domingos; Carvalho, Agostinho; Pinheiro, Paula, Portugal
P195
A RARE CASE OF A MALIGNANT SERTOLI-LEYDIG CELL TUMOR IN A POSTMENOPAUSAL WOMAN
Prata, Joao Pedro, Ferreira, Sandra; Gonçalves, Elisabete; Carvalho, Agostinho; Magalhaes, Domingos; Pinheiro, Paula, Portugal
P196
COMPARATION OF CLINICAL AND PATHOLOGIC CHARACTERISTICS IN WOMEN WITH ENDOMETRIAL CANCER (EC) WITH DIFFERENT BODY MASS
INDEX (BMI)
Rego, Joana, Botto, Isabel; Peralta, Fátima, Portugal
-62-
P197
ENDOMETRIAL ADENOCARCINOMA DURING THE FERTILE AGE
Rego, Joana, Silva, Carla; Henriques, Isabel; Barros, Margarida; Peralta, Fátima, Portugal
P198
OVARIAN BORDERLINE TUMOR AND FERTILITY - CASE REPORT
Reis Correia, André, Leitão, Carla; Mahomed, Fazila, Portugal
P199
BREAST CANCER IN YOUNG WOMEN–WHAT CONSEQUENCES?
Ribeiro, Vera, Sousa, Rita; Sousa, Gabriela; Castelo Branco, Elisabeth; Sá, Luís; Pereira da Silva, Daniel, Portugal
P200
VULVAR SARCOMA-CASE REPORT
Ribeiro, Vera, Sousa, Rita; Aldinhas, Paulo; dos Mártires, Francisco; Pereira da Silva, Daniel, Portugal
P201
FEMALE CANCER PATIENTS DEALING WITH POSSIBLE INFERTILITY
Richter, Diana, Geue, Kristina; Sender, Annekathrin, Dorst, Jana; Brähler, Elmar, Germany
P202
UTERINE SARCOMAS - CHEDV RETROSPECTIVE STUDY OF 13 AND A HALF YEARS
Rocha, Ilda, Caldas, Rita; Oliveira, Paula; Leitão, Susana; Costa, Cristina; Ferreira, Soledade; Lanhoso, António, Portugal
P203
GESTATIONAL TROPHOBLASTIC DISEASE - CHEDV RETROSPECTIVE STUDY OF 13 AND A HALF YEARS
Rocha, Ilda, Caldas, Rita; Oliveira, Paula; Leitão, Susana; Costa, Cristina; Ferreira, Soledade; Lanhoso, António, Portugal
P204
CASE REPORT: ENLARGED MEDIASTINAL LYMPH NODES IN A PATIENT WITH HISTORY OF ENDOMETRIAL CARCINOMA – ALWAYS METASTASES?
Rodrigues, Ana Isabel, Paiva, Catarina; Lopes, Helena; Gomes, Susana; Fernandes, Eugénia; Marques, Cláudia; Morgado, Alexandre; Marta, Susana, Portugal
P205
ENDOMETRIOID BORDERLINE OVARIAN TUMOR: A CASE REPORT
Rodrigues, Goncalo, Mendes, Sofia, Portugal
P206
BREAST CANCER AND DECEIVING TUMOUR MARKERS – A CASE REPORT
Rosado, Vanessa, Vieira, Silvia; Valadares, Sara; Sereno, Pedro, Portugal
P207
ISOLATED DRAINAGE SITE METASTASIS IN A CASE OF ENDOMETRIAL CANCER AFTER LAPAROTOMY
Simsek, Erhan, Yalcinkaya, Cem; Onal, Huseyin Cem; Yuksel Simsek, Seda; Bulgan, Esra; Kuscu, Esra, Turkey
P208
GIANT PHYLLODES TUMOR OF THE BREAST – A CASE REPORT
Sousa, Evanira, Estevinho, Sofia; Vicente, Ana; Ribeiro Carvalho, Francisco; Nogueira, Madalena; Fiel, José; Teixeira, José, Portugal
P209
INCIDENCE OF DIANDRIC TRIPLOIDY IN MISCARRIAGE
Tasha, Ilir, Tavo, Vangjel; Nonaj, Blenard; Xhani, Anila; Kurti, Erlind; Manoku, Nikita Toci, Ervin, Albania
P210
RECURRENT BLEEDING OF GESTATIONAL TROPHOBLASTIC TUMOR WITH VAGINAL METASTASES EVEN NORMAL SERUM hCG: A CASE REPORT
Tiyayon, Jitima, Thailand
P211
ROMA2 INDEX IN POSTMENOPAUSAL WOMEN
Topolcan, Ondrej, Kucera, Radek; Presl, Jiri; Fuchsova, Radka; Vrzalova, Jindra; Novotny, Zdenek; Rokyta, Zdenek; Betincova, Lucie, Czech Republic
P212
BREAST CANCER IN PREGNANCY - A COHORT STUDY OF A PORTUGUESE TERCIARY CENTER
Torres, Rita, Vieira, Silvia; Valadares, Sara; Sereno, Pedro, Portugal
P213
PRIMARY PULMONARY CHORIOCARCINOMA IN A MALE WITH GYNECOMASTIA
Tsikouras, Panagiotis, Csorba, Roland; Pinidis, Petros; Zambas, Aristotelis; Dafopoulos, Alexandros; Galazios, Georgios; Liberis, Vasileios; Teichmann, Alexander
Tobias; von Tempelhoff, Georg-Friedrich, Greece
-63-
P214
WHEN CAN LYMPHADENECTOMY BE OMITTED IN ENDOMETRIAL CANCER?
Urzal, Cecília, Sousa, Rita; Baltar, Vítor; Correia, Paulo; Cruz, Eugénia; Pereira da Silva, Daniel, Portugal
P215
HORMONAL CHANGES IN FEMALE SEXUALITY AFTER GYNECOLOGICAL OR BREAST CANCER TREATMENT
Vaidakis, Dennis, Kouloura, Andriana;Greece, Zarkadas, Stavros, Cyprus; Makris, George- Marios; Poulakaki, Nikiforita; Panoskaltsis, Theodoros, Greece
P216
CERVICAL CANCER IN PREGNANCY: A CASE REPORT
Vicente, Ana, Karakus, Gunes; Nogueira, Madalena; Matias, Judite; Luís, Alda; Francisca, Ana; Teixeira, José, Portugal
P217
IMPLANON SPONTANEOUS EXPULSION
Câmara, Sara, Abreu dos Santos, Filipa; Silva, Manuela; Freitas, Cláudia; Pereira, Helena, Portugal
P218
PERINATAL HIV TRANSMISSION DATA FROM MADEIRA ISLAND – PORTUGAL, BETWEEN 2003-2011: A RETROSPECTIVE STUDY
Abreu Dos Santos, Filipa, Silva, Manuela; Freitas, Tânia; Câmara, Sara; Pinto, Paula; Faria, Nancy; Magno, Carlos, Portugal
P219
PRETERM BIRTH IN TWIN GESTATIONS – 3 CASE REPORTS AND A REVIEW OF LITERATURE
Abreu Silva, Joao, Morais, Maria Jose; Maia, Catarina; Pinho, Manuela; Cunha, Emilia, Portugal
P220
BIRTH AFTER CESAREAN SECTION – IS INDUCTION OF LABOR WORTH IT?
Abreu Silva, Joao, Castro, Jorge; Pinho, Manuela; Cunha, Emilia, Portugal
P221
PERIPARTUM PERIOD FOR STILLBIRTH - DESCRIPTIVE STUDY OF FIVE YEARS
Afonso, Hermínia, Reis, Isabel; Costa, Sofia; Duarte, Carla; Sardinha, Rosa; Brás, Filipa, Portugal
P222
OUR EXPERIENCE OF 17-YEARS OF MANAGEMENT OF GESTATIONAL TROPHOBLASTIC DISEASE
Afonso, Hermínia, Reis, Isabel; Duarte, Carla; Costa, Sofia; Sardinha, Rosa; Brás, Filipa; Figueiredo, Pedro; Ferreira, Dânia , Portugal
P223
UNROOFED CORONARY SINUS ASD RESEMBLING CRISS-CROSS HEART: EARLY PRENATAL DIAGNOSIS
Agmon, Arnon, Bronshtein, Moshe; Egenburg, Sandro; Jaffa, Ariel J. ; Amster, Reuven, Israel
P224
ANTENATAL BETAMETHASONE VERSUS DEXAMETHASONE AND THEIR NEONATAL OUTCOMES: DIFFERENT OR THE SAME?
Aguilar, Sofia, Correia, Lucia; Gonçalves, Ana; Massa, Ana; Silva, Patricia; Ribeiro, Vânia; Palma, Fatima; Alves, Maria José; Campos, Ana, Portugal
P225
CLINICAL SIGNIFICANCE OF VERY ECHOGENIC AMNIOTIC FLUID AT TERM, CASE REPORT AND LETERATURE REVIEW
Tam, Genevieve, Canada, Aldughaishi, Tamima R., Oman
P226
MANAGEMENT OF A PREGNANT PATIENT WITH SEVERE DILATED CARDIOMYOPATHY AND AN AUTOMATIC IMPLANTABLE
CARDIOVERTER-DEFIBRILLATOR (ICD)
Almeida, Daniela, Vieira, Bruna; Dias, Cristina; Braga, Jorge; Pinheiro, Vieira, Portugal
P227
AFTER 40’S – HOW THEIR PREGNANCY IS REPRESENTED IN OUR HEALTH SYSTEM
Almeida, Diana, Leite, Tatiana; Dias, João; Lobo, Ivone, Portugal
P228
ADNEXECTOMY AFTER A PREVIOUS HYSTERECTOMY
Almeida, Patricia, Rebelo, Teresa; Torgal, Isabel, Portugal
P229
EVALUATION OF OXIDATIVE STRESS AND ANTIOXIDANT STATUS IN DIABETIC AND HYPERTENSIVE WOMEN DURING LABOR
Al-Shebly, Mashael, Mansour, Mahmoud, Saudi Arabia
-64-
P230
VAGINAL BIRTH AFTER CAESAREAN SECTION - 5 YEARS CASE REVIEW OF SANTARÉM HOSPITAL
Alves, Olga, Karakus, Günes; Estevinho, Sofia; Sousa, Evanira; Ribeiro, Rita; Vicente, Ana; Rodrigues, Carlos; Matias, Judite, Portugal
P231
INDUCTION OF LABOR AFTER PREVIOUS CAESAREAN SECTION - 5 YEARS CASE REVIEW OF SANTARÉM HOSPITAL
Alves, Olga, Karakus, Günes; Estevinho, Sofia; Sousa, Evanira; Ribeiro, Rita; Vicente, Ana; Rodrigues, Carlos; Matias, Judite, Portugal
P232
ECTOPIC PREGNANCY AND LEVONOGESTREL INTRAUTERINE DEVICE: A CASE REPORT
Amaral, Patrícia, Júlio, Catarina; Machado, Ana Isabel, Portugal
P233
FETAL OVARIAN CYST - BY A CASE
Ambrosio, Bruna, Ferreira, Ana Paula; Nazaré, Antónia, Portugal
P234
TITRATED ORAL SUSPENSION COMPARED WITH VAGINAL MISOPROSTOL FOR LABOR INDUCTION: A RANDOMIZED CONTROLLED TRIAL
Amorim, Melania Maria Ramo, Feitosa, Francisco Edson; Scavuzzi, Adriana; Katz, Leila; Souza, Alex Sandro, Brazil
P235
CESAREAN SCAR PREGNANCY: A CASE OF SUCCESSFUL TREATMENT WITH METHOTREXATE
Andrade, Marlene, Nogueira-Silva, Cristina; Marques, Eduarda; Machado, Ana Paula ; Moucho, Marina; Montenegro, Nuno, Portugal
P236
CHRONIC HYPERTENSION WITH SUPERIMPOSED PREECLAMPSIA COMPLICATED WITH HELLP SYNDROME AT 24 WEEKS OF GESTATION –
A CASE REPORT
Andrade, Marlene, Lima, Joana; Machado, Ana Paula; Mesquita, Rosa; Montenegro, Nuno, Portugal
P237
PRETERM BIRTH AND ADOLESCENCE - ONE YEAR REVIEW IN AN ADOLESCENCE UNIT
Antunes, Inês, Gomes, Guida; Correia, Lúcia; Martins, Isabel; Palma, Fátima, Portugal
P238
PRETERM BIRTH AND ADOLESCENCE - EXPERIENCE IN A TERTIARY CENTRE
Antunes, Ines, Gomes, Guida; Martins, Isabel; Palma, Fátima, Portugal
P239
PLACENTAL TRANSPORT OF GLUCOSE AND NEUTRAL AMINO ACIDS IS REDUCED BY OXIDATIVE STRESS IN A HUMAN TROPHOBLAST CELL LINE
Araújo, João, Pereira, Ana; Correia-Branco, Ana; Ferraz, Tiago; Keating, Elisa; Martel, Fátima, Portugal
P240
PRENATAL DIAGNOSIS CASE WITH AN INHERITED EUCHROMATIC CHROMOSOME 15 MARKER MOSAICISM
Azevedo, Ana , Caetano, Paula; Ribeiro, Catarina; Gonçalves, Diana; Correia, Isa; Barreta, Ana; Lança, Anabela; Silva, Fernando; Tarelho, Ana; Cavaleiro,
Catarina; Moreira, Isabel; Liehr, Thomas; Klein, Elisabeth; Hamid, Ahmed B.; Chaves, Joaquim; Correia, Hildeberto, Portugal/Germany
P241
DOUBLE BUBBLE SIGN AND THE CHALLENGE OF THE DIAGNOSIS
Azevedo, Sara, Torrão, Maria Manuel; Carreira, Helena; Seabra, Margarida, Portugal
P242
UNCOMMOM PRESENTATION OF A 3p DELECTION SYNDROME
Azevedo, Sara, Inocencio, Gonçalo; Rodrigues, Graça; Carmo, Olimpia; Guedes, Ana; Lopes, Luisa; Rodrigues, Maria Céu, Portugal
P243
PARTIAL HYDATIDIFORM MOLE, A CASE REPORT AND LITERATURE REVIEW
Bacalhau, Denise, Martins, Ana; Lilaia, Carla; Veca, Patrícia; Sousa, Ana Margarida; Costa, Cristina; Toller, Alexia; Djokovik, Dusan; Cirurgão, Fernando, Portugal
P244
UTERINE INVERSION, CASE REPORT AND LITERATURE REVIEW
Bacalhau, Denise ,Neto, Vitor; Gonçalves, Paula; Martins, Ana; Sousa, Ana Margarida; Cirurgião, Fernando; Sousa Pereira, Eduardo; Toller, Alexia; Djokovic,
Dusan, Portugal
P245
SEVERE PRE ECLAMPSIA COMPLICATED BY SUBCAPSULAR HEPATIC HEMATOMA-CASE REPORT
Bacelar, Filipe, Alves, Paulo; Silva, M.; Ledo, Marta; Silva, P.; Pereira, M. Portugal
P246
INCIDENCE OF HEREDITARY THROMBOPHILIA AND ITS IMPACT ON RECURRENT PREGNANCY LOSS IN POLAND
Balajewicz-Nowak, Marta, Pitynski, Kazimierz; Milewicz, Tomasz, Poland
-65-
P247
PREECLAMPSIA WITH SEVERE HYPONATRAEMIA - CASE REPORT
Baptista, Eduardo, Cabrita, Sofia; Jardim, Ondina; Marta, Elvira; Moura, Paulo, Portugal
P248
PREGNANCY DURING BREAST CANCER – CASE REPORT
Batista, Joana, Sousa, Ana; Cerveira, Isabel; Monteiro, Amélia; Cortez Vaz, Francisco, Portugal
P249
CONSERVATIVE MANAGEMENT OF SEVERE PREECLAMPSIA: MATERNAL AND PERINATAL OUTCOME
Bimbashi, Astrit, Ndoni, Eriseida; Dokle, Anika, Albania
P250
UTERINE ARTERIOVENOUS MALFORMATION IN PREGNANCY: A LIFE - THREATENING DIAGNOSIS
Birnbaum, Roee, Har-Toov, Joseph, Israel
P251
SPONTANEOUS INTRACRANIAL HYPOTENSION – A RARE CAUSE OF HEADACHE DURING PREGNANCY
Braga, António, Lima, Tânia; Chaves, João; Moreira, Clara, Portugal
P252
PREGNANCY WITH AUTOIMMUNE HEPATITIS
Braga, António, Vieira, Bruna; Pessegueiro, Helena; Gomes, Susana; Braga, Jorge, Portugal
P253
CASE REPORT: ADNEXAL TORSION IN PREGNANCY
Braga, Luís, Fernandes, E.; Cruz, Etelvina; Saleiro, Manuel; Cabrita, Pedro, Portugal
P254
THE EX UTERO INTRAPARTUM TREATMENT PROCEDURE IN A FETAL CERVICAL/SUB-MANDIBULAR LYMPHANGIOMA WITH PROTRUDING
TONGUE- A CASE REPORT
Brandão, Ana , Nunes, Filipa; Lobo, António; Barros, José; Ramalho, Rosa; Henriques, Raquel; Miranda, Teresa; Moura, Paulo, Portugal
P255
A 12 MONTHS REVIEW OF THE OBSTETRIC ASSESSMENT UNIT AT A LARGE UNIVERSITY TEACHING HOSPITAL, UK
Kropiwnicka, Zofia, Burrell, Celia, United Kingdom
P256
A 12 MONTHS REVIEW OF THE OBSTETRIC ASSESSMENT UNIT AT A LARGE UNIVERSITY TEACHING HOSPITAL, UK.
Burrell, Celia, Kropiwnicka, Zofia, United Kingdom
P257
SONOGRAPHYC MEASUREMENTS OF CERVICAL LENGTH PERFORMED AT 10 – 14 WEEKS AND 20 – 24 WEEKS OF GESTATION
AND IT’S IMPACT ON PREDICTING PRETERM DELIVERY
Bylykbashi, Edlira, Kosturi, Erinda; Bylykbashi, Ilir V.; Manaj, Aferdita, Albania
P258
EVALUATING WOMEN WITH RECURRENT SPONTANEOUS ABORTIONS (RFL)
Bylykbashi, Edlira, Bylykbashi, Ilir V.; Kosturi, Erinda, Albania
P259
MULLERIAN ANOMALIES AND PREGNANCY- 7 YEAR EXPERIENCE IN A TERTIARY HOSPITAL
Caeiro, Ana Filipa, Santos, Vanessa, Portugal
P260
PREGNANCY IN THE OBESE WOMEN - THE IMPACT OF BARIATRIC SURGERY
Campos, Sara, Lopes, Helena; Costa, Fernando Jorge; Lobo, António Carlos; Machado, Natália; Marta, Elvira; Moura, Paulo, Portugal
P261
GASTRIC DUPLICATION ASSOCIATED WITH CONGENITAL CYSTIC ADENOMATOID MALFORMATION, TYPE II
Campos, Sara, Tavares, Mariana; Franco, Sofia; Guerra, Nuno; Julião, Maria José; Machado, Natália; Vasco, Elsa; Moura, Paulo, Portugal
P262
POOR PROGNOSIS OF VASA PRAEVIA WHEN THE ANTENATAL DIAGNOSIS IS MISSED
Caramelo, Olga, Baptista, Eduardo; Areia, Ana; Vasco, Elsa; Moura, Paulo, Portugal
P263
THE IMPORTANCE OF PRENATAL DIAGNOSIS OF UMBILICAL CORD ABNORMALITIES-A CASE REPORT OF VELAMENTOUS INSERTION
Caramelo, Olga, Brandão, Ana; Miranda, Teresa; Moura, Paulo, Portugal
-66-
P264
VARICELLA IN PREGNANCY: REPORT OF CASE IN A MATERNITY LEAVE SCHOOL IN BRAZIL
Da Cunha Germano, Bianca Caroline, Freitas Bessa, Cintia Glenda; Cartaxo da Costa, Luciana Araujo; Freitas Bessa, Isaura Amalia; Freitas Galvao, Rafael
Bessa; de Souza, Maria Aparecida Cardoso, Brazil
P265
PREGNANCY AND OVARIAN cancer: REPORT OF CASE IN A BRAZILIAN SCHOOL MATERNITY.
Caroline Da Cunha Germano, Bianca, Freitas Bessa, Cintia Glenda; Freitas Bessa, Isaura Amalia; Cartaxo da Costa, Luciana Araujo; Freitas Galvao, Rafael
Bessa; De Souza, Maria Aparecida Cardoso, Brazil
P266
GUILLAIN-BARRE SYNDROME IN PREGNANCY: A CASE REPORT OF SUSPECTED ASSOCIATION TO CMV INFECTION
Cavaco-Gomes, João, Lima-Silva, Joana; Duarte, Sónia; Gamboa, Cristina; Montenegro, Nuno, Portugal
P267
PSEUDOANEURYSM OF UTERINE ARTERY: A RARE CAUSE OF LATE POSTPARTUM HEMORRHAGE
Cavaco-Gomes, João, Moreira, Cátia; Santos, Angela; Carraca, Teresa; Madureira, Miguel; Calejo, Lucinda; Montenegro, Nuno, Portugal
P268
FREE ß-HCG AND PREGNANCY-ASSOCIATED PLASMA PROTEIN A IN PREGNANT WOMEN WITH PREVIOUS UNEXPLAINED RECURRENT
MISCARRIAGE
Correia, Lúcia, Oliveira, Natacha; Torres, Rita; Martins, Ana Teresa; Nogueira, Isabel; Serrano, Fátima, Portugal
P269
SHORT CERVICAL LENGTH AND PREGNANCY OUTCOMES
Correia, Lúcia, Silva, Patrícia; Massa, Ana; Gonçalves, Ana; Aguilar, Ana Sofia; Ribeiro, Vânia; Palma, Fátima, Portugal
P270
ACUTE FATTY LIVER IN A TWIN PREGNANCY RESULTING IN INTRAUTERINE FETAL DEATH – A CASE REPORT
Correia, Patricia, Lisboa, Joana; Andrade, Marlene; Esteves, Francisco; Moutinho, Osvaldo, Portugal
P271
MANAGEMENT OF ATONIC POSTPARTUM HEMORRHAGE: OUR EXPERIENCE IN UTERINE ATONY
Costa, Sofia, Afonso, Hermínia; Duarte, Carla; Figueiredo, Pedro; Ferreira, Dânia; Pires, Maria José; Vilas Boas, Alice; Oliveira, Pedro; Sardinha, Rosa, Portugal
P272
GASTROSQUISIS, A CASE REPORT - WHEN AND HOW TO INTERVENE?
Coutinho-Borges, José Pedro, Gonçalves, Elisabete; Prata, João; Ribeiro, Domingos; Abreu, Rita; Almeida, Avelina; Pinheiro, Paula., Portugal
P273
HEMIVERTEBRAE, A CASE REPORT - THE IMPORTANCE OF ULTRASONOGRAPHY
Coutinho-Borges, José Pedro, Ferreira, Sandra; Santos, Angela; Ribeiro, Domingos; Abreu, Rita; Almeida, Avelina; Pinheiro, Paula, Portugal
P274
LAPAROSCOPIC MANAGEMENT OF A TORTED DERMOID CYST WITH PROSTATIC TISSUE IN PREGNANCY
Das, Sayantana, Guha, C.; Honakeri, S.; Fleming, A.; Uchil, D., United Kingdom
P275
PROPHYLACTIC ANTIBIOTICS FOR PREVENTION OF ENDOMETRITIS IN MANUAL EXTRACTION OF PLACENTA
Dede, Eneida, Hoxhaj, Odeta; Bajo, Rexhina, Albania
P276
MATERNAL BMI VERSUS PREGNANCY AND FOETAL OUTCOMES IN OXFORDSHIRE UK
Ding, Jane, Collins, Sally; Black, Rebecca, United Kingdom
P277
FOLLOW-UP AFTER GESTATIONAL TROPHOBLASTIC DISEASE: EXPERIENCE OF 17- YEARS
Duarte, Carla, Reis, Isabel; Oliveira, Pedro; Afonso, Hermínia; Ferreira, Dânia; Figueiredo, Pedro, Portugal
P278
THE RELIABILITY OF PRENATAL ULTRASOUND DIAGNOSIS OF GASTROINTESTINAL MALFORMATIONS
Dukanac Stamenkovic, Jelena, Ljubic, Aleksandar; Vrzic Petronijevic, Svetlana; Lukac, Marija; Petronijevic, Milos; Krsmanovic, Jovana, Serbia and Montenegro
P279
STEINERT SYNDROME – CLINICAL CASE
Enes, Pedro, Gomes, A.; Rodrigues, G.; Mota, L.; Carmo, O. Portugal
P280
SEVERE HYPOSPADIAS: AN ILLUSTRATED CASE REPORT
Estevinho, Sofia, Sousa, Evanira Sousa; Karakus, Gunes; Vicente, Ana; Barroso, Paula; Martins, Cristina; Delgado, josé; Luis, Alda, Portugal
-67-
P281
UTERINE RUPTURE AFTER SECOND TRIMESTER MEDICAL PREGNANCY TERMINATION WITH MISOPROSTOL IN WOMAN WITH PREVIOUS
CESAREAN: A CASE REPORT
Fernandes, Ana, Castro, Teresa; Ferraz, Tiago; Marques, Eduarda; Mesquita, Rosa Maria; Montenegro, Nuno, Portugal
P282
PRETERM PREMATURE RUPTURE OF MEMBRANES (PPROM) WITH GESTACIONAL AGE LESS THAN 32 WEEKS – EXPERIENCE OF OUR SERVICE
Ferreira, Anabel, Ramos, Vera; Domingues, Ana Patricia; Regedor, Augusto; Fonseca, Etelvina; Moura, Paulo, Portugal
P283
MOLAR PREGNANCY AFTER PERSISTENT GESTATIONAL TROPHOBLASTIC DISEASE: A CASE REPORT
Ferreira, Dânia, Afonso, Hermínia; Duarte, Carla; Figueiredo, Pedro; Azevedo, Horácio; Reis, Isabel, Portugal
P284
PITFALLS IN THE DIAGNOSIS OF INTERSTITIAL PREGNANCY – A CASE REPORT
Ferreira, Sandra, Portugal
P285
Episiotomy: is the suture of the skin important?
Ferreira, Leonor, Oliveira, Carolina; Leite, Tatiana; Cruz, Carmo; Lobo, Ivone; Viseu, Olga, Portugal
P286
DO WOMEN MAKE AN INFORMED CHOICE ABOUT THE SECOND TRIMESTER ULTRASOUND? WHO DOES NOT?
Georgsson Öhman, Susanne, Björklund, Ulla; Marsk, Anna, Sweden
P287
INTRAUTERINE GROWTH RESTRICTION MODIFIES THE NORMAL GENE EXPRESSION IN KIDNEY FROM RABBIT FETUSES
Goity, Cecilia, Lozano, Mauricio; Figueroa, Horacio; Tagle, Isabel; Bustos, Benjamin; Eixarch, Elizenda; Gratacos, Eduard; Hernández-Andrade, Edgar;
Irarrazabal, Carlos, Chile/Spain/Mexico
P288
OGILVIE'S SYNDROME-A RARE POST CAESAREAN SECTION COMPLICATION
Gokool, Yoginee, Robson, Gordon; Sircar, Shikhar, United Kingdom
P289
EARLY INTRAUTERINE GROWTH RESTRICTION: A CHALLENGE - CASE REPORT
Gomes, Ariana, Enes, Pedro; Rodrigues, Graça; do Carmo, Olímpia, Portugal
P290
MULTIPLE SCLEROSIS IN PREGNANCY – A CASE REPORT
Gomes, Guida, Antunes, Inês; Machado, Ana Isabel, Portugal
P291
PRIMARY GASTRIC DIFFUSE LARGE B-CELL LYMPHOMA DURING EARLY GESTATION: A CLINICAL REPORT
Gonçalves, Inês, Sampaio, Joana; Malafaia, Sofia; Rebelo, Cláudio; Ramada, Dulcina; Manarte, Paulo; Silva, Pedro, Portugal
P292
CVT IN PREGNANCY - A BOLT IN THE BLUE SKY
Hameed, Jamila, S. Radhika; Sophia, Anitha, India
P293
DANGEROUS ABDOMINAL PREGNANCY
Hoshino, Tatsuji, Matsumoto, Yuki; Hayashi, Nobutaka; Miyamoto, Taito; Hirao, Asuka; Oyama, Ruriko; Ohtake, Noriko; Kitamura, Sachiko; Suga, Mami;
Miyamoto, Kazunao; Takaoka, Aki; Aoki, Takuya; Imamura, Yuko; Kita, Masato, Japan
P294
EXPRESSION OF TOLL-LIKE RECEPTOR3 IS LOW IN CASES OF POSTPARTUM ENDOMETRITIS
Ivashova, Olesya, Lebedeva, Olga; Samborskaya, Natalia; Pakhomov, Sergey, Russian Federation
P295
DEVELOPING A PAIN MANAGEMENT MODEL FOR WOMEN WHO UNDERWENT CESARIAN SECTION IN PRACHOMKLAO HOSPITAL, THAILAND
Kansukcharearn, Angsinee, Thailand
P296
RECTAL CANCER DURING PREGNANCY - A CASE REPORT
Karakus, Gunes, Vicente, Ana Rita; Gameiro, Jose; Luis, Alda; Nogueira, Madalena; Matias, Judite, Portugal
P297
THE EVOLUTION OF C-SECTION’S INDICATIONS COMPARED TO ALTERNATIVE WAYS OF GIVING BIRTH IN ALBANIA
Kosturi, Erinda, Bylykbashi, Edlira; Bylykbashi, Ilir V; Manaj, Aferdita, Albania
-68-
P298
FATHERS’ INVOLVEMENT IN INFANT CARE: A MIXED METHOD STUDY
Kuruçirak, Sirin, Kulakaç, Özen, Turkey
P299
EARLY TREATMENT OF CERVICAL SHORTENING AFTER CONIZATION: IS THERE PLACE FOR THE ARABIN-PESSARY AND ABDOMINAL CERCLAGE?
Kyvernitakis, Ioannis, Schmidt, Stephan; Arabin, Birgit, Germany
P300
SEVERE OVARIAN HYPERSTIMULATION SYNDROME IN TWIN PREGNANCY – A CASE REPORT
Leal, Rui, Portugal
P301
PRENATAL DIAGNOSIS OF RECURRENT ENCEPHALOCELE IN TWIN PREGNANCY
Ledo, Marta, Silva, Manuela; Santos, Filipa; Pinto, Paula; Gomes, Manuel; Pereira, Helena, Portugal
P302
IS SUBSTITUTION OF IV IRON WITH A 'SIMILAR' ACCEPTABLE CLINICAL PRACTICE?
Lee, Eun Sil, Lee, Jeong-jae, Republic of Korea
P303
VON WILLEBRAND DISEASE AND PREGNANCY: AN UNUSUAL PRESENTATION
Leite, Tatiana, Almeida, Diana; Viana, José; Lobo, Ivone, Portugal
P304
Midline developmental defects - What is the present?
Leite, Tatiana, Almeida, Diana; Leça, Oriana; Mourinha, Vera; Viana, José; Páramos, Ana, Portugal
P305
HETEROTOPIC PREGNANCY: THE NEED FOR EARLY DIAGNOSIS
Lima, Tânia, Pinto, Ana Rita; Dias, Cristina; Oliveira, Teresa, Portugal
P306
MULTIPLE SCLEROSIS AND PREGNANCY: A TWO-WAY RELATIONSHIP?
Lima-Silva, Joana, Moreira, Ana; Cavaco-Gomes, João; Mesquita, Rosa; Montenegro, Nuno, Portugal
P307
A SECOND TRIMESTER UTERINE RUPTURE, A CONSEQUENCE OF ALCOHOLISM?
Lisboa, Joana, Correia, Patrícia; Andrade, Marlene; Castro, Diana; Moutinho, Osvaldo, Portugal
P308
OPERATIVE VAGINAL DELIVERY – FORCEPS DELIVERY VERSUS VACUUM EXTRACTION
Luz, Rita, Machado, Helena; Leal, Rui; Mendonça, Rubina; Simões, Jorge; Matos, Isabel, Portugal
P309
OBSTETRICAL OUTCOMES OF PREGNACIES COMPLICATED WITH FETAL MACROSOMIA
Luz, Rita, Machado, Helena; Leal, Rui; Mendonça, Rubina; Simões, Jorge; Matos, Isabel, Portugal
P310
REFRACTORY PERINATAL ATRIAL FLUTTER: A CLINICAL MANAGEMENT CHALLENGE
Machado, Lovina S.M., Mathew, Mariam; Abdullatif, Mohammed; Al-Senaidi, Khalfan, Oman
P311
PRENATAL SCREENING FOR FETAL ANEUPLOIDY - REALITY OF DR. DANIEL DE MATOS MATERNITY
Magalhães, Magda, Marques, Cecília; Franco, Sofia; Coelho, Filomena; Oliveiros, Bárbara; Martinho, Filomena; Moura, Paulo, Portugal
P312
FOETAL CARDIAC ARRHYTHMIAS: TWO CLINICAL CASES
Maia, Catarina, Silva, João; Morais, Maria José; Barbosa, Marta; Miranda, Nise; Carvalho, Claudina, Portugal
P313
TWIN-TWIN TRANSFUSION SYNDROME: A CLINICAL CASE
Maia, Catarina, Silva, João; Pinho, Manuela, Portugal
P314
MATERNAL MOLECULAR HYDROGEN ADMINISTRATION AMELIORATES RAT FETAL HIPPOCAMPAL DAMAGE BY IN UTERO ISCHEMIA-REPERFUSION
Mano, Yukio, Watanabe, Yuriko; Tsuda, Hirouki; Sumigama, Seiji; Kotani, Tomomi; Kikkawa, Fumitaka, Japan
-69-
P315
LATE POSTPARTUM ECLAMPSIA: A CASE REPORT
Marinho, Carla, Almeida, Amélia; Oliveira, Cristina; Meireles, Isabel; Morgado, Ana, Portugal
P316
PLACENTA PREVIA IN A PORTUGUESE TERTIARY CARE CENTER
Marques, Catarina, Pedroso, Célia; Torres, Rita; Martins, Isabel; Correia, Joaquim; Campos, Ana, Portugal
P317
BURKITT’S LYMPHOMA DURING PREGNANCY - CASE REPORT
Marques, Catarina, Simões, Mafalda; Gonçalves, Ana; Pierdomenico, Francesca; Nogueira, Isabel; Campos, Ana, Portugal
P318
AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE – THE IMPORTANCE OF PRENATAL DIAGNOSIS
Marques, Cecília, Magalhães, Magda; Bento, Nélia; Morais, Clara; Saraiva, Jorge; Moura, Paulo, Portugal
P319
CONGENITAL DIAPHRAGMATIC HERNIA– EXPECTANT PRENATAL MANAGEMENT
Martins, Diana, Godinho, Ana; Carvalho, Rui; Melo, Maria, Portugal
P320
COMPLETE VS PARTIAL HELLP SYNDROME: CHARACTERISTICS AND OUTCOMES
Martins, Diana, Pereira, Isabel; Henriques, Alexandra; Rocha, Pedro; Ferreira, Helena, Portugal
P321
THE IMPORTANCE OF UROGENITAL INFECTIONS IN WOMEN ADMITTED FOR THREATENED PRETERM LABOR
Massa, Ana, Correia, Lúcia; Silva, Patrícia; Gonçalves, Ana; Aguilar, Sofia; Ribeiro, Vânia; Palma, Fátima, Portugal
P322
ENTERIC DUPLICATION CYST IN A TWIN FETUS: DIAGNOSIS AND MANAGEMENT
Mathew, Mariam, Machado, Lovina; Sheik, Shahila; Mandhan, Prakash, Oman
P323
INTESTINAL OBSTRUCTION- A HARD DIAGNOSIS IN PREGNANCY
Mendonça, Rubina, Rijo, Cláudia; Matos, Isabel; Gabriel, Vítor; Martins, Cidália; Nascimento, João; Rocha, Vítor, Portugal
P324
SINGLE UMBILICAL ARTERY: A 3 YEAR REVIEW
Mesquita Pinto, Rita, Santos, Joana; Morais, Marta; Veríssimo, Renata; Melo, Ângela; Cerveira, Isabel, Portugal
P325
RISK FACTORS FOR ACCIDENTAL DURAL PUNCTURE IN OBSTETRIC ANALGESIA
Michaan, Nadav, Lotan, Michael; Galiner, Masha; Amzalag, Sagi; Tsafrir, Ziv; Many, Ariel, Israel
P326
MATERNAL AND FETAL OUTCOME FOR BREECH PRESENTATION AT TERM
Mijailovic Borlja, Radenka, Kontic Vucinic, Olivera; Stefanovic, Tomislav ; Avramovic, Ljiljana J.; Skender, Maja.; Ljubic, Vesna, Serbia and Montenegro
P327
SPONTANEOUS UMBILICAL CORD HEMATOMA AND FETAL DEATHS
Mijailovic Borlja, Radenka, Avramovic, Ljiljana J; Stefanovic, Tomislav; Pavlovic Raicevic, Mirjana; Kontic Vucinic, Olivera; Kiurski, Milosav, Serbia and
Montenegro
P328
HEMOCHROMATOSIS AND PREGNANCY
Miranda, Alexandra, Rodrigues, Fedra; Cardoso, Luísa; Castro, Luís, Portugal
P329
PREGNANCY IN WOMEN WITH CHRONIC KIDNEY DISEASE. NEPHROTIC SYNDROME; REVIEW AND CLINICAL CASE.
Morais, Maria, Maia, Catarina; Silva, João; Carvalho, Claudina, Portugal
P330
LUPUS NEPHRITIS AND PREGNANCY, REGARDING TWO CLINICAL CASES.
Morais, Maria, Silva, Fatima; Lourenço, Catia; Carvalho, Claudina, Portugal
P331
SPONTANEOUS RUPTURE OF RENAL ANGIOMYOLIPOMA DURING PREGNANCY
Mouraz, Mariana, Brito, Íris; Reis, Maria Inês; Proença, Sara; Martins, Luisa; Viana, Rui; Colaço, João; Nunes, Filomena, Portugal
-70-
P332
A STUDY ON THE UPTAKE OF DOWN'S SYNDROME SCREENING AND PREGNANCY OUTCOMES AT LANCASHIRE TEACHING HOSPITALS
TRUSTS(LTHTr) PRE- AND POST-IMPLEMENTATION OF FIRST TRIMESTER SCREENING, OVER YEARS 2009-2011
Ng, Natasha, United Kingdom
P333
RADICAL LEFT NEPHRECTOMY IN SECOND TRIMESTER PREGNANCY
Nunes, Carla, Barros, Joana; Reis, Inês; Araújo, Cláudia; Centeno, Mónica; Pinto, Luísa; Mendes Graça, Luís, Portugal
P334
UNUSUAL CHROMOSOME PLACENTAL MOSAICISM IN A DICHORIONIC TWIN PREGNANCY
Olival, Vanessa, Caetano, Paula; Correia, Hildeberto; Silva, Marisa; Enes, Margarida; Mira, Ricardo, Portugal
P335
ANKYLOSING SPONDYLITIS – EFFECTS ON PREGNANCY CASE REPORT
Olival, Vanessa, Enes, Margarida; Nunes, Maria João; Caetano, Manuela; Mira, Ricardo, Portugal
P336
DOES THE TYPE OF DELIVERY INTERFERE WITH BREECH PRESENTATION OUTCOME?
Oliveira, Natacha, Correia, Lúcia; Machado, Ana Isabel; Campos, Ana, Portugal
P337
CHORIOAMNIONITIS AND FETAL DEMISE: A REVIEW OF LITERATURE AND OUR EXPERIENCE
Oliveira, Nuno, Santos, Ana Cláudia; Almeida, Maria José; Neto, Sara; Oliveira, Mário, Portugal
P338
EVALUATION OF THE FUNCTIONAL STATUS OF WOMEN AFTER CHILDBIRTH AND EFFECTIVE FACTORS
Sanli, Yasemin, Oncel, Selma, Turkey
P339
ABERRANT RIGHT SUBCLAVIAN ARTERY – IS IT A MARKER FOR CROMOSOMIAL ABNORMALITIES?
Ionescu, Cringu, Pacu, Irina C., Romania
P340
PRENATAL DIAGNOSIS OF FETAL OVARIAN CYSTS
Pacu, Irina, Ionescu, Cringu, Romania
P341
TREATING PATIENTS DIAGNOSED WITH GESTATIONAL DIABETES UNDER THE NEW IADPSG RECOMMENDATIONS: INTERIM RESULTS OF
OUTCOMES
Page, Ann-Sophie, Belgium
P342
MULTIPLE INTERVILLOUS THROMBI AS A REFLECTION OF FETOMATERNAL HEMORRHAGE: A CASE REPORT
Paiva, Catarina, Vaz, Inês; Rodrigues, Ana; Marta, Susana; Ramos, Umbelina; Cunha, Ana, Portugal
P343
VAGINAL BIRTH AFTER PREVIOUS CESAREAN DELIVERY – A RETROSPECTIVE ANALYSIS OF 26 MONTHS IN A TERTIARY HOSPITAL
Patrício, Luciana, Nunes, Carla; Policiano, Catarina; Rocha, Pedro; Ferreira, Helena; Graça, Luís, Portugal
P344
PRETERM PREMATURE RUPTURE OF MEMBRANES - MATERNAL AND NEONATAL OUTCOMES OF A CONSERVATIVE APPROACH
Pereira, Ines I., Barros, Joana G.; Clode, Nuno; Graça, Luis M., Portugal
P345
THE EFFICIENCY OF VAGINAL MISOPROSTOL IN SECOND TRIMESTER MEDICAL TERMINATION OF PREGNANCY
Pereira, Ines, Santo, Susana; Clode, Nuno; Graça, Luis M., Portugal
P346
FETAL HEMODYNAMICS AND HEART RATE MONITORING PRECEDING INTRA-UTERINE DEATH IN A DICHORIONIC TWIN PREGNANCY
Pereira, Joana, Moreira, Cátia; Nunes, Inês; Rodrigues, Teresa; Montenegro, Nuno, Portugal
P347
MULTIDISCIPLINARY APROACH FOR PREGNANT WOMEN AT RISK FOR THROMBOTIC EVENTS
Pestana, Ines, Salselas, Ana; Guimaraes, Mariana; Andrade, Joaquim; Montenegro, Nuno, Portugal
P348
DIGITAL ROTATION FOR POSTERIOR POSITION IN LABOUR: FINDINGS OF THE POP-OUT PILOT TRIAL
Phipps, Hala, Graham, Kathy; de Vries, Bradley; Ludlow, Jo-anne; Mackie, Adam; Hyett, Jon, Australia
-71-
P349
NEUROSONOGRAPHY: WHAT IS THE ROLE OF FETAL BRAIN MAGNETIC RESONANCE IMAGING (MRI) TODAY?
Pinto, Fatima, Guedes, Luís; Inocêncio, Gonçalo; Mendes, Maria José; Moreira, Madalena; Saraiva, Joaquim; Dias, Cristina; Ferreira, Luísa; Costa, Vítor; Ribeiro,
Valentina; Teixeira, João; Rodrigues, Maria Céu, Portugal
P350
INDICATIONS FOR CESAREAN DELIVERIES DURING A 7-YEAR PERIOD IN A TERCIARY HOSPITAL
Costa, Ana, Policiano, Catarina; Clode, Nuno; Graça, Luís, Portugal
P351
PHENOTYPIC VARIABILITY IN FETUSES WITH DOWN SYNDROME: A CASE-CONTROL PATHOLOGICAL EVALUATION
Ramalho, Carla, Brandao, Otilia; Matias, Alexandra; Montenegro, Nuno, Portugal
P352
CARDIAC FINDINGS IN ROUTINE FETAL AUTOPSIES: MORE THAN MEETS THE EYE?
Ramalho, Carla, Brandao, Otilia; Monterroso, José; Matias, Alexandra; Montenegro, Nuno , Portugal
P353
ALOBAR HOLOPROSENCEPHALY, PROBOSCIS AND TRISOMY 13
Raposo, Sofia, Jardim, Ondina; Rocha, Branco; Guerra, Nuno; Moura, Paulo, Portugal
P354
PREGNANCY OUTCOMES IN SYSTEMIC LUPUS ERYTHEMATOSUS WITH AND WITHOUT PREVIOUS NEPHRITIS
Raposo, Sofia, Gonçalves, Helena; Bento, Nélia; São José Pais, Maria; Jardim, Ondina; Moura, Paulo, Portugal
P355
PREGNANCY AND DELIVERY IN PATIENTS AFTER FONTAN REPAIR – CASE REPORT
Rebelo, Joana, Barreto, Sandra; Menezes, Isabel; Serrano, Fátima, Portugal
P356
IMPORTED MALARIA INFECTION– A CASE REPORT
Reis, Maria Inês, Poland, Mouraz, Mariana; Brito, Íris I.M. Proença, Sara; Conde, Pedro; Martins, Luisa; Nunes, Filomena, Portugal
P357
ADVERSE PERINATAL OUTCOMES IN MEXICAN PREGNANT WOMEN WITH UTERINE LEIOMYOMAS: A COHORT STUDY
Flores-Gudiño, Emmanuel, Reyes-Muñoz, Enrique; Arellano-Eguiluz, Arturo, Mexico
P358
ANAPLASTIC LARGE-CELL LYMPHOMA (ALCL) DIAGNOSED IN THE THIRD TRIMESTER OF PREGNANCY – A CASE REPORT
Rocha, Juliana, Gomes, Ariana; Melo, Anabela; Costa, Fernanda, Portugal
P359
VELAMENTOUS CORD INSERTION IN A SINGLETON PREGNANCY – IMPORTANCE OF PRENATAL DIAGNOSIS – A CASE REPORT
Rocha, Juliana, Carvalho, Joana; Enes, Pedro; Costa, Fernanda, Portugal
P360
GESTATIONAL DIABETES IN FIRST TRIMESTER: EXPERIENCE FROM A TERTIARY CENTER
Rocha, Sara, Marques, Catarina; Gonçalves, Ana; Simões, Mafalda; Costa, Ana; Campos, Ana, Portugal
P361
WOMEN WITH GESTATIONAL DIABETES IN THE FIRST TRIMESTER: WHAT ABOUT RISK FACTORS?
Rocha, Sara, Gonçalves, Ana; Marques, Catarina; Simões, Mafalda; Costa, Ana; Campos, Ana, Portugal
P362
PLACENTA PREVIA: RISK FACTORS AND TIME OF DELIVERY
Rodrigues, Fedra, Fernandes, Emídio; Miranda, Alexandra; Nogueira-Silva, Cristina; Cruz, Etelvina; da Pena, Jardim; Vides, Belisa, Portugal
P363
RECURRENT HEMOPTYSIS IN A PREGNANT WOMAN WITH SJÖGREN SYNDROME
Rodrigues, Fedra, Vale-Fernandes, Emídio; Miranda, Alexandra; Nogueira-Silva, Cristina; Teixeira, Neusa; Barros, Judite, Portugal
P364
IMPORTANCE OF MRI IN THE DIAGNOSIS OF FETAL ABNORMALITIES OF THE CNS - ANALYSIS OF 5 YEARS
Lopes, Catarina, Rodrigues, Milene; Almeida, Manuela; Leite, Cristina; Casal, Ester; Duarte, Julia; Santos, Antónia; Romão, Fátima, Portugal
P365
RUPTURE OF RENAL ANGIOMYOLIPOMA DURING CHILDBIRTH
Rodrigues, Milene, Ramos, Rodrigo; Lopes, Catarina; Santos, Antónia; Romão, Fátima, Portugal
-72-
P366
Takayasu Disease in Twin Pregnancy: Case report
Rujiwetpongstorn, Jittima, Thailand
P367
FETAL DEATH AT TERM: 5-YEAR RETROSPECTIVE ANALYSIS
Santos, Ana, Oliveira, Nuno; Almeida, Maria José; Neto, Sara; Oliveira, Mário, Portugal
P368
LABOUR INDUCTION IN PREVIOUS CESAREAN SECTION
Santos, Ana Vanessa, Caeiro, Ana Filipa; Ambrosio, Bruna; Landim, Elsa; Matos, Teresa; Costa, Ana Cristina; Nazaré, Antónia, Portugal
P369
PUERPERAL TRANSVERSE SINUS THROMBOSIS: A CASE REPORT
Santos, Ângela, Prata, João; Coutinho-Borges, José; Domingues, Fátima; Abreu, Rita; Gama, Ana Paula; Pinheiro, Paula, Portugal
P370
CORTICOSTEROIDS IN HELLP SYNDROME: BENEFIC OR USELESS?
Santos, Fernanda, Ribeiro, Rita, Portugal
P371
FETAL TRANSVERSE LIMB DEFECT: A CASE REPORT
Sardinha, Tania, Monteagudo, Ana; Cordoba, Marcos; Patrick, Sharon; Timor-Tritsch, Ilan, Portugal/United States
P372
ENLARGED FETAL KIDNEYS OF UNDETERMINED ETIOLOGY- A CASE REPORT
Sardinha, Tania, Sousa, Vera; Pinto, Patrícia; Sarmento, Ricardo; Pinho, Maria de Lurdes, Portugal
P373
INTERSTICIAL PREGNANCY – A CASE REPORT
Sardinha, Rosa, Costa, Sofia; Bras, Filipa; Duarte, Carla; Oliveira, Pedro; Rosmaninho, Adosinda, Portugal
P374
TOLL-LIKE RECEPTORS GENE POLYMORPHISMS IN PRETERM DELIVERY
Seremak-Mrozikiewicz, Agnieszka, Drews, Krzysztof; Drews-Piasecka, Elzbieta, Poland
P375
SUCCESSFUL MANAGEMENT OF A RARE CASE OF PRIMARY SCLEROSING CHOLANGITIS IN PREGNANCY
Sheik, Shahila, Mubbashir, Saba; Khaskheli, AbdulMannan; Mathew, Mariam, Oman
P376
HIV AND PREGNANCY – CASE REVIEW 2001-2011
Silva, Joana Raquel, Montes, Luísa; Abreu Silva, João; Carrilho, Marcelina, Portugal
P377
SACROCOCCYGEAL TERATOMA – A FIRST TRIMESTER DIAGNOSIS
Silva, Patricia, Remesso, Lília; Silva, Manuela; Bacelar, Filipe; Ledo, Marta, Portugal
P378
IS PRIOR PRETERM BIRTH A TRUE RISK FACTOR IN THREATENED PRETERM LABOUR?
Silva, Patrícia, Correia, Lúcia; Massa, Ana; Gonçlves, Ana; Aguilar, Sofia; Ribeiro, Vânia; Palma, Fátima; Campos, Ana, Portugal
P379
THE RELATION BETWEEN THE 1ST TRIMESTER BIOCHEMICAL SCREENNG AND THE INCIDENCE OF GESTATIONAL DIABETES
Silva Morais, Marta, Santos, Joana; Andrade, Claudia; Veríssimo, Renata; Torres, Isabel, Portugal
P380
OBSTETRIC CHOLESTASIS: MANAGING THE RISK OF FETAL DEATH
Simões, Ana, Vasconcelos, Catarina; Nogueira, Isabel, Portugal
P381
SYSTEMATIC REVIEW: MORBIDITY OF ELECTIVE CESAREAN SECTION VERSUS PLANNED VAGINAL DELIVERY IN LOW-RISK PREGNANCY
Staley, Stuart-Allison, United States
P382
SPONTANEOUS UTERINE RUPTURE AT NON CESAREAN SECTION SCAR SITE WITH PLACENTA PERCRETA IN THE SECOND TRIMESTER:
A CASE REPORT
Suwannarurk, Komsun, Pongrojpaw, Densak; Manusook, Sakol; Suthiwartnarueput, Worapop; Bhamarapravatana, Kornkarn, Thailand
-73-
P383
INVASIVE PRENATAL DIAGNOSIS: BALANCING THE RISKS OF ANEUPLOIDY, FETAL LOSS AND SUBSEQUENT INFERTILITY
Sylvestre, Georges, Sapra, Eshanjit, United States
P384
SIGNS OF DECLINE OF OBSTETRICS AS SPECIALTY AT EAST-TALLINN CENTRAL HOSPITAL BASED ON DOCTORS WORKING
AND POSTGRADUATE LEARNING PREFERENCES
Szirko, Ferenc, Tammemae, Lee, Estonia
P385
CASE REPORT: CERVICAL VARIX AS A CAUSE OF VAGINAL BLEEDING DURING IVF PREGANANCY
Tammiste, Triin, Klementsov, Jana, Estonia
P386
TWIN PREGNANCY AND POTENTIAL COMPLICATIONS
Teixeira, Neusa, Silva, Cristina; Cunha, Diogo; Vale, Emidio; Abreu, Cátia; Ramos, Teresa; Gil, Belandina; Cadilhe, Alexandra, Portugal
P387
POST-PARTUM HEPATIC RUPTURE AFTER CAESARIAN SECTION IN TWIN PREGNANCY ASSOCIATED WITH PREECLAMPSIA AND HELLP SYNDROME
Csorba, Roland, Tsikouras, Panagiotis; Pinidis, Petros; Zambas, Aristotelis; Dafopoulos, Alexandros; Galazios, Georgios; Liberis, Vasileios; Teichmann, Alexander
Tobias; Von Tempelhoff, Georg-Friedrich, Greece
P388
AMNIOTIC LAMELLAR BODY COUNTS AND NEONATAL RESPIRATORY OUTCOMES IN TWIN PREGNANCIES
Tsuda, Hiroyuki, Kotani, Tomomi; Sumigama, Seiji; Mano, Yukio; Watanabe, Yuriko; Nakano, Tomoko; Takahashi, Yuichiro; Kawabata, Ichiro; Kikkawa,
Fumitaka, Japan
P389
HETEROTOPIC TRIPLET SPONTANEOUS GESTATION
Valdoleiros, Sandra, Silva, Ricardo; Santos, Maria; Antunes, Madalena; Apolinário, P.; Castilho, Ana, Portugal
P390
SPONTANEOUS TWIN ANEMIA-POLYCYTHEMIA SEQUENCE (TAPS) – A CASE REPORT
Vieira, Bruna, Paiva, Ana C.; Reis, Ana P.; Casanova, João; Sampaio, Maria M.; Rodrigues, Rosa M.; Cunha, Ana C.; Carvalho, Carmen, Portugal
P391
IMPLEMENTING UMBILICAL CORD BLOOD GAS ANALYSIS
Vilar Soares, Sandra, Sá, Isabel; Rodrigues, Rosa Maria; Cunha, Ana Cristina, Portugal
P392
MAGNESIUM SULFATE FOR FETAL NEUROPROTECTION: WHAT DO WE KNOW?
Vilhena, Cristina, Tomás, Cláudia; Gameiro, Cátia; Casal, Ester; Romão, Fátima, Portugal
P393
PHARMACOKINETICS OF ANTIMALARIALS IN PREGNANCY: A CRITICAL EVALUATION OF MATERNAL RISKS
Wilby, Kyle J., Qatar, Ensom, Mary HH, Canada
P394
DEVELOPMENT OF AN INNOVATIVE TOOL FOR ASSESSMENT OF PHARMACISTS' KNOWLEDGE AND PERCEPTIONS REGARDING FETOMATERNAL
MEDICINE
Wilby, Kyle J., Qatar, Bains, Serena; Rowe, Hilary, Canada
P395
EXPERIMENTAL ASSESSMENT OF DUCTUS ARTERIOSUS DYNAMICS, OXIDATIVE STRESS AND POLYPHENOL EXCRETION AFTER CONTROLLED
MATERNAL POLYPHENOL DIET IN LATE PREGNANCY
Zielinsky, Paulo, Bubols, Guilherme; Nicoloso, Luiz Henrique; Piccoli Jr., Antônio Luiz; Vian, Isabele; Charão, Mariele; Barbisan, Carolina; Pizzato, Patrícia; Busato,
Stefano; Lopes, Mauro; Zilio, Ana; Alievi, Marcelo; Barra, Marinez; Garcia, Solange, Brazil
P396
INDUCTION OF LABOUR IN GESTATIONAL DIABETES: A USEFUL MANAGEMENT TOOL OR CREATING FURTHER COMPLICATIONS?
English, Jennifer, Chattington, Paula, United Kingdom
-74-
Abstracts
A1
FERTILITY EVALUATION AFTER LAPAROSCOPIC REMOVAL OF MATURE CYSTIC TERATOMAS OF THE OVARY IN INFERTILE WOMEN
Qirko, Robert, Qirko (Cipo), Margareta; Nonaj, Blenard; Kurti, Erlind; Treska, Entela, Albania
A2
RELATIONSHIP BETWEEN OOCYTE MEIOTIC SPINDLE VISUALISATION AND IVF ET TREATMENT OUTCOMES
Swiatecka, Jolanta, Bielawski, Tomasz; Anchim, Tomasz; Lesniewska, Monika, Poland
A3
DOES OVARIAN HIPERSTIMULATION PROTOCOL INFLUENCE ZONA PELLUCIDA BIREFRINGENCE DURING IVF-ICSI PROCEDURES?
Swiatecka, Jolanta, Bielawski, Tomasz; Anchim, Tomasz; Milewski, Robert; Lesniewska, Monika; Wolczynski, Slawomir, Poland
A4
PARATUBAL BORDERLINE SEROUS TUMOUR - AN UNUSUAL ENTITY
Fialho Gomes, Rui, Ramilo, Irina; Aleluia, Clara; Gomes, Fernando; Mendinhos, Gustavo; Igreja, Fernando; Azevedo, Luísa; Silva Pereira, José; Nazaré, Antónia,
Portugal
A5
EXTRACTION OF TWINS IN THE INTACT AMNIOTIC SAC
Akhmadeyev, Nariman, Radzinsky, Viktor; Fatkullin, Ildar; Fatkullin, Farid; Mukhammyatovich, Semyatov Said, Russian Federation
A6
USE OF ULRTASONOGRAPHY TO PREDICT DIABETIC FETOPATHY
Devyatova, Ekaterina, Bogdanova, Galina; Startseva, Nadezhda; Zlatovratskaya, Tatyana; Kovalev, Maxim; Kirienko, Anna, Russian Federation
A7
48-HOURS ADMINISTRATION OF FENOTEROL IN SPONTANOUS PRETERM LABOR – DOES IT AFFECT FETAL PRELOAD ?
Grzesiak, Mariusz, Hincz, Hincz P.; Wilczynski, Jan, Poland
A8
HOW TO PREDICT DIABETIC FETOPATHY IN WOMEN WITH GESTATIONAL DIABETES MELLITUS?
Karpova, Elena, Litvinenko, Inessa; Bratchikova, Tatyana; Orazmuradov, Agamurad; Morozov, Sergei; Starceva, Nadezhda; Stikin, Yaroslav, Russian Federation
A9
MULTIPLE-FREQUENCY BIOELECTRICAL IMPEDANCE ANALYSIS OF JAPANESE NOMAL PREGNANT WOMEN
Matsuda, Kaori, Japan
A10
DIABETES INSIPIDUS IN THE THIRD TRIMESTER, IUGR, OLIGOHYDRAMNIOS
Pelkic, Ksenija, Slovenia
A11
THE ROLE OF THE FIBRONECTIN AND ULTRASOUND CERVICOMETRY FOR PREDICTION OF PRETERM BIRTH
Bare, Teuta, Mitre, Anila; Vata, Ervis; Shkurti, Endrin; Hoxhaj, Odeta, Albania
A12
EFFECTIVENESS OF MIFEPRISTONE IN COMPARISON TO DINOPROSTONE FOR LABOR INDUCTION
Startseva, Nadezhda, Devyatova, Ekaterina; Kovalev, Maxim; Kirienko, Anna; Zlatovratskaya, Tatyana; Bratchikova, Tatyana, Russian Federation
A13
THE SIGNIFICANCE OF INFLAMMATORY MARKER IN VIRAL DETECTION IN SPONTANEOUS ABORTION
Bogavac, Mirjana, Jakovljevic, Branislava Stajic, Dragan, Serbia and Montenegro
-75-
As the of ficial airline network for the 17 th World Congress on
Controversies in Obstetrics, Gynecology & Infertility (COGI),
we’d like to thank you for choosing the Star Alliance network
and hope that all goes really well for you here today.
Whilst you concentrate on the day’s events, we hope you’ll
consider us the next time you need to attend a conference.
With over 21,555 flights a day to 1,356 airpor ts across 193 countries,
our 27 member airlines will extend a wide choice of flights to any
future conference you’re planning to attend. And no matter which
of those airlines’ frequent flyer programmes you belong to, you
can earn and redeem miles across all of them.
So the next time you want to concentrate all your energies
on your conference, we hope you’ll decide to leave the travel
arrangements to us.
staralliance.com
Information correct as at 06/2012
-76-
INDEX
COGI
-77-
L i s b o n
Portugal
November
8-11, 2012
Abdi, J.
54
Amaral, R.L.
54
Abdul Rahim, F.A.
51
Amaral, S.P.
45
Abdul Wahab, A.Y.
51
Amaro, T.
57
Abdullah Agha, M.M.
45
Ambrosio, B.
65, 73
Abdullatif, M.
69
Ambrosio, P.
60
Aboulfalah, A.
60, 61
Amendoeira, I.
56
Abreu dos Santos, F.
47, 64
Amorim, M.M.R.
65, 47
Abreu Silva, J.
64, 73
Amorim-Costa, C.
47
Abreu, C.
53, 60, 61, 74
Amster, R.
64
Abreu, R.
67, 73
Amzalag, S.
70
Acharya, V.
49, 57
Ana Castro, D.
47
Adamiak-Godlewska, A.
45
Anatoly, Z.V.
56
Adiga, S.
44
Anchim, T.
75
Afonso, H.
61, 45, 62, 64, 67, 68
Anderson, K.
59
Afonso, M.
48, 53, 61
Andrade, C.
73, 57
Aggarwal, R.
58
Andrade, J.
71
Agmon, A.
64
Andrade, L.L.
59
Aguiar, A.
45, 47
Andrade, M.
47, 65, 67, 69
Aguilar, A.S.
67
Andreeva, J.
46, 59
Aguilar, J.
52
Andreeva, P.
51
Aguilar, S.
49, 64, 70, 73
Antsaklis, A.
28, 35, 39
Ahmed, A.
62
Antunes, I.
65, 56, 60, 68
Ahonen, S.
48
Antunes, M.
74
Ait Benkaddour, Y.
60
Aoki, T.
48, 68
Akhmadeyev, N.
75
Aparício, C.
47, 61
Al Ali, F.
49
Apatheodorou, A.
52
Al Kharusi, L.
49
Apolinário, P.
74
Albornoz, J.
47
Arabin, B.
28, 36, 35, 69
Aldinhas Santos, P.
44
Arapidi, G.A.
59
Aldinhas, P.
63
Araújo, C.
48, 71
Aldughaishi, T.R.
64
Araújo, J.
65
Aleksandrova, N.
45
Arav, A.
38
Aleluia, C.
75
Areia, A.
66
Alenius, J.
60
Arellano-Eguiluz, A.
72
Alho, C.
48, 54, 57, 59
Argyro Maiz, N.
48
Alievi, M.
74
Asmouki, H.
60, 61
Almeida, A.
70, 67
Assumpció Pérez Benavente, M.
20
Almeida, A.J.
48
Atiomo, W.
43, 44, 49
Almeida, D.
64, 47, 69
Atti, C.d.S.
59
Almeida, M.
72
Aurell, R.
26
Almeida, M.J.
71, 73
Avilés, P.
58
Almeida, P.
64
Avramovic, L.J.
70
Almeida-Santos, T.
53
Aydogan, B.
38
Almeida-Sousa, A.T.
44
Ayres-de-Campos, D.
28, 35, 47
Al-Senaidi, K.
69
Azevedo, A.
65
Al-Shebly, M.
64
Azevedo, H.
45, 68
Altfeld, S.
62
Azevedo, L.
54, 75
Altunyurt, S.
47
Azevedo, S.
65
Alushani, M.
55
Bacalhau, D.
65
Alvarez, A.P.
55
Bacelar, F.
46, 47, 65, 73
Alves, J.
61
Bahamondes, L.
56, 57, 59
Alves, M.
49
Bahamondes, L.G.
59
Alves, M.J.
56, 64
Bains, S.
74
Alves, O.
65
Bajo, R.
67
Alves, P.
65
Bajraktari, D.
53, 55
Alvim, K.
58
Bakir, N.
58
Amaral, N.
62
Balajewicz-Nowak, M.
65
Amaral, P.
65
Baltar, V.
64
I
Banasik, M.
43
Blazar, A.S.
44
Bangal, V.B.
55
Blazer, S.
48
Baptista, E.
66
Blickstein, D.
36, 37
Baptista, M.
45
Blickstein, I.
28, 35, 36, 37, 39
Baracat, E.
46
Bogavac, M.
75
Baranowski, W.
55
Bogdanova, G.
75
Barbara, M.
59
Bombas, T.A.
24
Barbedo, C.
48
Borgfeldt, C.
60
Barbisan, C.
49, 74
Borrego, J.
60
Barbosa, A.
53
Borsari, R.
46
Barbosa, A.P.
34
Bosch, X.
32
Barbosa, L.
57
Bosquet, E.G.
20
Barbosa, M.
69
Botelho, M.C.
45
Bare, T.
55, 75
Botto, I.
62
Barra, M.
74
Bouchard, P.
21
Barreiro, M.
57, 51, 52
Bozzini, N.
46
Barreta, A.
65
Braehler, E.
62
Barreto, S.
46, 72
Braga, A.
66
Barros, A.
45
Braga, J.
64, 66, 56
Barros, C.
56
Braga, L.
58, 61, 66
Barros, J.
66, 71, 72
Braga, L.F.
43
Barros, J.G.
71
Brähler, E.
63
Barros, L.
53, 56
Branco, P.
61
Barros, M.
63
Brandao, A.
44
Barros, N.
58, 62
Brandão, A.
66
Barros, N.P.
43
Brandao, O.
72
Barroso, P.
67
Brännström, M.
21, 25
Bas, S.
46
Bras, F.
73
Batarshina, O.
46
Brás, F.
51, 61, 64
Batista, J.
60, 66
Bratchikova, T.
75
Bayrakal, V.
55
Brazão, K.
47
Becker Jr., E.
49
Breda, N.
54
Beires, J.
46
Breitenfeld, L.
44
Belaskova, S.
52, 53
Brincat, M.
26, 33, 34, 33, 45, 51
Bell, A.
58
Brincat, M.P.
56
Bello, A.
53, 60
Briones-Lara, E.
55
Ben Rafael, Z.
21, 23, 29, 30
Brito, I.
49, 56, 61, 70, 72
Bender, L.B.
49
Bronshtein, M.
28, 64
Benedetti Panici, P.
31, 32
Broughton, K.S.
54
Bento, N.
70, 72
Brunetti, X.O.
45
Bentov, Y.
45
Bruno, D.
62, 54, 55
Benvenuto, S.
44, 52
Bruno, V.
58
Berisha, F.
51
Bubols, G.
74
Bernardes, J.
47
Bujold, E.
27
Bernardo, M.J.
60
Buldurucu, S.
58
Bespalov, I.V.
56
Bulgan, E.
63
Bessa-Monteiro, S.
48
Bulugma, M.M.
54, 62
Betincova, L.
62, 63
Burke, Y.
48
Bhakta, R.
44
Burrell, C.
48, 66
Bhamarapravatana, K.
73
Burstein, E.
45
Bharathan, R.
58
Busato, S.
74
Bielawski, T.
75
Bustos, B.
68
Bimbashi, A.
49, 66
Bylykbashi, E.
66, 68
Bird, S.
45
Bylykbashi, I.V.
68, 66
Birnbaum, R.
66
Bytchenko, V.
46
Bitzer, J.
24
C Nunes, F.
61
Björklund, U.
68
Caballero-Trejo, A.
55
Black, R.
67
Cabral, M.
51, 53
II
Cabrita, P.
53, 60, 61, 66
Castro, G.
61
Cabrita, S.
66
Castro, J.
64
Cadilhe, A.
48, 74
Castro, L.
43, 70, 48
Caeiro, A.F.
66, 73
Castro, M.G.
47
Caetano, C.
61
Castro, P.V.
61
Caetano, M.
71
Castro, T.
46, 68
Caetano, P.
65, 71
Catarino, A.
47, 61
Cakir Gungor, A.
45, 46
Cater, E.
51
Cakoni, A.
60
Catia, P.
55
Caldas, R.
48, 63
Cavaco-Gomes, J.
48, 67, 69
Caldeira, B.
56
Cavaleiro, C.
65
Calejo, L.
67
Cenko, F.
43
Calhaz Jorge, C.
48, 57, 61
Centeno, M.
48, 71
Calhaz-Jorge, C.
45, 47, 43, 54, 59
Cerdeira, A.S.
47
Calleja Aguis, J.
56
Cerveira, I.
66, 70
Calleja-Agius, J.
45
Chan, L.W.D.
47
Câmara, S.
64
Chandana, A.
44
Campo, M.
62
Chappel, S.
30
Campos, A.
64, 70, 71, 72, 73
Charão, M.
74
Campos, M.C.
51
Charkiewic, R.
55
Campos, S.
66
Chattington, P.
74
Cantwell, M.B.
54
Chatzi, E.
46
Capela, E.
60
Chaves, J.
66
Caramelo, O.
66
Chen, S.
51
Cardoso, A.
44, 51
Chen, Z.
29
Cardoso, L.
70
Chernych, E.R.
48
Carmo, O.
67, 54, 65, 56
Chian, R-C.
23
Caroline Da Cunha Germano, B.
67
Chmyr, E.
46
Carraca, T.
46, 67
Chong, Y.
44
Carrapato, M.
39
Chonina, N.A.
48
Carrapatoso, C.
55
Chow, T.Y.
47
Carreira, H.
65
Chrelias, C.
58
Carrilho, M.
73
Chung, T.
43, 58
Carrillo, S.
58
Churnosov, M.
55
Cartaxo da Costa, L.A.
67
Cin-Custo, M.
51
Carvalho, A.
57, 62
Cirurgão, F.
65
Carvalho, C.
74, 48, 69, 70
Cirurgião, F.
65
Carvalho, G.
59, 61
Clarke, S.
60
Carvalho, J.
46, 54, 61, 72
Clode, N.
27, 48, 49, 53, 71, 72
Carvalho, K.
46
Coelho, A.
48
Carvalho, L.
49, 58
Coelho, D.
61
Carvalho, M.
45
Coelho, F.
69
Carvalho, R.
70
Coelho, P.
34
Carvalho, S.
57
Coelingh Bennink, H.J.T.
24
Carvalhosa, R.
55, 58
Cohen, J.
21, 22, 23, 29
Casal, E.
49, 72, 74
Colaço, A.
43
Casalinho, L.
44
Colaço, J.
61, 70
Casanova, J.
58, 74
Collins, S.
67
Casas, J.P.
49
Conde, P.
61, 72
Caseiro, L.
60
Condeco, R.
60
Casoy, J.
43
Condeço, R.
56
Casper, R.F.
45
Cordeiro, I.
45
Castelo Branco, E.
63
Cordoba, M.
73
Castilho, A.
74
Correia da Costa, J.M.
45
Castro, A.
49
Correia, A.
56
Castro, A.J.
51
Correia, H.
71
Castro, C.
53, 54, 57, 59
Correia, I.
65
Castro, D.
51, 69
Correia, J.
27, 70
III
Correia, L.
49, 64, 56, 65, 67, 70, 71, 73
Dewantiningrum, J.
47
Correia, P.
46, 47, 67, 51, 69, 64
Di Renzo, G.C.
29, 35
Correia-Branco, A.
65
Diamanti-Kandarakis, E.
43
Cortez Vaz, F.
66
Dias, C.
48, 64, 69, 72
Cosar, E.
45
Dias, G.
54
Costa, A.
60, 72
Dias, J.
47, 64
Costa, A.C.
73
Diaz, M.P.
58
Costa, A.R.
47
Diedrich, K.
26, 38
Costa, C.
63, 65
Dietrich, K.
29
Costa, F.
54, 55, 56, 61, 72
Dimitrov, I.
51
Costa, F.J.
66
Ding, J.
67
Costa, J.
56
Diniz da Costa, T.
43, 48
Costa, S.
61, 64, 67, 73, 56
Diogo Miranda, M.
43
Costa, T.
54, 59
Diogo, B.
56
Costa, V.
72
Djokovic, D.
65
Costa-Pereira, A.
49
do Carmo, I.
34
Costa-Santos, C.
47
do Carmo, O.
68
Courcoutsakis, N.
46
Dobychina, A.
59
Coutinho, T.
53
Dokle, A.
45, 49, 61, 66
Coutinho-Borges, J.
62, 73
Dolmans, M.M.
38
Coutinho-Borges, J.P.
67
Domingues, A.P.
68
Couto, S.
54
Domingues, F.
73
Cruz, C.
60, 68
Donders, G.
35
Cruz, E.
44, 66, 72, 64
Dorst, J.
63
Cruz, J.
27, 47
Doru, C.
54
Csorba, R.
63, 74
dos Mártires, F.
63
Cubal, A.
54, 55, 56
Dostal, J.
52
Cunha, A.
71
Dreier, K.
44
Cunha, A.C.
74, 58
Drews, K.
73
Cunha, D.
74
Drews-Piasecka, E.
73
Cunha, E.
64
Drobinskaja, A.N.
48
Cunha, M.
45
Drugan, A.
48
Cunha, V.
54
Drymiotou, S.
44
Custódio, A.
55
Duarte, C.
45, 62, 64, 67, 68, 73
Da Cunha Germano, B.C.
67
Duarte, J.
72
da Pena, J.
72
Duarte, S.
49, 46, 67
Dafopoulos, A.
63, 74
Dudbridge, F.
49
DalÁva, N.
57
Dukanac Stamenkovic, J.
67
Damasceno, D.C.
60, 61
Dulai, A.
61
Daneshgari, F.
60, 61
Duthie, S.
45
Dantas, S.
51
Edmiston, K.H.
54
Darlin, L.
60
Egenburg, S.
64
Darzi, A.
58
Eixarch, E.
68
Das, D.
60
Eladel, C.
61
Das, S.
60, 67
Eldar, I.
51
Daya, S.
23, 25, 26, 29
Ellenbogen, A.
22, 23, 44, 51
De Barros Pereira, I.
47
Elmariamy, O.
54
de Oliveira, C.
21
Elrishi, M.
45
de Paula, T.
58
Enes, M.
71
de Souza, M.A.C.
67
Enes, P.
67, 68, 72
de Vries, B.
48, 71
English, J.
74
Dede, E.
55, 67
Ensom, M.H.H.
74
Delerue, E.
51
Esfandiari, N.
45
Delgado, E.
58
Eskandarani, H.
45
Delgado, j.
67
Esteves, F.
67
Derici, Y.
55
Estevinho, F.
43
Deval, B.S.
44
Estevinho, S.
61, 63, 65, 67
Devyatova, E.
75
Estrela, A.
61
IV
Fainaru, O.
51
Frajndlich, R.
49
Fakokunde, A.
46
Franca, C.E.
43
Falcão, F.
53, 59, 61, 62
Francisca, A.
64
Faller, E.
47
Francisco, E.
47
Fan, Y.
57
Franco, A.
43, 56, 54, 55
Faria Vaz Cardoso, K.
48
Franco, S.
66, 69
Faria, B.
54
Freire de Oliveira, C.
31, 32
Faria, N.
64
Freitas Bessa, C.G.
67
Farine, D.
27, 28, 35, 36, 37, 39
Freitas Bessa, I.A.
67
Fatkullin, F.
75
Freitas Galvao, R.B.
67
Fatkullin, I.
75
Freitas, C.
46, 64
Fauser, B.C.J.M.
22, 23, 29, 30
Freitas, P.
51
Fausto, V.
46
Freitas, R.
47
Fedorovich, O.K.
56, 48
Freitas, T.
46, 47, 64
Fehm, T.
46, 59
Frutuoso, C.
59, 62
Feitosa, F.E.
65
Frydman, R.
21, 22, 23, 26, 29, 30
Felgueira, E.
44, 53, 57
Fuchsova, R.
62, 63
Felisbino, S.L.
60, 61
Gabriel, V.
70
Fernandes, A.S.
46, 68
Gago, C.
60
Fernandes, E.
61, 66, 72, 55, 57, 63
Gaivão, I.
52
Fernandes, F.
57, 60
Galazios, G.
63, 74
Fernandes, M.
51
Galazis, N.A.
43, 44
Fernandes, S.
44, 47
Galazis, N.D.
49
Fernandez, I.
52
Galczynski, K.
45, 44
Ferraz, T.
65, 68
Galiner, M.
70
Ferraz, Z.
59, 62
Gama Pinto, C.
49
Ferrazzi, E.
35
Gama, A.P.
73
Ferreira Souza, S.
54
Gamboa, C.
48, 49, 67
Ferreira, A.
54, 68, 43
Gameiro, C.
49, 54, 74
Ferreira, A.P.
65
Gameiro, J.
68
Ferreira, C.
60
Gandolfi, A.
52
Ferreira, D.
45, 62, 64, 67, 68
Garcia Velasco, J.
29
Ferreira, F.
47
Garcia, S.
74
Ferreira, H.
47, 70, 71
Garrido Puchalt, N.
29
Ferreira, J.
56, 59, 46
Gawas, M.
62
Ferreira, L.
60, 68, 72
Gencer, M.
45, 46
Ferreira, S.
62, 67, 68, 48, 63
Georgsson Öhman, S.
68
Fialho Gomes, R.
54, 75
Geraldes, F.
57
Fiel, J.
43, 61, 63
Geue, K.
62, 63
Figueiredo, H.
44, 53
Geva, M.
51
Figueiredo, O.
61
Ghezzi, F.
25
Figueiredo, P.
45, 62, 64, 67, 68
Gil, B.
74
Figueroa, H.
68
Giraldo, P.
54
Findri Guštek, Š.
46, 54
Giurea, I.
54
Finnegan, L.
62
Gjata, E.
51, 52
Firestone, C.
45
Gjoni, M.
53
Firestone, R.
45
Gleicher, N.
22, 23
Fishel, S.
22, 23, 51
Glowacka, E.
43, 62
Fistonic, I.
46, 54
Godinho, A.
70
Fistonic, M.
46
Godinho, A.B.
59
Fistonic, N.
46
Godinho, B.
54, 57
Fleming, A.
67
Gogacz, M.
45
Florescou, A.
46
Goity, C.
68
Flores-Gudiño, E.
72
Gokool, Y.
68
Fonseca Moutinho, J.A.
32, 44
Gomel, V.
25, 26, 31
Fonseca, E.
68
Gomes, A.
67, 53, 68, 72
Fontes, T.
55, 58
Gomes, F.
75
Fougo, J.
56
Gomes, G.
60, 65, 68
V
Gomes, M.
69
Helin, A.
48
Gomes, R.
56
Henic, E.
60
Gomes, S.
63, 66
Henriques, A.
47, 70
Gomes, Z.
46, 52
Henriques, I.
63
Gonçalves, A.
49, 64, 67, 70, 72
Henriques, R.
66
Gonçalves, A.K.
54
Hernández-Andrade, E.
68
Gonçalves, C.
49
Hershberger, P.E.
62
Gonçalves, D.
65
Hijaz, A.
60, 61
Gonçalves, E.
46, 55, 62, 67
Hilário, S.
46
Gonçalves, H.
72
Hincz, H.P.
75
Gonçalves, I.
57, 68
Hingorani, A.D.
49
Gonçalves, P.
65
Hirao, A.
48, 68
Gonçlves, A.
73
Hirshfeld-Cytron, J.
62
Gonsalves, H.
56
Ho, T.
56
González-Díaz, O.A.
55
Honakeri, S.
67
Gorken, I.B.
62
Horner, C.
54
Gouveia, A.
61
Hoshino, T.
68, 48
Gouveia, M.J.
45
Hoxhaj, O.
53, 55, 67, 75
Gouveia, P.
52
Hsiao, C.
43, 55
Gouveia, S.
48
Hsueh, A.
30
Gowri, V.
49
Huang, K.
47
Graça, A.
48
Hucke, J.
25
Graca, L.
36, 39, 61, 71, 72
Hunjak, B.
54
Graça, L.M.
71
Hussain, Z.
47
Graham, K.
71
Hwang, L.
43, 55
Gratacos, E.
68
Hyett, J.
48, 71
Grilo, I.
61
Igreja, F.P.
62, 54, 56, 75
Grund, K.
52
Imamura, Y.
48, 68
Grunebaum, A.
28, 35, 39
Inceboz, T.
55
Grzesiak, M.
75
Inceboz, U.
55, 59
Guedes, A.
65
Inglis, S.
53
Guedes, L.
72, 49
Inocêncio, G.
65, 72
Guedes-Martins, L.
49, 52
Ionescu, C.
71
Guerra, C.
61
Ivashova, O.
55, 68
Guerra, N.
66, 72
Jadid, I.
61
Guerreiro, R.
47
Jaffa, A.J.
64
Guha, C.
67
Jakovljevic, B.
75
Guimarães, M.
48, 71
Janas, L.
62
Gulekli, B.
47
Jardim da Pena, D.
53, 60
Guler, C.
59
Jardim Pena, D.
49, 58
Gurtovoya, Y.
45
Jardim, O.
66, 72
Gutman, T.
58
Jenner, L.
51
Hacivelioglu, S.
45, 46
Jesus, A.
55, 59
Haddad, C.
43
Joglekar, U.
48
Haines, C.
43
Joglekar, U.M.
55
Hallak, M.
51
Johannesson, L.
25
Hameed, J.
46
Johnson, M.H.
21
Hameed, J.S.R.
68
José, F.
46
Hamid, A.B.
65
Julião, M.J.
66
Hamoda, H.
44
Júlio, C.
65
Hantisteanu, S.
51
Kacerovsky, M.
28, 36
Hantisteanu, S.M.
44
Kamrava, M.
45
Harel, Z.
24, 25
Kansukcharearn, A.
68
Har-Toov, J.
66
Karakus, G.
64, 67, 68, 65
Haxhihyseni, A.
55
Karamani, A.
46
Hayashi, N.
48, 68
Karatag, O.
46
Heinonen, R.
59
Karatrasoglou, E.
46
Helidon Dasho, K.
43
Karpova, E.
75
VI
Karumanchi, S.A.
47
Leal, F.
45
Katz, L.
65
Leal, M.
57
Kawabata, I.
74
Leal, R.
69
Kayaalp, E.
53
Lebedeva, O.P.
55, 68
Keating, E.
65
Leça, O.
69
Keyik, B.
59
Lédée, N.
22
Khaskheli, A.
73
Ledo, M.
47, 46, 57, 65, 69, 73
Ki, K.
59, 62
Lee, E.S.
69
Kiesel, L.
26
Lee, J.
69, 59, 62
Kikkawa, F.
48, 49, 69, 74
Lee, K.
62
Kinnunen, T.I.
48
Lee, S.
56
Kirienko, A.
75
Lee, S.S.
52
Kisielewski, R.
55
Leitão, C.
53, 63
Kita, M.
48, 68
Leitão, S.
63
Kitamura, S.
48, 68
Leite, C.
72
Kiurski, M.
70
Leite, M.d.F.
49
Kizildag, B.
46
Leite, T.
47, 64, 68, 69
Klasa-Mazurkiewicz, D.
55
Lejnieks, A.
58
Klein, C.
49
León, E.
58
Klein, E.
65
Lesniewska, M.
75
Klementsov, J.
74
Levy, R.
29
Koc, E.
45
Lewkowicz, P.
43
Köhler, C.
52
Leyland, A.
45
Konecna, H.
52
Li, C.
43
Kontic Vucinic, O.
70
Li, H.
48, 49
Kopcow, H.D.
47
Liberis, V.
63, 74
Kopjar, N.
54
Liehr, T.
65
Korennaya, V.
46, 59
Lilaia, C.
65
Kosar, S.
45, 46
Lima Silva, J.
48
Kosova, H.
60
Lima, J.
65
Kosturi, E.
66, 68
Lima, M.
45
Kotani, T.
48, 49, 69, 74
Lima, T.
66, 69
Kouloura, A.
58, 64
Lima-Silva, J.
48, 67, 69
Kovalev, M.
75
Lin, C.
43
Koyuncuoglu, M.
62
Lindenberg, S,.
23, 25
Kropiwnicka, Z.
66
Lindsay, R.S.
27
Krsmanovic, J.
67
Lisboa, J.C.
46, 47, 67, 69
Kuantan, P.
51
Lisi, F.
52
Kucera, R.
52, 53, 62, 63
Litvinenko, I.
75
Kucukyangoz, A.
59
Ljubic, A.
67
Kulabuchova, E.
46
Ljubic, V.
70
Kulakaç, Ö.
69
Lo, A.
47
Kumar, P.N.
44
Lobo, A.C.
66
Kumar, R.
45
Lobo, I.
47, 64, 68, 69
Kurashvili, J.
46
Lodhi, W.
46, 58, 59
Kurti, E.
63, 75
Long, L.
60
Kuruçirak, S.
69
Lopes, C.
72
Kuscu, E.
63
Lopes, F.
52
Kyvernitakis, I.
69
Lopes, H.
55, 63, 66
Lake, S.
62
Lopes, L.
57, 65
Lança, A.
65
Lopes, M.
49, 74
Landim, E.
56, 62, 43, 55, 73
Lopes, T.
51
Langer, R.
33
Lopez, B.
44, 52
Lanhoso, A.
48, 63
Lotan, M.
70
Lanowska, M.
52
Loucky, J.
52, 53
Laudanski, P.
55
Lourenco, A.
31
Laven, J.S.E.
38
Lourenço, C.
70, 53, 57
Leal, C.
44, 51, 52, 53
Louro, N.
51
VII
Lozano, M.
68
Marques, E.
65, 68
Ludlow, J.
71
Marques, J.P.
53, 59
Lugina, I.
46
Marsk, A.
68
Luis, A.
67, 68
Marta, E.
66
Luís, A.
64
Marta, S.
63, 71
Lukac, M.
67
Martel, F.
65
Luoto, R.M.
48, 59
Martinez, B.
52
Luz, R.
69
Martinho, F.
69
M Carvalho, R.
49
Martinho, M.
46
M. Bangal, V.B.
48
Martins, A.
33, 65
Macaes, A.
47
Martins, A.T.
67
Macedo, T.
47
Martins, C.
56, 70, 67
Machado, A.I.
20, 56, 58, 65, 68, 71
Martins, D.
47, 70
Machado, A.P.
65
Martins, F.
43, 57
Machado, H.
69
Martins, H.
46
Machado, L.
46, 56, 70
Martins, I.
65, 70
Machado, L.S.
55, 69
Martins, L.
70, 72
Machado, N.
66
Martins, L.G.
49
Machairiotis, C.
46
Mártires, F.
44
Machairiotis, N.Z.
46
Mascarenhas, M.R.
34
Mackie, A.
71
Mascarenhas, T.
31
Macklon, N.
22, 23, 29
Masliy, Y.
52
Madeira, L.
61
Massa, A.
49, 64, 67, 70, 73
Madureira, M.
67
Mathew, M.
49, 55, 56, 69, 70, 73
Magalhães, Â.
48
Matias, A.
28, 48, 72
Magalhaes, D.
62
Matias, J.
64, 65, 68
Magalhães, M.
69, 70
Matos, I.
69, 70
Magno, C.
64
Matos, T.
73
Mahomed, F.
63
Matsuda, K.
56, 75
Maia Jr., H.
43
Matsumoto, Y.
48, 68
Maia, C.
64, 69, 70
Maxia, N.
52
Maia, R.
43
McIntosh, C.
54
Majeed, G.
46
Md Arifin, N.
51
Mak, F.
48
Meireles, I.
46, 70
Makino, T.
29
Meisel, A.
52
Makris, G.M.
58, 64
Melania Rsouza, A.S.
47
Malafaia, S.
55, 57, 68
Melinda, L.
44
Malinowski, A.
43
Melo Castro, D.
46, 52
Manaj, A.
66, 68
Melo, A.
46, 72
Manarte, P.
68
Melo, Â.
70
Mandhan, P.
70
Melo, M.
70
Mangler, M.
52
Menaldo, G.
44, 52
Mano, Y.
48, 49, 69, 74
Mendes da Graça, L.
48, 49
Manoku, N.
43, 63
Mendes Graça, L.
71
Mansikkamäki, K.
59
Mendes, M.J.
72
Mansour, M.
64
Mendes, N.
56
Mansouri, M.Z.
60
Mendes, S.
61, 63
Manuaba, F.
45
Mendinhos, G.
54, 56, 75
Manusook, S.
73
Mendonça, R.
56, 69, 70
Many, A.
70
Menezes, I.
72
Mardesic, T.
52
Mercado-Velazquez, E.d.R.
55
Mårdh, P.
46
Mesquita Guimarães, J.
52
Mari, E.
58
Mesquita Pinto, R.
70
Maria Raul Neves, J.P.C.
45
Mesquita, M.
62
Marinho, C.
46, 54, 55, 56, 70
Mesquita, R.
48, 65, 69
Marini, G.
60, 61
Mesquita, R.M.
68
Marques, A.
52, 53
Mesquita, R.M.M.
49
Marques, C.
43, 56, 70, 72, 69, 63
Mesquita-Guimarâes, J.
44
VIII
Mesquita-Guimarães, J.
44, 51, 52, 53
Mulet, J.
54
Messina, M.
46
Munoz, E.
52
Metushi, S.
60
Munro, K.
58
Micallef Fava, A.
56
Murlewska, J.
27
Michaan, N.
70
Muruzabal, J.C.
20
Michaeli, M.
51
Musa, R.
51
Michelin Matheus, S.M.
60, 61
Myriokefalitaki, E.
62
Miguelote, R.C.
49
Na, Y.J.
57, 59
Miguelote, R.F.
48
Nadarajah, S.
44
Mijailovic Borlja, R.
70
Nadasan, V.
56
Mikkola, T.
59
Nakano, T.
48, 74
Milczek, T.
55
Nargund, G.
22, 23
Milewicz, T.
65
Narvekar, N.
44
Milewski, R.
75
Nascimento, J.
70
Milne, K.J.
60
Naujorks, A.
49
Mira Coelho, M.
60
Nazaré, A.
56, 54, 65, 73, 75
Mira, R.
60, 71
Ndoni, E.
49, 66
Miranda, A.
48, 70, 72
Negrão, L.
47, 61
Miranda, M.
54, 55, 56, 62
Nelson, S.M.
22, 38
Miranda, N.
69
Nércio, A.
53
Miranda, T.
66
Neto, S.
71, 73
Miskry, T.
58
Neto, V.
65
Mitre, A.
75
Neubauer, H.
46, 59
Mittal, M.
44
Neuman, M.
31
Miyamoto, K.
48, 68
Neves, J.P.
48
Miyamoto, T.
48, 68
Neves-e-Castro, M.
33
Mlinaric-Missoni, E.
54
Ng, N.
71
Mohamed, M.A.
62
Nicolaides, K.
48
Mohd Bustaman, S.K.
51
Nicolalde, A.
58
Mohd Yatim, H.
51
Nicoloso, L.H.
49, 74
Moita, B.
59, 62
Niklinski, J.
55
Monteagudo, A.
73
Nikolina Nicolaides, K.
49
Monteiro, A.
66
Nogueira, I.
67, 70, 73
Monteiro, I.
46, 57
Nogueira, M.
43, 61, 63, 64, 68
Monteiro, I.I.
59
Nogueira-Silva, C.
49, 65, 72
Monteiro, I.M.I.
59
Nonaj, B.
60, 63, 75
Montenegro, N.
48, 65, 67, 68, 69, 71, 72
Noruegas, M.J.
57
Monterroso, J.
72
Novikova, V.A.
48, 56
Montes, L.
73
Novotny, Z.
62, 63
Morais, C.
70
Nowak, M.
43, 62
Morais, M.J.
64, 69, 70
Nunes, C.
71, 46
Moreira, A.
69
Nunes, E.
57, 61
Moreira, C.
67, 71, 54, 66
Nunes, F.
56, 59, 43, 57, 66, 49, 61, 70, 72
Moreira, I.
65
Nunes, I.
71
Moreira, M.
72
Nunes, J.
45, 47
Morgado, A.
57, 63, 56, 70
Nunes, M.J.
71
Morozov, S.
75
Nygård, C.
59
Mota, F.
32, 43, 61
O’Connor, H.
48
Mota, L.
67, 54
Ohtake, N.
48, 68
Motamed, K.
43, 55
Okyay, E.
62
Moucho, M.
65
Olanovski, I.D.
48
Moura, P.
66, 68, 69, 70, 72
Olgan, S.
62
Mouraz, M.
49, 56, 61, 70, 72
Olgan, S.P.M.
47
Mourinha, V.
69
Olival, V.
71
Moutinho, O.
46, 47, 51, 52, 67, 69
Oliveira, A.
43
Mubbashir, S.
73
Oliveira, C.
68, 45, 46, 54, 70
Mueck, A.O.
24, 33, 34, 34, 46, 59
Oliveira, E.
60
Mukhammyatovich, S.S.
75
Oliveira, M.
54, 71, 73
IX
Oliveira, N.
56, 57, 67, 71, 54, 73
Pereira da Silva, D.
34, 20, 63, 64
Oliveira, P.
63, 67, 73
Pereira, A.P.
60, 65
Oliveira, P.N.
48
Pereira, H.
64, 69
Oliveira, T.
69
Pereira, I.
52, 70, 71
Oliveiros, B.
69
Pereira, I.I.
71
Olnowsky, I.
48
Pereira, J.P.
56, 62, 71, 56, 54
Onal, H.C.
63
Pereira, M.
65
Oncel, S.
71
Perzylo, K.
45
Ooki, S.
52
Pessegueiro, H.
66
Opara, E.
45
Pestana, I.
71, 46
Orazmuradov, A.
75
Petronijevic, M.
67
Orešcanin, V.
54
Petrovic-Raškovski, B.
54
Osório, F.
48, 53, 54, 57, 59
Phipps, H.
48, 71
Osório, M.
44, 53
Phoon, C.
52
Oyama, R.
48, 68
Piccione, E.
58
Ozge Okyay, E.
47
Piccoli Jr., A.L.
49, 74
P. Silva, D.
44
Piculo, F.
60, 61
Paavonen, J.
32
Pierdomenico, F.
70
Pacheco, A.
60
Pietropolli, A.
58
Pacu, I.
71
Pietrzik, K.
28
Pacu, I.C.
71
Pina, C.
48
Paez, M.C.D.
49
Pinelo, S.
53, 44
Page, A.
49, 71
Pinheiro, P.
62, 67, 73
Paiva, A.C.
74
Pinheiro, V.
64
Paiva, C.
45, 58, 63, 71
Pinho, M.
64, 69
Paixão, C.
56, 62
Pinho, M.d.L.
73
Pakhomov, S.
55, 68
Pinidis, P.
63, 74
Palacios, S.
33, 34
Pinto Leite, R.
52
Palha, J.
48
Pinto, A.
44, 48, 51, 52, 53
Palma, F.
64, 49, 65, 67, 70, 73
Pinto, A.R.
69
Paluka, E.
55
Pinto, C.L.
59
Pandravada, A.
45
Pinto, F.
72
Pandurangan, K.
46
Pinto, L.
71
Panoskaltsis, T.
64
Pinto, P.
73, 64, 69
Papaioannou, G.S.
48
Pinto, R.
57
Papatheodorou, A.
51
Pires, I.
53
Páramos, A.
69
Pires, I.C.
44
Pardal, C.
49, 62
Pires, M.J.
67
Pardal, F.
43
Pitynski, K.
65
Pascon Barbosa, A.M.
60, 61
Pizzato, P.
49, 74
Pasman, N.M.
48, 56
Plakhotna, O.
52
Passos, F.
48
Podzolkova, N.
46, 59
Patricio, L.
47
Policiano, C.
71, 72
Patrício, L.
71
Poljak, M.
32
Patrick, S.
73
Ponce, J.
20
Patrizio, P.
23, 38
Pongrojpaw, D.
73
Paul Stylianaki, A.
46
Poon, L.
27, 28
Paula, T.B.
46, 60
Portela, S.
52
Pavlovic Raicevic, M.
70
Postawski, K.
44
Paz, G.
44
Poulakaki, N.
64
Pedro, A.
56, 43, 54
Prapas, N.
51, 52
Pedroso, C.
43, 56, 70
Prapas, Y.
51
Pedroso, S.
49, 61
Prapas, Y.N.
52
Peixoto, F.
52
Prata, J.
57, 67, 73
Pelkic, K.
75
Prata, J.P.
62
Pena, J.
43, 61
Presl, J.
62, 63
Penzhoyan, G.A.
48, 56
Prifti, M.
55
Peralta, F.
62, 63
Proenca, S.
56
X
Proença, S.
49, 61, 70, 72
Ricardo, C.
53, 60
Publicover, S.
45
Richter, D.
62, 63
Puchkov, K.
46, 59
Rijo, C.
60, 61, 70
Puga, M.
47
Robalo, R.
56
Qirko (Cipo), M.
60, 75
Robson, G.
68
Qirko, R.
55, 60, 75
Robson, M.
36, 39
Quintas, A.
57
Rocha, A.
43
Radley, S.
61
Rocha, B.
72
Radzinsky, V.
75
Rocha, I.
63
Radzinsky, V.E.
59
Rocha, J.
72
Raitanen, J.
48, 59
Rocha, M.
43
Rajakumar, A.
47
Rocha, P.
47, 70, 71
Ramachandran, A.
44
Rocha, S.
72
Ramada, D.
68
Rocha, V.
70
Ramalhinho, A.C.
44
Rodrigues, A.
48, 54, 57, 59, 61, 71
Ramalho, C.
72
Rodrigues, A.I.
57, 63
Ramalho, G.
57
Rodrigues, C.
65, 47
Ramalho, R.
51, 66
Rodrigues, F.
49, 57, 58, 70, 72
Ramalho-Santos, J.
45, 53
Rodrigues, G.
67, 63, 65, 68
Ramilo, I.
56, 54, 75
Rodrigues, M.
72
Ramli, R.
51
Rodrigues, M.C.
65, 72
Ramos, R.
72
Rodrigues, R.
49, 56
Ramos, T.
74
Rodrigues, R.M.
74, 58
Ramos, U.
71
Rodrigues, T.
71
Ramos, V.
53, 59, 62, 68
Rokyta, Z.
62, 63
Raposo, L.
44
Romanek, K.
45
Raposo, S.
72
Romanek-Piva, K.
44
Rasteiro, C.
46, 56
Romão, F.
49, 54, 72, 74
Ray-Gaheer, N.
45
Rosado, V.
56, 57, 63
Rebelo, C.
57, 55, 68
Rosenblum, I.
44
Rebelo, J.
72
Rosenthal, A.
32
Rebelo, T.
64
Rosmaninho, A.
73
Redinger, D.
54
Ross, J.
48
Regalo, A.
60
Rostad, B.
53
Regedor, A.
68
Rotfarb, N.
51
Rego, J.
62, 63
Rowe, H.
74
Reis Correia, A.
63
Royle, C.M.
47
Reis, A.
57
Ruan, X.
34, 46, 59
Reis, A.P.
74
Rui Montenegro, N.
45
Reis, I.
45, 51, 62, 64, 67, 68, 71
Rujiwetpongstorn, J.
73
Reis, I.M.
61
Rumpik, D.
52, 53
Reis, J.
57
Rumpikova, T.
52, 53
Reis, J.L.
43
Rysak-Luberowicz, D.
55
Reis, M.I.
49, 56, 61, 70, 72
S, R.
46
Reis, M.I.B.
49
Sá, I.
74
Reis, S.X.
45
Sá, I.F.
48
Relph, S.
58
Sá, L.
63
Remesso, L.
46, 57, 73
Saatli, B.
62
Remohí, J.
52
Sahin Yilmaz, T.
53
Reyes-Muñoz, E.
72
Saleiro, M.
48, 66
Reynolds, A.
49
Saleiro, S.
43
Rezeberga, D.
58
Salgado, L.
61
Ribeiro Carvalho, F.
63
Salselas, A.
71
Ribeiro, C.
65
Salvado, R.
57
Ribeiro, D.
67
Samborskaya, N.
68
Ribeiro, R.
57, 65, 73
Sampaio, J.
55, 57, 68
Ribeiro, S.R.
45
Sampaio, M.M.
74
Ribeiro, V.
72, 49, 64, 67, 70, 73, 60, 63
Samsulhadi, W.
43
XI
Sanchez del Rio, Á.
20
Shpati, D.
60
Sanli, Y.
71
Shterev, A.
51
Santamaría Costa, J.
25, 30
Sidhu, H.
61
Santo, S.
20, 71
Siedentopf, F.
62
Santos Paulo, A.
60
Silva Morais, M.
73
Santos Pereira, H.
49, 56
Silva Pereira, J.
56, 55, 43, 54, 75
Santos, A.
49, 62, 67, 72, 73
Silva, A.
53
Santos, Â.
73
Silva, C.
57, 61, 63, 48, 74
Santos, A.C.
54, 71
Silva, F.
70, 57, 65
Santos, Â.C.
49
Silva, J.
69, 70, 45
Santos, A.V.
73
Silva, J.R.
53, 73
Santos, F.
73, 69
Silva, M.
65, 47, 46, 64, 69, 73, 71
Santos, J.
57, 70, 73, 45
Silva, P.
65, 47, 49, 64, 73, 46, 57, 67, 70, 68
Santos, L.
45
Silva, P.T.
55
Santos, M.
74, 57
Silva, R.
74
Santos, R.
48, 51
Silva, T.
57
Santos, R.L.
53
Simões, A.
58, 73
Santos, V.
43, 54, 66
Simoes, E.
34
Santoso, B.
43
Simões, J.
69
São José Pais, M.
72
Simões, M.
61, 70, 72
Saparamadu, P.
56
Simoes, M.P.
46
Sapra, E.
53, 74
Simoes, R.
49
Saraiva, J.
54, 48, 72, 70
Simoes, T.
39
Sardinha, R.
61, 64, 67, 73
Simon, C.
25, 30
Sardinha, T.
73
Simsek, E.
63
Sarkar, D.
49, 57
Sircar, S.
68
Sarmento, I.
55
Siristatidis, C.
58
Sarmento, R.
73
Sivashanmugarajan, V.
58
Savvas, M.
44
Skender, M.
70
Saygili, U.
62
Skouby, S.
24, 25, 33, 34
Scavuzzi, A.
65
Smirnova, Y.A.
56
Scavuzzi, A.A.
47
Smith, M.
62
Scavuzzi, A.F.
47
Soares, A.
47
Schei, B.
53
Soares, A.P.
45
Schmidt, L.
53
Soares, F.
55
Schmidt, R.
62
Soares, P.
48, 58
Schmidt, S.
69
Soares, P.R.
55
Schneck, H.
59
Solheiro, H.
57, 60
Schneider, A.
52
Song, Y.J.
57, 59
Scoccia, B.
62
Sonia, C.
58
Seabra, M.
65
Sophia, A.
68
Seeger, H.
46, 59
Sorokina, A.
59
Sender, A.
62, 63
Sorta Bilajac Turina, I.
46
Seremak-Mrozikiewicz, A.
73
Sotiropoulou, G.
46
Sereno, P.
54, 56, 63
Soummani, A.
61, 60
Serra Zantop, B.
37, 39
Sousa Pereira, E.
65
Serra, F.
61
Sousa Pereira, I.
53
Serra, H.
53
Sousa, A.
66
Serra, H.B.
44
Sousa, A.M.
65
Serrano, .
49
Sousa, A.P.
44, 53
Serrano, F.
36, 67, 72
Sousa, C.
47
Serrano, P.
58, 61, 62
Sousa, E.
43, 61, 63, 65
Serrano, S.
44
Sousa, E.S.
67
Setchall, T.
58
Sousa, F.
53, 56
Sheik, S.
49, 70, 73
Sousa, G.
63
Sheiner, E.
36, 37
Sousa, J.
43, 49
Shen, C.
44
Sousa, M.
45
Shkurti, E.
60, 75
Sousa, N.
48
XII
Sousa, R.
43, 57, 63, 64
Teixeira da Silva, J.
45
Sousa, S.
45, 47
Teixeira, Á.
43, 57
Sousa, V.
73
Teixeira, J.
72, 43, 57, 61, 63, 64
Sousa-Santos, R.C.
49
Teixeira, M.
57
Souza, A.S.
47, 65
Teixeira, N.
49, 57, 72, 74
Speiser, D.
52
Teles, M.L.
58
Staines Urias, E.S.
49
Telles, M.L.
55
Stajic, D.
75
Teodorescu, C.
54
Staley, S.
73
Thadhani, R.I.
47
Starceva, N.
75, 55
Thalia Xenophontos, M.
43
Startseva, N.
75
Thornhill, A.R.
45
Stefanovic, T.
70
Thoukididou, S.
44
Stepanov, A.
46
Ticconi, C.
58
Stetkiewicz, T.
62
Tilly, J.
30
Stikin, Y.
75
Timor-Tritsch, I.
73
Stoebel-Richter, Y.
62
Tinoco, D.
58
Studd, J.
33, 34
Tinoco, L.
58
Subba, B.
46
Tinoco, R.
58
Sudoma, I.
52
Tiyayon, J.
63
Suga, M.
48, 68
To, W.K.W.
47
Sukhatme, V.P.
47
Toci, E.
63
Sultan, C.
24
Toller, A.
65
Sumigama, S.
69, 74
Tomás, C.
74
Sundby, J.
53
Tomas, E.
59
Susanto, E.
43
Tong, S.
62
Sutchritpongsa, P.
60
Topolcan, O.
52, 53, 62, 63
Suthiwartnarueput, W.
73
Torcida Gonzalez, M.E.
55
Suwannarurk, K.
73
Torgal, A.
54, 55, 61
Svobodova, S.
62
Torgal, I.
43, 53, 55, 59, 61, 62, 64
Swiatecka, J.
75
Torgal, M.
49
Sylvestre, G.
74
Torrão, M.M.
65
Szirko, F.
74
Torres, I.
73
Szpakowski, M.
43
Torres, R.
43, 63, 67, 70
Szyllo, K.
43
Torres, S.
54
Taboas, E.
52
Trebesch de Perez, I.
52
Tagle, I.
68
Treska, E.
75
Takahashi, Y.
74
Trieu, V.
43, 55
Takaoka, A.
48, 68
Tsafrir, Z.
70
Tam, G.
64
Tsar, O.
56, 58
Tammemae, L.
74
Tsar, O.M.
51
Tammiste, T.
74
Tsikouras, P.
63, 74
Tan, H.
44
Tsuda, H.
69, 48, 49, 74
Tan, W.W.
52
Uccella, S.
25, 26
Tang, C.
56
Uchil, D.
67
Tania, F.
57
Ureyen, E.
59
Tarelho, A.
65
Urmi Kreatsas, M.
44
Tasha, I.
63
Urzal, C.
64
Tasha, I.K.
43
Uzgoren, E.
59
Tavares Izzo, I.
55
Vaidakis, D.
58, 64
Tavares, A.
44, 53
Valadares, S.
43, 54, 63
Tavares, I.
58
Valdoleiros, S.
74
Tavares, M.
66
Vale Fernandes, E.
49, 58, 62
Tavares, R.
45, 53
Vale, E.
57, 74
Tavares, R.B.
45
Vale, N.
45
Tavo, V.
63
Vale-Fernandes, E.
72
Tchorzewski, H.
43
Vali, S.
45, 58
Tegan, E.
54
Vanessa Santos, A.
54
Teichmann, A.T.
63, 74
Varela, M.G.
55
XIII
Vasaraudze, I.
58
Vilhena, C.
49, 54, 74
Vasco, E.
66
Virtanen, S.M.
48
Vasconcelos, C.
58, 73
Viseu, O.
68
Vasiljeva, J.
52
Visser, G.H.A.
27, 28, 36
Vassallo, J.
59
Vizcaíno, R.
57
Vassallo, M.C.
51
Von Tempelhoff, G.
63, 74
Vassena, R.
30
Vrancic, S.
44
Vata, E.
60, 75
Vrzalova, J.
62, 63
Vaz De Macedo, C.
49
Vrzic Petronijevic, S.
67
Vaz, I.
71
Walker, S.
46
Veca, P.
65
Watanabe, Y.
48, 49, 69, 74
Vedmedovska, N.
35
Wattiez, A.
47
Vella, K.
51, 56
Weissman, A.B.
48
Ventolini, G.
43
Wilby, K.J.
74
Vercuni, D.
55
Wilczynski, J.R.
43, 62, 75
Verissimo, C.
49, 53, 54
Wilde, C.
60
Veríssimo, R.
70, 73
Wolczynski, S.
75
Verwoerd, G.
53
Wolff, L.P.
59
Veujoz, M.
47
Wolter, K.
24
Vian, I.
74
Wong, W.
56
Viana, J.
60, 69
Xercavins, J.
20
Viana, P.
45
Xhani, A.
63
Viana, R.
61, 70
Yalcin, G.
55
Vicente, A.
43, 57, 61, 63, 64, 65, 67, 68
Yalcinkaya, C.
63
Vide Tavares, M.
43
Yangin, H.B.
58
Vides, B.
43, 48, 72
Yesiltepe Oskay, U.
53
Vieira Cunha Rudge, M.
60, 61
Yildiz, Y.
46
Vieira de Castro, P.
61
Yoong, W.
46, 58, 59
Vieira, B.
57, 64, 66, 74
Yoshida, L.
54
Vieira, S.
63
Yu, S.S.
52
Vilar Soares, S.
58, 74
Yuksel Simsek, S.
63
Vilas Boas, A.
67
Zacharopoulou, C.
47
XIV
Notes
L i s b o n
Portugal
November
8-11, 2012
-94-
WOMN-1041133-0000
Nome do Medicamento e Forma Farmacêutica: Zoely 2,5 mg/1,5 mg comprimidos revestidos por película. Composição Qualitativa e
Quantitativa: cada comprimido contém 2,5 mg de acetato de nomegestrol e 1,5 mg de estradiol. Indicações terapêuticas: Contracepção.
Posologia e modo de administração: tomar um comprimido por dia durante 28 dias consecutivos. O blister seguinte é iniciado imediatamente
após o final do blister anterior, sem qualquer intervalo na toma do comprimido diário e independentemente da presença ou ausência de
hemorragia de privação. Os comprimidos devem ser tomados todos os dias aproximadamente à mesma hora independentemente das refeições.
Os comprimidos devem ser tomados com um pouco de líquido de acordo com a necessidade, e pela ordem indicada no blister. Advertências
e precauções especiais de utilização: patologias circulatórias; tumores; outras situações tais como as mulheres com hipertrigliceridemia
ou antecedentes familiares relacionados, hipertensão mantida clinicamente significativa, icterícia e/ou prurido relacionados com colestase,
litíase biliar, porfíria, lúpus eritematoso sistémico, síndrome urémica hemolítica, coreia de Sydenham, herpes gestacional e perda de audição
relacionada com otoesclerose, angioedema hereditário, alterações agudas ou crónicas da função hepática, diabetes, agravamento da depressão,
doença de Crohn, colite ulcerosa, cloasma, doentes com problemas hereditários raros de intolerância à galactose, deficiência de lactase ou máabsorção de glucose galactose, não devem tomar este medicamento. Antes de se iniciar ou re-instituir a utilização do COC deve ser feita uma
história clínica completa (incluindo antecedentes familiares) e excluir a possibilidade de gravidez. As mulheres devem ser informadas que os
contracetivos orais não protegem contra as infeções por VIH (SIDA) ou outras doenças sexualmente transmissíveis. A eficácia dos COCs pode
ser reduzida em situações como, por exemplo, esquecimento de comprimidos, perturbações gastrointestinais durante a toma de comprimidos
ativos ou uso concomitante de medicamentos. Interacções medicamentosas e outras formas de interacção: Medicamentos indutores
enzimáticos. Não foram realizados estudos de interação medicamentosa com Zoely, mas foram realizados dois estudos com rifampicina e
cetoconazol, respetivamente, com uma associação de alta dosagem de acetato de nomegestrol e estradiol (acetato de nomegestrol 3,75 mg
+ estradiol 1,5 mg) em mulheres pós menopáusicas. O uso concomitante de rifampicina diminui a AUC0-∞ do acetato de nomegestrol em 95
% e aumentou a AUC0-tlast do estradiol em 25 %. O uso concomitante do cetoconazol (200 mg em dose única) não modifica o metabolismo do
estradiol enquanto foram observados aumentos na concentração máxima (85 %) e na AUC0-∞ (115 %) do acetato de nomegestrol, os quais não
tiveram qualquer relevância clínica. São esperadas conclusões similares em mulheres em idade fértil. Os CO podem afetar o metabolismo de
outros medicamentos. Deve ser dada especial atenção à interação com lamotrigina; a utilização de contracetivos esteroides pode influenciar
os resultados de certas análises laboratoriais, incluindo os parâmetros bioquímicos das funções hepática, tiroideia, supra-renal e renal, os
valores plasmáticos das proteínas (de transporte), parâmetros do metabolismo dos hidratos de carbono, de coagulação e fibrinólise. Efeitos
indesejáveis: Muito frequentes acne; hemorragia de privação anormal. Frequentes libido diminuída, depressão do humor/humor deprimido,
humor alterado; cefaleia, enxaqueca; náusea; metrorragia, menorragia, dor mamária, dor pélvica; peso aumentado Pouco frequentes apetite
aumentado, retenção de líquidos; rubor quente; distensão abdominal; hiperhidrose, alopécia, prurido, xerose cutânea, seborreia; sensação
de peso; hipomenorreia, tumefacção mamária, galactorreia, espasmo uterino, síndrome pré-menstrual, massa da mama, dispareunia, secura
vulvovaginal; irritabilidade, edema; enzima hepática aumentada. Titular da Autorização de Introdução no Mercado: Theramex S.r.l., Via
Messina 38, 20154 Milano, Itália. Data de Revisão do Texto: 08/2012 Informação pormenorizada sobre este medicamento está disponível na
Internet no site da Agência Europeia de Medicamentos: http://www.ema.europa.eu Medicamento sujeito a receita médica. Medicamento não
comparticipado. Para mais Informações deverá contactar o titular da autorização de introdução no mercado ou o seu representante
local, Schering-Plough Farma, Lda.
Merck Sharp & Dohme, Quinta da Fonte, 19 - Edifício Vasco da Gama,2770-192 Paço de Arcos
www.msd.pt | www.univadis.pt | NIPC 500 191 360 | Linha Verde 800 20 25 20
Todos os direitos reservados.
Uma combinação única de
hormonas, feita para ela.1
1. The European Journal of Contraception and Reproductive Health Care,
December 2010;15(S2):S12–S18
-95- deverá contactar o titular da AIM ou o seu representante local.
Medicamento não comparticipado. Medicamento sujeito a receita médica. Para mais informações
Lisbon, Portugal,
Portugal
November 8-11, 2012
CongressMed | 20 Lincoln Street | Tel Aviv 67134 | Israel
Controversies
Debates & Consensus
Tel. +972-73-7066950 | Fax. +972-73-7066959
[email protected] | www.congressmed.com/cogiLisbon

Lisbon - CongressMed

Transcrição

Documentos relacionados

Curriculum Vitae October 2014

Programa preliminar

- Escola Superior de Enfermagem do Porto

here - Uninova

slow roads! - Tamlyn

Hyphenations: The Other Lives of Feminist and

Robin Hood versus Piggy Bank: Income

Read more

PROGRAM - Uninova

CURRICULUM VITAE

2015 10th Iberian Conference on Information

View PDF

Building on Faults - médialab Sciences Po

São Paulo

Scientific Report 2015 - Instituto de Medicina Molecular

A Cost Analysis of Colposcopy following Abnormal Cytology in Post

Inverno 2013 - Massachusetts Alliance of Portuguese Speakers

Apresentação 1 - Sociedade Portuguesa de Psicologia da Saúde

Full text for subscribers

Infertility and Inherited Thrombophilia

Livestock and Poultry: Estrus Synchronization

A PASSION SERVE